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Abstract
This thesis set out to consider risk factors, in isolation and in combination, for
symptomatic and asymptomatic Peripheral Arterial Disease (PAD), which unlike
Coronary Heart Disease, has not been undertaken in a sample from the general
population aged 55 - 74 years.
PAD shares a common aetiology with coronary heart disease and so it would
be expected that these two conditions would have similar risk factors. Study of the
risk factors for peripheral arterial disease would therefore shed light on important
factors for atherosclerosis in general and hence is relevant to millions in the Western
world suffering from atherosclerosis. The main difference in relative importance of the
risk factors appears to be that smoking is a more important risk factor for peripheral
arterial disease than coronary heart disease.
The risk factors were considered in a hierarchy with health related behaviours
or lifestyle factors such as diet and physical activity preceding the intermediate factors
such as blood viscosity and fibrinogen. Each set of risk factors was considered
separately, followed by consideration of the two clusters of lifestyle and intermediary
factors. Finally, all factors were analysed simultaneously. Social class was strongly
related to many of the lifestyle and intermediary factors.
The results showed that the risk factors in relationship to the Ankle Brachial
Pressure Index (ABPI), an indicator of the extent of asymptomatic and symptomatic
PAD, differed for men and women and for smokers and non-smokers. In women
smoking was the main risk factor, while blood viscosity and fibrinogen although
univariately related to the ABPI, were not independent risk factors.
In men who had never smoked, nonHDL cholesterol and diabetes were the
important risk factors. In men who had ever smoked there were synergistic effects of
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smoking on the relationships between the ABPI and fibrinogen, blood viscosity, leisure
activity, and energy adjusted vitamin C. Other independent risk factors for men who
had ever smoked were diabetes, social class, nonHDL and HDL cholesterol. This
suggests that in considering arterial disease, analyses should be carried out separately
for men and women and perhaps for smokers and non-smokers.
These results indicated that some health education programmes could be aimed
at specific groups, such as female smokers. On the other hand dietary programmes to
reduce cholesterol level could be aimed at the general population.
Finally, the calculation of power and sample size for epidemiological studies
showed that the simple two group comparison calculations generally used
underestimated the sample size required v/hen adjusting for numerous confounders and
when subgroup analyses are likely, as in a cross-sectional study.
iii
Acknowledgements
I would like to thank Dr R.J. Prescott for his help and guidance in the
preparation of this thesis. I would also like to thank Dr F.G.R. Fowkes for giving
access to the data collected for the Edinburgh Artery Study, and for his contribution
to the papers which developed from the analysis of this data. Those who also
contributed their particular expertise to these papers were Maijory Thomson, in the
diet paper, Dr G.C. Leng in the exercise paper, Dr G.D.O. Lowe in the rheological
and blood pressure papers, Dr. I.J. Deary in the personality paper, and Dr J.M. Connor
in the genetics papers. I would also like to thank those involved in the collection and
measurement of the data in the Edinburgh Artery Study, namely, J. Dunbar, A.
Rattray, E. Cawood, E. Kerracher, M. Apps, and F. Smith. Mr Juan-Hua Mao shared
his experience in the use of the Statistical/Graphics computer package S. Finally, I
would like to thank Sandra Watson for her support and encouragement in the final









1.2 Aims and Objectives 1
1.3 Plan of Thesis 1
CHAPTER 2 : BACKGROUND TO THE EDINBURGH ARTERY STUDY
2.1 Cross-sectional study 4
2.1.1 Study Population 4
2.1.2 The Questionnaire 7
2.1.3 The Clinical Examination 10
2.2 Case-Control study 15
2.2.1 Cases 15
2.2.2 Controls 16
2.2.3 Statistical Methods 16
v
CHAPTER 3 : DIET
3.1 Introduction 17
3.2 Dietary survey methodology 19
3.3 Methods 22
3.3.1 Statistical Methods 22
3.3.2 Total Energy Intake 23
3.4 Results 25
3.5 Discussion 31
3.5.1Bias in regression coefficients due to measurement error 31
3.5.2 Dietary risk factors 33
CHAPTER 4 : PHYSICAL ACTIVITY
4.1 Introduction 37
4.1.1 Physical Activity and Ischaemic Heart Disease 37
4.1.2 Physical Activity and Peripheral Arterial Disease 38
4.1Methods 39
4.2.1 Physical Activity vs Physical Fitness 39
4.2.2 Measurement of Physical Activity 39




CHAPTER 5 : PERSONALITY
5.1 Introduction 49
5.2 Methods 51
5.2.1 Measurement of personality 51
5.2.2 Statistical methods- Principal Components Analysis 53
5.3 Results 56
5.3.1 The Bortner Inventory 56
5.3.2 The Bedford-Foulds Questionnaire 60
5.4 Discussion 62
CHAPTER 6 : RHEOLOGICAL FACTORS
6.1 Introduction 64
6.2 Methods 66
6.2.1 Measurement of Rheological Factors 66
















CHAPTER 8 : FIBRINOGEN HAPLOTYPE
8.1 Introduction 95
8.2 Methods 98
8.2.1 Measurement of fibrinogen and fibrinogen haplotypes 98
8.2.2 Statistical Methods 99
8.3 Results 102
8.3.1 Plasma fibrinogen and fibrinogen haplotypes 102
8.3.2 Fibrinogen haplotypes as risk factors 107
8.4Discussion Ill
viii




9.3.1 Lifestyle factors 116
9.3.2 Intermediary factors 122
9.3.3 Lifestyle and Intermediary factors 126
Females 126
Males who had ever smoked 129
Males who had never smoked 131
9.4 Summary 133
ix
CHAPTER 10 : POWER AND SAMPLE SIZE ESTIMATION IN
EPIDEMIOLOGICAL STUDIES
10.1 Introduction - terminology 135
10.2 Power for Continuous Outcomes 136
10.2.1 Pearson correlation coefficient 136
10.2.2 Partial correlation coefficient 139
10.2.3 Multiple Linear Regression 141
10.2.4 Generalised Linear Models 148
10.3 Power for binary outcomes 150
10.3.1 k independent 2x2 tables 150
10.3.2 Logistic regression 153
10.4 Sample size for continuous outcomes 157
10.4.1 Pearson correlation coefficient 157
10.4.2 Multiple linear regression 158
10.4.3 Generalised linear models 161
10.5 Sample size for binary outcomes 162
10.5.1 k 2x2 independent tables 162
10.5.2 Logistic regression 163
10.6 Sample size and measurement error in dietary studies 166
10.7 Discussion 167
10.7.1 Continuous outcomes 167
10.7.2 Binary outcomes 168
10.7.3 Multiple testing 168
10.7.4 Software 168
x
CHAPTER 11 : DISCUSSION
11.1 Introduction 170
11.2 Analysis of individual risk factors 170
11.2.1 Diet 170
11.2.2 Leisure activity 173
11.2.3 Personality 175
11.2.4 Rheological factors 177
11.2.5 Diabetes 179
11.2.6 Cholesterol 179
11.2.7 Social Class 182
11.3 Analysis of all Risk Factors 184
11.3.1 Females 184
11.3.2 Males who never smoked 185
11.3.3 Males who had ever smoked 185
11.4 Recommendations 190
11.4.1 Questionnaire design 190
11.4.2 Sample size and power 191
11.4.3 Within-person measurement error 192
11.5 Future Research 192
11.5.1 Implications for prevention 192
11.5.2 Implications for treatment 195
11.6 Summary 195
References 196
Appendix 1: The Edinburgh Artery Study Questionnaire
Appendix 2: Published Papers
xi
List of Tables
Table 2.1 Age-sex distribution in the Edinburgh Artery Study 6
Table 2.2 Social Class (OPCS 1980) distribution in the Edinburgh Artery Study . 6
Table 2.3 Prevalence of Ischaemic Heart Disease in the Edinburgh Artery Study . 8
Table 2.4 Overlap of IHD and PAD in the Edinburgh Artery Study 14
Table 3.1 Medians and upper and lower quartiles of absolute nutrient intake and as a
percentage of energy in males and females aged 55-74 years in the Edinburgh Artery
Study 26
Table 3.2 Age-adjusted mean (se) ABPI by frequency of individual food consumption
in females in the Edinburgh Artery Study 27
Table 3.3 Age-adjusted mean (se) ABPI by frequency of individual food consumption
in males in the Edinburgh Artery Study 28
Table 3.4 Multiple linear regression of age, sex, height, smoking and energy adjusted
nutrients on the ABPI in the Edinburgh Artery Study 30
Table 4.1 Percentages (n) of men and women taking part in leisure activity when aged
35-45 years in the Edinburgh Artery Study 42
Table 4.2 Spearman Rank Correlations of Leisure Activity aged 35-45 years with the
ABPI and risk factors for Peripheral Arterial Disease in males and females ... 43
Table 4.3 Mean (se) ABPI by degree of Leisure Activity aged 35-45 years in males
and females 44
Table 4.4 Results of multiple regression of leisure activity aged 35-45 on the ABPI
46
Table 5.1 Principal components analysis and relationship to the Bortner scale . . 56
Table 5.2 Varimax rotated principal component loadings and correlations with the
ABPI 57
xii
Table 5.3 Mean (se) Bortner scores and first four Principal Components in relation to
severity of peripheral arterial disease 59
Table 5.4 Mean (se) levels of Bedford-Foulds scales in Intermittent Claudicants and
others 60
Table 5.5 Logistic regression on Intermittent Claudication 61
Table 6.1 Spearman Rank Correlations between rheological variables 69
Table 6.2 Differences in mean (se) levels of rheological variables in men and
women 70
Table 6.3 Trends in mean (se) of rheological variables in females across categories of
peripheral arterial disease 71
Table 6.4 Trends in mean (se) of rheological variables in males across categories of
peripheral arterial disease 72
Table 6.5 Results of multiple linear regression of rheological factors on the ABPI73
Table 6.6 Odds ratios of intermittent claudication unadjusted and adjusted for all
factors 75
Table 7.1 Multiple regression of rheological factors on systolic blood pressure in
females (Adjusted R2 = 16.5%) 83
Table 7.2 Multiple regression of rheological factors on diastolic blood pressure in
females (Adjusted R2 = 6.8%) 84
Table 7.3 Multiple regression of rheological factors on systolic blood pressure in
males (Adjusted R2 = 16.4%) 85
Table 7.4 Multiple regression of rheological factors on diastolic blood pressure in
males (Adjusted R2 = 13.3%) 86
Table 7.5 Summary of multiple linear regressions on systolic and diastolic pressure
in males and females 87
xiii
Table 7.6 Standardised coefficients for canonical variables for systolic and diastolic
blood pressure in females 88
Table 7.7 Standardised coefficients of canonical variables for risk factors in
females 89
Table 7.8 Standardised coefficients for canonical variables for systolic and diastolic
blood pressure in males 90
Table 7.9 Standardised coefficients of canonical variables for risk factors in male£l
Table 8.1 Characteristics of cases and controls 102
Table 8.2 Comparison of observed genotype numbers to those expected from Hardy-
Weinberg equilibrium 103
Table 8.3 Combinations of genotypes to form haplotypes in cases and controls
combined 104
Table 8.4 Plasma fibrinogen level by fibrinogen genotype 105
Table 8.5 Plasma fibrinogen level (adjusted by age, sex and smoking ) by
haplotype 106
Table 8.6 Distribution of genotypes in cases and controls 107
Table 8.7 Distribution of haplotypes by cases and controls 108
Table 8.8 Univariate and Multivariate logistic regressions of fibrinogen haplotypes,
cigarette smoking and plasma fibrinogen, adjusted for age and sex on peripheral
arterial disease 109
Table 8.9 Univariate and multivariate logistic regressions of p-fibrinogen genotypes,
cigarette smoking and plasma fibrinogen, adjusted for age, and sex on peripheral
arterial disease 110
Table 9.1 Trend in mean (se) ABPI and lifestyle risk factors for peripheral arterial
disease by social class in females 117
xiv
Table 9.2 Trend in mean (se) ABPI and lifestyle and hostility risk factors for
peripheral arterial disease by social class in males 118
Table 9.3 Multiple regression of lifestyle factors on the ABPI in males and females
(adjusted for all lifestyle factors) 120
Table 9.4 Relationship between social class and lifestyle factors in males in multiple
linear regression on the ABPI 121
Table 9.5 Trend in mean (se) ABPI and intermediary risk factors for peripheral arterial
disease by social class in females 123
Table 9.6 Trend in mean (se) ABPI and intermediary risk factors for peripheral arterial
disease by social class in males 124
Table 9.7 Multiple regression of intermediary factors on ABPI x 100 in males and
females (adjusted for all intermediary factors) 125
Table 9.8 Multiple regression of all factors on ABPI x 100 in females (n = 783)127
Table 9.9 Multiple regression of all factors on ABPIxlOO in males who ever smoked
(n = 568) 130
Table 9.10 Multiple regression of all factors on ABPI x 100 in males who never
smoked (n = 224) 132
Table 10.1 Pearson Correlations of the ABPI and smoking with risk factors for
peripheral arterial disease 138
Table 10.2 Power (%) to detect p with sample size n at a = 0.05 139
Table 10.3 Approximate power (%) with number of variables p = 4 from tables of
Gatsonis and Sampson (1989) at 5% significance level 143
Table 10.4 Power (%) for partial multiple correlation coefficient with pt = 1 . 144
Table 10.5 Power (%) for partial multiple correlation coefficient for u = 1 variable of
interest adjusting for w = 4 covariates from the tables of Cohen (1988) 146
xv
Table 10.6 Calculation of estimated sample size using Gail's (1973) method with data
from the Edinburgh case-control study 152
Table 10.7 Power (%) according to Gail (1973) for 8 strata and 1 stratum
(unadjusted) 152
Table 10.8 Power (%) for adds ratios of 1.5 and 2.0 from tables of Hsieh (1989)155
Table 10.9 Sample size estimation for Pearson Correlation Coefficient (p) for a = 0.05
and power = 80%, 90% and 95% 157
Table 10.10 Sample size estimates from Gatsonis and Sampson (1989) with p = 20
158
Table 10.11 Sample size with one variable of interset (pj = 1) adjusting for 20
covariates ( p - Pi = 20), a = 0.05 159
Table 10.12 Sample size for various Pyxica adjusting for w = 20 covariates with u =
1 variable of interest, with significance level a 160
Table 10.13 Comparison of estimated sample size unadjusted and adjusted for two
covariates 163
Table 10.14 Estimates of sample size for logistic regression (Hsieh 1989) (a = 5%
one-tailed) 164
Table 10.15 Estimates of sample size for logistic regression (Hsieh 1989) with OR =
1.5 and range of values of MCC of the covariates 165
xvi
List of Figures
Figure 2.1 Distribution of a) Packyears and b) Alcohol in the Edinburgh Artery
Study 9
Figure 2.2 Distribution of the ABPI in the Edinburgh Artery Study 12
Figure 2.3 Distribution of Peripheral Arterial Disease in the Edinburgh Artery
Study 13
Figure 4.1 Trends in mean (± 2 se) ABPI by degree of leisure activity aged 35 - 45
in (a) females and (b) males 45
Figure 9.1 Relationship between blood viscosity and extent of leisure activity aged 35-
45 128
Figure 11.1 Relationships between Dietary Cholesterol, Saturated fat, and the ABPI
in male non-smokers 180
Figure 11.2 Risk factors for women in the Edinburgh Artery Study 185
Figure 11.3 Relationship between risk factors for Peripheral Arterial Disease in males
who had ever and who had never smoked 187
Figure 11.4 Possible mechanism of relationships between cigarette smoking, Vitamin




Donnan P.T., Thomson M., Fowkes F.G.R., Prescott R.J., Housley E. (1993) Diet as
a risk factor for peripheral arterial disease in the general population: The Edinburgh
Artery Study. Am J Clin Nutr 57, 917 - 21.
Connor J.M., Fowkes F.G.R., Wood J., Smith F.B., Donnan P.T., Lowe G.D.O. (1992)
Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 29,
480-482.
Fowkes F.G.R., Connor J.M., Smith F.B., Wood J., Donnan P.T., Lowe G.D.O. (1992)
Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 339, 693 - 696.
Lowe G.D.O., Fowkes F.G.R., Dawes J., Donnan P.T., Lennie S.E., Housley E.
(1993). Blood viscosity, fibrinogen and activation of coagulation and leucocytes in
peripheral arterial disease; The Edinburgh Artery Study. Circulation 87, 1915 - 20.
Abbreviations
ABPI Ankle Brachial Pressure Index




FFQ Food Frequency Questionnaire
GLM Generalised Linear Models
HDL High density lipoprotein
IC Intermitttent Claudication
IHD Ischaemic Heart Disease
MI myocardial infarction




PAD Peripheral Arterial Disease
PCA Principal Components Analysis
PV Phenotypic Variability
RFLP Restriction Fragment Length Polymorphism
SD Standard Deviation
se standard error
SHHS Scottish Heart Health Study






Research into arterial disease has tended to concentrate on coronary heart
disease and stroke because of their high morbidity and mortality. Arterial disease of
the lower limbs has largely been ignored in epidemiological studies, even though it
is an important source of morbidity in the general population especially among those
over 55 years (Fowkes 1988c). In addition, study of risk factors for peripheral arterial
disease could shed light on coronary artery disease as these conditions share a
common aetiology.
1.2 Aims and Objectives
The main aim of this thesis is to assess risk factors in isolation and in
combination for symptomatic and asymptomatic Peripheral Arterial Disease in the
general population of Edinburgh aged 55 - 74 years. The term risk factor can have a
number of interpretations. This thesis uses the term to mean an attribute or exposure
that is associated with an increased probability of peripheral arterial disease as
outcome. This implies that a risk factor is not necessarily causal, but may be a risk
marker (Abrahamson 1988).
1.3 Plan of the Thesis
In order to meet this aim the analysis of peripheral arterial disease was
assessed using data from the Edinburgh Artery Study (Fowkes et al 1991). The Case-
Control study used a subset of the population from the main cross-sectional study and
the background to both these studies is described in chapter 2.
For the purposes of this analysis risk factors can be approximately grouped into
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two clusters, that is, lifestyle and personality factors, and intermediary factors. Under
the umbrella of the term intermediary were included rheological and lipid risk factors.
Lifestyle or health behaviour factors included diet, leisure activity, smoking and
alcohol. Lifestyle factors influence rheological factors and plasma lipid levels which
in turn are risk factors for arterial disease. In this sense, lifestyle factors precede or
influence the lipids and rheological factors (intermediary), which may be considered
to be more directly related to peripheral arterial disease. On this basis, the lifestyle
factors in relation to disease are assessed in the next three chapters, dietary factors in
chapter 3, followed by the relationship of leisure activity when aged 35-45 to current
disease status in chapter 4, and finally, the role of personality, especially measures of
hostility in chapter 5.
The next step is concerned with the effect of rheological factors and these are
analysed in chapter 6. There is evidence that lifestyle factors such as exercise are
related to the resistance to flow of blood or viscosity (Ernst 1985) which in turn may
be related to arterial disease status. As blood pressure is also a risk factor for arterial
disease (MacMahon et al 1990) as well as directly and indirectly part of the outcome
measures it is difficult to assess the role of blood pressure in relation to peripheral
arterial disease. Chapter 7 considers the relationship between rheological variables and
systolic and diastolic blood pressure and thereby relates blood pressure indirectly to
peripheral arterial disease through the rheological factors.
Plasma fibrinogen is an important risk factor for atherosclerosis and it is not
clear whether smoking or genetic factors are the cause of raised levels in the general
population. The role of fibrinogen haplotype in determining the level of serum
fibrinogen is considered in chapter 8. In addition, fibrinogen haplotype as a risk factor
independently of serum fibrinogen level is examined. This analysis used data from the
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case-control study which is a subset of the Edinburgh Artery Study and therefore the
sample size was very much smaller.
Chapter 9 brings together the simultaneous consideration of all risk factors to
assess the relative importance of risk factors and their independent relationship to
peripheral arterial disease. Since social class may be related to atherosclerosis it is
introduced in this chapter and the relationship between social class and other risk
factors is also examined.
Having examined the role of risk factors in relation to peripheral arterial
disease chapter 10 turns to the problem of estimating power and sample size in
epidemiological studies with specific examples from the Edinburgh Artery study to
illustrate the procedures discussed.
Finally, chapter 11 discusses the results from previous chapters focusing on the
independence of risk factors for peripheral arterial disease and presents some
implications of these results.
3
CHAPTER 2
BACKGROUND TO THE EDINBURGH ARTERY STUDY
2.1 CROSS-SECTIONAL STUDY
2.1.1 Study Population
The population for the cross-sectional study in 1988 consisted of the men and
women of Edinburgh aged 55 to 74 years. Ten general practices with catchment
populations spread geographically and socioeconomically throughout the city were
chosen and an age stratified random sample was selected from the age-sex registers
of these practices. The sample size of approximately 1500 was estimated on the basis
of the number required to conduct a subsequent follow-up study. In order to produce
at least 1500 participants, 272 subjects were selected from each practice; 34 males and
34 females from each five year age band. General practitioners reviewed lists of their
patients selected for the study and excluded those who had severe mental illness or
terminal disease, those who had moved from the practice or those who had died.
These exclusions were replaced by other randomly sampled patients.
The study was publicised in the local media and letters of invitation signed
jointly by the study director and a partner in each general practice were sent to the
subjects inviting them to attend a university clinic for a medical examination. An
examination at home was available for those who had difficulty in attending the clinic.
Letters returned by the post office were replaced with invitations to other randomly-
sampled patients. An appointment, map, and details of the examination were sent to
those who agreed to take part in the study. Nonresponders were sent a second letter
of invitation. Respondents who did not attend were offered another appointment,
usually by telephone.
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Approximately 20% of subjects in each practice who did not respond or attend
were randomly selected for follow-up. Each was sent a letter enclosing a short
questionnaire. Subjects not returning the questionnaire were telephoned or visited at
home on up to three occasions at different times of the day and evening.
Out of the 2720 subjects aged 55-74 years selected from the age-sex registers,
19% were subsequently replaced; 13% had been excluded by general practitioners and
6% had invitation letters returned by the Post Office. Invitations were finally sent to
2709 subjects of whom 1592 attended for examination, which gave a crude response
rate of 59%. The follow-up of the random sample of nonresponders showed that 19%
had moved and 3% were dead or in hospital. Extrapolation of these results to the
whole sample suggested that the response rate of those receiving an invitation was
65%.
The responders were reasonably typical of the target population. The crude
response rate did not differ substantially by age or sex, although there was some
under-representation of women aged 70-74 years and males aged 55-59 years who
comprised 21.3% and 22.5% (instead of 25%) of women and men respectively (Table
2.1). The social class distribution of responders (Table 2.2) was similar to that of
Edinburgh adult residents in the 1981 census except that the responders contained
fewer social classes IV and V (13% compared to 19%). The crude response rate varied
between the ten general practices from 47% to 71% with the lower response rates
occurring in practices serving deprived areas, thus also suggesting a slight under-
representation of lower social classes.
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Table 2.1 Age-Sex Distribution in the Edinburgh Artery Study
Age Group Total
55-59 60-64 65-69 70-74
Females 216 201 199 167 783
(27.6%) (25.7%) (25.4%) (21.3%) (49.2%)
Males 182 205 228 194 809
(22.5%) (25.3%) (28.2%) (24.0%) (50.8%)
Total 398 406 427 361 1592
(25.0%) (25.5%) (26.8%) (22.7%) (100%)
Table 2.2 Social Class(OPCS 1980) distribution in the Edinburgh Artery Study
Social Class Edinburgh* EAS
n Percentage n Percentage
I Professional 3056 9.9% 168 10.6%
II Intermediate 7962 25.9% 505 31.7%
III Non-manual/ clerical 4873 15.9% 254 16.0%
ID Skilled manual 8881 28.9% 452 28.4%
IV Semi-skilled manual 4028 13.1% 148 9.3%




The questionnaire was self-administered and contained mostly validated
questions enquiring about personal characteristics, social class (OPCS 1980),
intermittent claudication and angina by the WHO questionnaire (Rose 1962), medical
history including diabetes, smoking, physical activity, personality (Bedford and Foulds
1978, Bortner 1969), diet, and alcohol consumption (Duffy 1985). The complete
questionnaire is in appendix 1, while detailed description of the personality
questionnaires are left to later chapters.
Unemployment or change of occupation can often occur in middle-age or later,
because of ill-health and this may bias social class comparisons if based on current
occupation. Consequently social class was based on either current occupation or if
retired or unemployed, the respondents longest held occupation. The classification
(OPCS 1980) was I - Professional, II - Intermediate, III Non-manual/clerical, HI -
Skilled, manual, IV - Semi-skilled, manual, V - Unskilled, manual, VI - Unknown,
unclassified. Married women were classified according to their husband's occupation.
Social deprivation was also calculated based on small area statistics (Carstairs and
Morris 1991).
Information on Ischaemic Heart Disease was obtained using doctor recall
questions (appendix 1) concerning angina, heart attack and stroke and also from the
WHO questionnaire. Doctor recall questions gave a lower level of angina than the
WHO definition, while doctor recall of heart attack gave a slightly higher prevalence
than the WHO questionnaire (Table 2.3)
7






134 (8.4%) 1458 (91.6%)




99 (6.2%) 1491 (93.7%)
256 (16.1%) 1336 (83.9%)
Smoking was measured by current, former and never smoked categories, while
a measure of cumulative lifetime smoking (packyears) was calculated as the average
number of packs of cigarettes multiplied by the number of years as a smoker. As the
packyears included a large number of individuals who had never smoked (Fig 2.1a)
a square root transformed variable was used in all the analyses. Similarly, the number
of alcohol units was also positively skewed (fig 2.1b) and a square root transformation
was also used in all analyses.
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Figure 2.1 Distribution of a) Packyears and b) Alcohol in the Edinburgh Artery Study
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2.1.3 Clinical Examination
The clinical examinations were held each weekday morning from August 1987
to September 1988. Ten subjects were invited to each session and were asked to fast
from 11 p.m. the previous evening (if not diabetic) and to refrain from smoking for
two hours prior to the examination. Each subject had two sets of clinical procedures
performed by one of two teams each comprising a nurse and technician. The self-
administered questionnaire was also completed at the clinical examination and then
checked by a member of the survey team.
Peripheral arterial disease was assessed in the clinical examination by
measurement of the Ankle Brachial Pressure Index (ABPI) and by a stress test; the
reactive hyperaemia test. Variability studies of the ABPI suggested that biological
variability was greater than inter- or intra-observer variability (Fowkes et al 1988a).
Reproducibility of the reactive hyperaemia measurements was also assessed (Fowkes
et al 1988 b). Prior to the main study, a pilot study of all clinical and laboratory
procedures was carried out on 50 volunteers from the general public. The quality of
the clinical measurements were checked before and during the study by repeat
measurements taken intermittently by the study co-ordinator.
At the beginning of the clinical examination, 20 ml of venous blood was taken
initially for subsequent estimation of biochemical, haemostatic and rheological factors.
From this the levels of serum total cholesterol, high density lipoprotein (HDL)
cholesterol, triglycerides, blood viscosity, plasma viscosity, haematocrit, and leucocyte
elastase were determined. NonHDL cholesterol was calculated as the total cholesterol
minus HDL cholesterol. Standing height was measured once to the nearest 5mm
without shoes using a free-standing metal ruler on a heavy base. Weight, without
shoes and outer clothing, was measured once to the nearest lOOg on a digital Soehnle
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scale. A 12-lead ECG and rhythm strip were taken using a Hewlett Packard
'Pagewriter' electrocardiograph. ECGs were later coded independently by two trained
staff using the 'Minnesota code' (Prineas et al 1982). A third member of staff checked
the two results and, in cases of disparity , coded a third time. If the third code did not
agree with either of the first two, the ECG was read by a consultant cardiologist and
a final code agreed following discussion between the coders.
Next, after ten minutes rest in the supine position, systolic and diastolic (Phase
V) blood pressures were taken in the right arm using a Hawksley random zero
sphygmomanometer. The femoral, posterior tibial and dorsalis pedis arteries were
palpated in both legs. Ankle systolic blood pressures in the right and left legs were
taken using the random zero sphygmomanometer and a Sonicaid Doppler probe. Blood
flow was detected where possible in the posterior tibial artery. The ankle brachial
pressure index (ABPI) was defined as the minimum ratio of ankle pressure to brachial
pressure of the left and right limbs. The distribution of the ABPI in males and females
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ABPI
Figure 2.2 Distribution of the ABPI in the Edinburgh Artery Study
In the reactive hyperaemia test which followed, ankle systolic pressure was
measured in the right and left legs 15 seconds after the release of a cuff occluding
arterial flow just above the knee for four minutes at about 50 mm Hg above systolic
pressure. The timing was standardised using an electronic timer. The maximium
percentage reduction of pressure on reactive hyperaemia was calculated.
Using the WHO intermittent claudication questionnaire, the ABPI and the
reactive hyperaemia test, the following categories of severity of peripheral arterial
disease were constructed:
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1) Intermittent Claudication - positive on WHO questionnaire
2) Major disease - ABPI < 0.7 or maximum percentage reduction on reactive
hyperaemia > 35% or ABPI < 0.9 plus maximum percentage reduction on reactive
hyperaemia > 20%
3) Minor disease - ABPI < 0.9 or maximum percentage reduction on reactive
hyperaemia > 20%
4) Normal
5) Not classified - one or more of the tests missing ( mainly due to incomplete
reactive hyperaemia tests.)
This classification gave 4.6% with intermittent claudication and 6.7% with
major peripheral arterial disease (Fig 2.3)
Norma I
14.3%
Figure 2.3 Distribution of Peripheral Arterial Disease in the Edinburgh Artery Study
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As might be expected there is some overlap between ischaemic heart disease
and peripheral arterial disease; 30.2% of those with intermittent claudication or major
peripheral arterial disease also had angina or myocardial infarction (table 2.4) as
indicated by WHO questionnaire
Table 2.4 Overlap of IHD and PAD in the Edinburgh Artery Study
WHO MI or Angina Total
Yes No
Intermittent 54 125 179
claudication or (30.2%) (69.8%)
Major PAD
None 243 1170 1413
(17.2%) (82.8%)
297 1295 1592
Statistical analyses were carried out using SPSS-X (1986), or BMDP (Dixon et al
1990) statistical packages, while all plots were produced using the statistical packages
S (Becker et al 1988) or Harvard Graphics (1991). Details of particular statistical
methods are described in the relevant chapters.
Before the analysis of the first lifestyle risk factors in the cross-sectional study,




The primary aim of the case-control study was to examine the role of
haemostatic factors in thrombogenesis and atherogenesis. This has been reported
elsewhere (Smith et al 1992) and will not be discussed in this thesis. It was not yet
known to what extent alterations in plasma levels of fibrinogen were due to genetic
or lifestyle factors and so fibrinogen haplotype was measured in the case-control
study in order to address this question. In addition, the role of fibrinogen haplotype
independently of plasma fibrinogen level, will be explored as possible risk factors for
peripheral arterial disease (chapter 8).
2.2.1 Cases
Cases of peripheral arterial disease included all subjects from the Edinburgh
Artery Study who fulfilled the following criteria:
1) Ankle Brachial Pressure Index < 0.7 or;
2) A drop in ankle pressure following occlusion of > 35% or;
3) Ankle Brachial Pressure Index < 0.9 plus Intermittent claudication according to
WHO questionnaire. Specificity was 98% (Criqui et al 1985) or;
4) A drop in ankle pressure following occlusion of > 20% plus Intermittent
Claudication.
Subjects excluded were those who had rest pain, ulcer, gangrene or previous
arterial surgery. The cut-off point of 0.9 for the ABPI was based on hospital studies
and was over 95% specific (Carter 1968).
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2.2.2 Controls
For each case an age and sex frequency matched control was selected within
a five year age band. Controls had:
1) no history of coronary artery disease, cerebrovascular disease or arterial surgery;
2) no angina pectoris or intermittent claudication according to WHO questionnaire;
3) no evidence of ischaemia or previous infarction on ECG (Minnesota coding).
Confirmation that the subject was a case or control was made by repeat
administration of the WHO questionnaire on angina and intermittent claudication and
measurement of ankle and brachial systolic pressures using Hawksley random zero
sphygmomanometer and Doppler probe.
Using information on the variability of plasma fibrinogen obtained in one of
the pilot studies, it was estimated by another statistician that in a study of 120 cases
and 120 controls, after allowing for smoking in the two groups, analysis of variance
would have 80% power at the 5% level of significance to detect a difference in
fibrinogen of 0.22 g/1. In fact, 153 cases and 153 controls were selected for the study.
2.2.3 Statistical Methods
Odds ratios were estimated using logistic regression and since the cases were
frequency matched by age and sex to the controls the appropriate procedure was to
stratify by age and sex in all analyses (Schlesselman 1982). All multiple logistic





The first lifestyle factor or health related behaviour considered was diet. As the
underlying mechanism of peripheral arterial disease and coronary heart disease is
atherosclerosis, similarities in dietary risk factors for these two conditions would be
expected. However, most research has concentrated on the relationship between diet
and coronary heart disease.
Epidemiological evidence suggests that high levels of consumption of fish oil
(Shekelle et al 1985a), dietary fibre (Morris et al 1977) and polyunsaturated fats
reduce the risk of coronary heart disease, while smoking is associated with a higher
incidence of coronary heart disease (Reid et al 1976). Lower levels of serum total
cholesterol have been shown to significantly lower the risk of coronary heart disease
(Kannel et al 1971, MRFIT 1982, Frick et al 1987) as well as lower total mortality
(Anderson et al 1987, Hjermann et al 1986). Recently it has been suggested that there
may be a link between cholesterol lowering trials and increased risk of death from
accidents/suicides (Muldoon et al 1990), so that cholesterol lowering in the general
population still remains controversial.
In contrast to coronary heart disease the relationship between diet and
peripheral arterial disease has not been studied extensively. In a hospital based case-
control study in Greece (Katsouyanni et al 1991) dietary intake of saturated fatty
acids, proteins and cholesterol were associated with increased risk of peripheral arterial
disease, while high intake of polyunsaturated fatty acids and crude fibre reduced risk.
They concluded that substitution of olive oil for saturated fats and/or the consumption
of high levels of vegetables and fruit and other fibre containing foods may help to
explain the low occurrence of atherosclerotic disease in Mediterranean countries. In
dietary intervention studies on patients with peripheral arterial disease clinical
improvement has been demonstrated in patients on low fat, high-fibre diets
(Hutchinson et al 1983, Brown et al 1984, Heller et al 1989). Fish oil
(eicosapentaenoic acid) supplementation produced a reduction in blood viscosity
(Woodcock et al 1984).
There has been considerable interest in the past in the role of vitamin E and
atherosclerosis. Vitamin E has been shown to be an effective inhibitor of platelet
adhesion. Intermittent claudication has been treated with a-tocopherol (Vitamin E)
supplementation (Livingstone and Jones 1958, Haegar 1974, Pinsky 1980, Williams
et al 1971) as has angina (Gillilan et al 1977) and thrombo-embolic disease (Kanofsky
1981).
The limited research on diet and peripheral arterial disease has been conducted
only on hospital patients. In The Edinburgh Artery Study one aim was to determine
the relationships between diet and a wide spectrum of peripheral arterial disease in a
representative sample from the general population of men and women aged 55-74
years surveyed in the Edinburgh Artery Study.
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3.2 Dietary Survey Methodology
The influence of nutrition on the genesis of chronic disease has become an
important area of research, but work is hindered by the difficulty of measuring
people's habitual diets. Diet assessment methods currently available include weighed
food records, food consumption with estimated weight of food, the daily (24 hour)
recall method, seven day recall, the diet history method, and the food frequency
questionnaire (FFQ). Each method may have random or systematic errors and each has
advantages and disadvantages in use (Block 1982). For example , the diet history
method measures the usual pattern of intake but requires a long interview with a
trained nutritionist.
The literature on dietary survey methodology is scattered and few textbooks
consider methods in detail. However, two comprehensive reviews have been published
(Bingham 1987, Cameron and Van Staverne 1988) which cover description of diet
assessment methods available and their accuracy. Biological markers of food
consumption and their potential validatory use are discussed by Bingham (1987) and
by Block (1982) who also make recommendations on the selection of suitable methods
for clinical and epidemiological research.
Diet assessment methods used for CHD epidemiological research have ranged
from weighed records of food intake (Keys 1970) to food frequency questionnaires
(Tunstall-Pedoe et al 1989). Weighed food records are considered to give reasonably
accurate measures of the actual nutrient intake. They usually cover a seven day period
which is not necessarily the most appropriate way to assess the habitual dietary intake
of all nutrients of all individuals within a population. However, this is usually
sufficient to assess an individual's current energy intake and percentage energy
derived from protein, fat and carbohydrate with an acceptable degree of precision and
to place individuals correctly at the very extremes of the distribution for more variable
nutrients (Thomson et al 1988). A single 24-hour record or recall should never be used
to assess dietary status or to test association between diet and other risk factors such
as serum lipids (Marr 1971, Bingham 1987), as a single day's intake may not be
representative of an individual's usual diet.
Among the short-cut methods available for dietary assessment is the use of a
questionnaire to assess the frequency of consumption of foods. Wiehl and Reed (1960)
suggested that a questionnaire should be used in epidemiological studies of
cardiovascular disease and a number were subsequently developed (Hankin et al 1975,
Jain et al 1982, Yarnell et al 1983). Quantitative estimation of their accuracy is not
possible in many cases, because food frequency methods and questionnaires are
designed to assess the intake of a specific nutrient or food, rather than intake of all
foods and despite their routine use in epidemiology, attempts to validate them are
sparse. Yarnell et al (1983) compared the results of a food frequency questionnaire
with a seven-day weighed record in a Welsh population and found correlation
coefficients for dietary intake ranged from 0.27 to 0.41, and 0.75 for alcohol.
Although correlation coefficients do not measure agreement it is clear that consistency
between FFQ and weighed intake (WI) is very good for alcohol and moderate for
other nutrients. The same questionnaire with some modifications for the alcohol intake
was used in the Scottish Heart Health Study (SHHS) of coronary heart disease risk
factors (Tunstall-Pedoe et al 1989). Bolton-Smith and Milne (1990) validated the FFQ
used in the SHHS and found correlations between 0.18 for sugar to 0.46 for fat, and
0.64 for alcohol. Whenever the percentage energy from nutrients or nutrient density
was calculated the correlation increased to 0.33 for protein to 0.71 for fat, and 0.68
for alcohol, indicating the necessity of adjusting for total energy intake (Willett et al
1986). The better agreement of the FFQ used in the SHHS compared to Wales
(Yarnell et al 1983) may have been due to the age differences, the longer time interval
of weighed diet assessment (14 days compared to 7 days), and the higher percentage
of non-manual workers (84%) in the Scottish sample. A more recent validation by
Hankin et al (1991) found good agreement between a quantitative diet history method
and detailed food records using intraclass correlation coefficient and weighted Kappa
statistics as measures of agreement. These few comparisons of the two methods
suggest reasonable agreement, and this is especially the case for alcohol intake. The
WI method is time-consuming and requires training to be administered properly, but
is considered to be the 'gold standard' for assessing dietary intake of nutrients. An
advantage of the FFQ is the ease of administration in large epidemiological surveys
where WI is not feasible for such large numbers. Many important epidemiological
questions can still be usefully addressed by FFQ's, even if they do not yield
completely accurate measures of nutrient intake, as required by nutritionists.
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3.3 METHODS
In the Edinburgh Artery Study, a version of a food frequency questionnaire
employed in a previous study (Tunstall-Pedoe et al 1989) was used to obtain nutrient
information. This was completed by all who attended the clinic, and a nurse was
available to go through the questionnaire if there were any problems of interpretation.
Calculation of energy and nutrient intakes for individuals was estimated by
multiplying the nutrient content of a typical portion size of the specified food item by
the frequency of consumption and summing over all food items. Where participants
failed to complete all questions, nutrients were still calculated providing a response
had been given to those foods which are major sources of a specific nutrient.
Consequently, some nutrients may have been slightly underestimated.
3.3.1 Statistical Methods
The results of the food frequency questionnaire in terms of nutrients have been
expressed as medians along with the upper and lower quartiles since many of the
nutrients had positively skewed distributions. The nutrients were expressed as
percentages of total energy intake or as energy adjusted nutrients using a procedure
described later. The Mann-Whitney test was used to compare differences in absolute
nutrient intakes between males and females. In addition, the relationships between the
frequency of consumption of individual foods and peripheral arterial disease were
explored by testing for linear trends across the frequency categories: rarely/monthly,
1-3 times/week and 4-7 times/week.
Multiple linear regression was used to assess the independence of associations
between dietary factors and the minimum ankle brachial pressure index of the two
limbs.
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3.3.2 Total Energy Intake
The interpretation of total energy intake, nutrients and their relationship to each
other and to disease in epidemiological studies is often difficult. Total energy intake
is related to body size, physical activity, metabolic efficiency and net energy balance.
Body size is easily obtained in terms of weight and height, while the other
components are more difficult to measure.
Willett et al (1986) suggests that it is important in epidemiological analyses to use
measures of nutrient intake which are independent of total energy intake, especially
whenever energy is related to disease. In the Edinburgh Artery Study total energy
intake was weakly correlated with disease status (r = 0.04) as measured by the ankle
brachial pressure index (ABPI). Nevertheless, Willett et al (1986) suggests nutrient
measures independent of total energy intake are preferable. Most nutrients are
positively correlated with total energy intake with weaker correlations for vitamin C
and |3-carotene. In order to produce uncorrelated nutrient measures, one method is to
express them as a percentage of total energy intake for macronutrients; and for
micronutrients, simply divide the absolute value by total energy intake in kilocalories.
In either case the resulting measure is known as nutrient density (ND). However, for
those nutrients only weakly correlated with total energy intake and disease, the result
of calculating ND is a measure which is more correlated with energy intake and
correlated in the opposite direction with respect to disease. Another potential drawback
is that this procedure may lead to a measure which has greater variance than the
original measure.
Alternatively, 'energy-adjusted ' nutrient intakes (Willett et al 1986) were obtained
from the residuals of the regression of each of the nutrients with total energy intake
as predictor, applying the usual assumptions of regression. The residuals were added
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to the expected nutrient intake for the mean total energy intake of the population to
give more meaningful measures of nutrient intake. This procedure gave relatively
uncorrelated measures of nutrient intake which were used in the multiple linear
regression models with ABPI as outcome.
Further models were fitted to assess the independence of dietary factors from
other factors known to be associated with the ABPI such as age, sex, height and
cigarette smoking. Smoking history was defined in two ways. Firstly, consumption
was estimated in terms of packyears which is a measure of the amount smoked and
the number of years as a smoker. A square root transformation of packyears was used
in the models to give a more symmetrical distribution for the analyses. Secondly,
when interactions with smoking were found, the population was divided into those




The absolute values of nutrient intakes and as a percentage of energy for males
and females in the population of the Edinburgh Artery Study are shown in Table 3.1.
Most levels of nutrient consumption were higher in males with the exception of
vegetable fibre and vitamin C which were significantly higher in females. In addition,
females had significantly greater intake of protein and polyunsaturated fat as a
percentage of total energy compared to males. Table 3.2 shows the trend in mean
ABPI in females across three categories of frequency of food consumption:
rarely/monthly, 1-3 times per week, and 4-7 times per week. There were significant
reductions in mean ABPI in females with increasing consumption of low fibre
breakfast cereal, meat pies and pasties and pork/bacon/ham, and significant trends in
mean ABPI with increasing frequency of consumption of onions and biscuits/sweets.
Among males (table 3.3) there were significant linear reductions in mean ABPI with
increasing consumption of white bread and meat pies and pasties, while significant
increases in mean ABPI were associated with increasing consumption of wholemeal
bread, high fibre breakfast and pears. Increasing lard consumption in males and
females was associated with lower levels of mean ABPI but this did not reach
statistical significance. Caution should be applied in interpreting these results because
of the problem of multiple testing, although the number of significant tests is greater
than would be expected by chance alone. Tests of association and for linear trend were
carried out. As the test for trend may be more powerful, these are presented and the
significant linear trends (tables 3.2 and 3.3) provide stronger evidence of cause and
effect than the more general tests for association.
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Table 3.1 Medians and upper and lower quartiles of absolute nutrient intake and
as a percentage of energy in males and females aged 55-74 years in the
Edinburgh Artery Study
EEMALES(n=783) MALES(n = 809)
1
Quartiles Quartiles
Median Lower Upper Median Lower Upper
Total Energy (kcal) 1774 1492 2090 2040 1731 2449 ***
(%) of Total Energy
(excluding alcohol) from:
Total fat 38.1 34.4 42.0 38.0 33.6 44.6
Carbohydrate 44.2 40.3 47.8 45.2 41.5 49.5 ***
Protein 17.4 15.9 19.1 16.8 15.5 18.3 ***
Saturated fat 16.5 14.0 19.5 16.2 13.9 18.8
Polyunsaturated fat 4.9 3.7 6.7 4.5 3.5 6.4 **
P:S ratio 0.31 0.20 0.46 0.30 0.19 0.44
Alcohol (g) 1.2 0.0 6.2 9.5 1.2 21.9 ***
Cereal fibre (g) 8.9 6.2 12.8 9.7 6.9 14.0 ***
Vegetable fibre (g) 12.2 9.5 15.0 10.5 7.8 13.7
Vitamin C (mg) 63.5 46.3 85.4 48.3 35.0 67.5 ***
Cholesterol (mg) 309.4 238.2 396.4 328.2 258.8 433.6 ***
Retinol (jig) 646.7 404.6 956.9 657.9 427.3 985.3
B-carotene (mg) 3.3 1.8 5.8 3.3 1.8 4.8
a-tocopherol (mg) 8.1 6.1 12.2 8.2 6.1 12.7
Linoleic acid (g) 7.2 5.1 11.7 7.7 5.4 11.9 ♦
H * p<0.05; ** p<0.01; *** p<0.001; Mann-Whitney test, Males v. Females
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Table 3.2 Age adjusted mean(se) ABPI by frequency of individual food consumption
in Females in the Edinburgh Artery Study
Age adjusted mean (se) ABPI
Frequency of food Monthly/ 1-3 4-7 Linear
consumption Rarely per week per week Trend
(p - value)
White bread 1.00 1.01 1.01 0.91
(0.01) (0.02) (0.01)
Wholemeal bread 1.01 1.01 1.01 0.93
(0.01) (0.02) (0.01)
Low fibre breakfast 1.02 0.98 0.98 0.04
cereal e.g.porridge, (0.01) (0.02) (0.02)
Rice Crispies
High fibre breakfast 1.01 1.01 1.01 0.75
cereal e.g. Bran (0.01) (0.03) (0.02)
Flakes, Puffed Wheat
Pork, bacon, ham 1.03 1.00 0.94 0.002
(0.01) (0.01) (0.03)
Meat pies and pasties 1.01 0.98 0.84 0.03
(0.01) (0.01) (0.24)
Kippers, herrings, 1.02 1.00 0.94 0.06
tuna, mackerel (0.01) (0.01) (0.06)
Carrots 0.99 1.02 0.99 0.71
(0.02) (0.01) (0.01)
Onions (raw, cooked) 1.00 1.00 1.03 0.04
(0.01) (0.01) (0.01)
Sweets, biscuits, 0.99 1.01 1.04 0.002
jellies, etc. (0.01) (0.01) (0.01)
Lard, dripping, solid 1.01 1.00 0.97 0.09
veg. oil (0.01) (0.01) (0.04)
Apples 0.99 0.99 1.03 0.11
(0.01) (0.01) (0.01)
Pears 1.01 1.01 1.02 0.46
(0.01) (0.01) (0.03)
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Table 3.3 Age adjusted mean(se) ABPI by frequency of individual food consumption
in Males in the Edinburgh Artery Study
Age adjusted mean (se) ABPI
Frequency of food Monthly/ 1-3 4-7 Linear
consumption Rarely per week per week Trend
(p-value)
White bread 1.08 1.05 1.04 0.0008
(0.01) (0.02) (0.01)
Wholemeal bread 1.05 1.08 1.07 0.03
(0.01) (0.02) (0.01)
Low fibre breakfast 1.06 1.04 1.06 0.97
cereal e.g.porridge, (0.01) (0.02) (0.02)
Rice Crispies
High fibre breakfast 1.05 1.08 1.10 0.02
cereal e.g. Bran (0.01) (0.03) (0.02)
Flakes, Puffed Wheat
Pork, bacon, ham 1.05 1.05 1.06 0.80
(0.01) (0.01) (0.03)
Meat pies and pasties 1.07 1.04 1.05 0.03
(0.01) (0.01) (0.07)
Kippers, herrings, 1.05 1.04 0.99 0.29
tuna, mackerel (0.01) (0.01) (0.09)
Carrots 1.03 1.05 1.07 0.07
(0.02) (0.01) (0.01)
Onions (raw, cooked) 1.04 1.06 1.08 0.08
(0.01) (0.01) (0.02)
Sweets, biscuits, 1.05 1.06 1.07 0.22
jellies, etc. (0.01) (0.01) (0.01)
Lard, dripping, solid 1.07 1.04 1.04 0.06
veg. oil (0.01) (0.01) (0.03)
Apples 1.05 1.05 1.08 0.14
(0.01) (0.01) (0.01)
Pears 1.05 1.08 1.13 0.004
(0.01) (0.01) (0.03)
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In the multiple linear regression model with ABPI as outcome, there were
significant relationships between ABPI and age (p < 0.0001), height (p = 0.03) and
smoking (ever vs. never, p < 0.0001). Sex (p = 0.22) and total energy intake (p =
0.76) were also added to the model and this formed the core model to which energy
adjusted nutrients were added simultaneously (Table 3.4). The number of diabetics in
the study (known or positive in glucose tolerance test) was small (5.7%) and when a
dummy variable representing diabetes was added to the model, this was not
statistically significant and did not greatly alter the regression coefficients of the
nutrients.
The energy adjusted intake of alcohol had the strongest correlation with the
ABPI and a significant interaction with sex was found in the regression analysis at the
low 10% level. Alcohol was positively associated with the ABPI in males (p = 0.01)
when added to the core model, while there was no significant association in females.
Similarly, cereal fibre intake had a significant interaction with sex (p = 0.05) and was
significantly related to the ABPI in males (p = 0.002), but not in females. A highly
significant interaction (p = 0.006) was found between vitamin C and smoking (ever
vs. never). In those who were ex-smokers or current smokers vitamin C was
significantly related to the ABPI (p=0.01) but this association was not significant in
lifelong non-smokers (Table 3.4). There were no other significant sex by nutrient or
smoking by nutrient interactions. Finally, the antioxidant a - tocopherol (Vitamin E)
was significantly associated (p = 0.03) with an increase in the ABPI, after adjustment
for all variables in the core model. Vegetable fibre and P-carotene were univariately
related to high levels of the ABPI (p < 0.1), although not reaching statistical
significance. In the multiple regression analysis these along with the other non¬
significant nutrients were not independently related to the ABPI.
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Table 3.4 Multiple linear regression of age, sex, height, smoking and energy
adjusted nutrients on the ABPI in the Edinburgh Artery Study
Change in ABPI
X 100 (se) p-value
Sex ( 1 = Female, 2 = Male) -6.23 (5.09) 0.22
Age ( + 10 years) -5.77 (0.81) <0.001









Vitamin C : Never Smoked -0.02 (0.03) 0.39
Ever Smoked 0.06 (0.02) 0.01
Cereal Fibre (In) : Males 4.91 (1.57) 0.002
Females 0.91 (1.49) 0.54
Alcohol (In) : Males 1.41 (0.58) 0.01
Females 0.17 (0.62) 0.78
Retinol (In) -0.77 (0.96) 0.42
a- tocopherol (In) 4.73 (2.11) 0.03
J3- carotene (In) 0.43 (0.66) 0.52
Carbohydrate (In) -0.01 (0.02) 0.74
Vegetable fibre 0.01 (0.17) 0.95
Protein (In) -2.56 (3.87) 0.51
Saturated fat (In) 1.75 (3.05) 0.57
Polyunsaturated fat (In) 5.17 (8.62) 0.55
Cholesterol -0.002(0.006) 0.69
Linoleic acid (In) -8.92 (7.74) 0.25
in - natural logarithm
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3.5 DISCUSSION
3.5.1 Bias in regression coefficients due to measurement error
The FFQ method of assessing nutrient intake is prone to error, both within
subject random error and systematic error (more likely underestimation). The
consequence of error in one measure is to bias the regression coefficient for that
particular measure towards the null value, that is, zero and hence it is less likely to
be significant. The problem is greater when a number of confounders are present and
correlated with the variable of interest. In this case the bias can be in either direction
and so inflate or reduce the size of the regression coefficient. Thus measurement error
can contribute to either giving falsely 'independent' associations or falsely non¬
significant results (Phillips and Davey Smith 1991).
A number of methods have been proposed to deal with this problem. One
method based on logistic regression (Rosner et al 1989, Rosner et al 1990) requires
a validation study that will provide an independent, unbiased estimate of each
subject's true nutrient intake value. This does not have to include all the subjects, a
random sample is sufficient. In a dietary study, for example, a random sample of
subjects would have nutrient intake assessed by the 'gold standard' method, weighed
record as well as by FFQ. Based on the regression coefficients X relating the true
measure to the surrogate measure in the subsample, the true logistic regression
coefficients (3* are estimated by (3' X"1 where f3' is the regression coefficient obtained
from the logistic regression on the surrogate measure for the whole sample. This
method also corrects the confidence interval, allowing for a component of variability
due to estimation of the measurement error from the validation study (Rosner et al
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1989). The method assumes multivariate normality for the error terms in the regression
of the surrogate measures on the true measures and is only suitable for continuous
exposures. It also assumes that the probability of disease is small. Rosner et al (1992)
extended this method further for measures such as cholesterol which does not have a
gold standard measure by using a reproducibility substudy to estimate corrected
regression coefficients for logistic regression.
Phillips and Davey Smith (1991) used a simulation method to estimate the
correct regression coefficients p* and found good agreement with the method of
Rosner et al (1989). The advantage of this method is that it requires a replicate study
rather than a validation study but its disadvantage is that it can only be used when a
limited number of exposures are being considered.
Thus, one way of overcoming the problem of bias in the regression coefficients
in dietary studies would be to have a validation study for a random sample of the full
study in which a 'gold standard' method such as the weighed record method is also
used to assess nutrient intake. However, one advantage of the procedure of calculating
energy adjusted nutrient measures (Willett et al 1986) was to produce relatively
uncorrelated variables and so the problem of confounding between the nutrients is
minimised. With regard to other non-dietary confounders, the general rule that the
relationship between an exposure and outcome cannot be due to confounding by a
factor more weakly associated with the outcome (Schlesselman 1978), it is clear that
smoking, being highly correlated with the ABPI, could explain the significance of
dietary associations. Unfortunately, the Edinburgh Artery study does not have
information on the measurement error of the nutrient intakes or smoking, so that these
methods cannot be applied to the analysis.
In any case, these methods only demonstrate biases and do not completely
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'correct' for them. Hence the problem needs to be addressed at the design stage of a
study either by a replication study or a validation study which uses a 'gold standard'
measure. Another suggestion made by Phillips and Davey Smith (1991) was to study
populations in which the confounding is not present, but this may be difficult in
practice, for example, when studying peripheral arterial disease in a population where
smoking is not related to the ABPI.
3.5.2 Dietary Risk Factors
The FFQ is a common tool in epidemiological studies of diet and disease. One
drawback of this method of estimating nutrient intake is the lack of validation studies.
The energy adjusted alcohol intake showed relatively high Spearman Rank correlations
with HDL cholesterol (r = 0.28 males; r = 0.18 females) and this suggested that
reasonably valid estimates of alcohol intake were obtained (Jackson et al 1991). As
discussed above, another disadvantage of the FFQ method is in terms ofmeasurement
imprecision both in the dietary measures and confounders, and systematic error in
estimating the nutrients, that is, underestimation. These problems can be alleviated to
some extent and a validation substudy in which nutrients are estimated using a 'gold
standard' is recommended for future work in this area (Phillips and Davey Smith
1991). Despite these methodological drawbacks significant associations of dietary
factors with peripheral arterial disease in terms of the ABPI were detected in the
Edinburgh Artery Study.
The total energy intake and nutrient intakes (Table 3.1) in males were slightly
lower than might be expected from a previous survey in Edinburgh (Thomson et al
1985), although time trends in consumption indicate some consistency with this
finding (MAFF 1989). The exception to the general decrease is a slight increase in
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cereal fibre in the Edinburgh Artery Study. However, comparisons are difficult since
the Edinburgh Artery Study population is older.
When the frequencies of consumption of individual foods were considered, low
ABPI was significantly associated with high frequency of consumption of low fibre
containing foods (white bread in males, low fibre breakfast cereals in females) and
high frequency of consumption of meat and meat products in both males and females.
The significant tests for trend indicate a dose-response relationship and provide
stronger evidence of cause and effect than the more general tests of association. The
results are consistent with the general consensus concerning a "healthy" diet, that is,
high fibre intake and a low intake of saturated fats.
The differences found in the frequency of consumption of individual foods,
especially those containing fibre, according to the ABPI and the calculated nutrient
intakes were also reflected in the regression analyses. In a multiple linear regression
model high cereal fibre intake in males was significantly associated with high levels
of the ABPI, and this relationship was independent of smoking. This finding was
consistent with the recent case-control study (Katsouyanni et al 1991) in Greece, in
which it was found that a significant relationship existed between intake of crude
fibre, which presumably included cereal fibre, and peripheral arterial disease
independently of smoking. In addition, in the Edinburgh Artery Study alcohol intake
in males was associated with an increase in the ABPI. Alcohol intake in males was
significantly related to the ABPI in males and not in females. This was consistent with
a case-control study of New Zealand men and women which showed a lower risk of
myocardial infarction in moderate drinkers compared to total abstainers (Jackson et
al 1991). There is also some evidence that high wine consumption may be beneficial
for coronary heart disease (Renaud and de Longeril, 1992). In the Edinburgh Artery
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Study current drinking habit will be confounded with disease status and this may
explain the positive association.
Dietary cholesterol was not significantly associated with the ABPI and this may
be due to inadequacies of the FFQ to measure cholesterol or that serum cholesterol
is the more important risk factor for peripheral arterial disease.
Food supplements contribute to the intake of nutrients, especially vitamin
intake. Although this was not measured in the Edinburgh Artery Study, a British
survey (Gregory et al 1990) suggests that the prevalence of food supplementation is
low; 16% in the 50-64 age range compared to 51% over one year or a daily use of
21%-40% in the 55-74 age range in the USA (Subar and Block, 1990). Food
supplementation is lower in males than females and the British survey (Gregory et al
1990) consisted of mainly English and Welsh respondents, and vitamin
supplementation was possibly even lower in Scotland. Thus, our measures of vitamin
intake will be underestimates, but it is unlikely that this could explain the significant
findings with vitamin C and a-tocopherol. Nevertheless, food supplementation is
growing in importance as a source of vitamins and so should be included in any future
studies using a food frequency questionnaire.
It is interesting that a - tocopherol (Vitamin E) had a significantly positive
effect on the ABPI (p=0.03), independently of smoking. This finding is consistent
with population studies where low vitamin E was correlated with ischaemic heart
disease (Gey et al 1989) and angina (Riemersma et al 1991). In fact, Vitamin E has
been used to treat intermittent claudication (Haegar 1974, Livingstone and Jones 1958,
Williams et al 1971, Pinsky 1980) and angina (Gillilan et al 1977). It is thought that
the mechanism of prevention of thrombo-embolic disease (Kanofsky 1981) by a-
tocopherol is through inhibition of platelet adhesion (Jondak et al 1989). The
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association of a - tocopherol and the ABPI occurred despite the fact that food
frequency questionnaire derived measures of vitamin E are not as accurate as blood
measures. The other main dietary antioxidant, Vitamin C, which is also thought to be
related to atherosclerosis, showed some positive relationship to the ABPI, but this was
only significant for those who had ever smoked. Non-smokers already had
significantly higher levels of the ABPI and vitamin C than smokers, and so high
intake of Vitamin C would have little effect in non-smokers. By contrast, high dietary
vitamin C intake may partly compensate for the reduction of vitamin C through
smoking, although never reaching the levels in non-smokers. Hence smoking remained





4.1.1 Physical Activity and Ischaemic Heart Disease
One of the first studies to show a relationship between physical activity and
ischaemic heart disease found greater mortality among London bus drivers compared
to the more active bus conductors, and also among post office supervisors compared
to postmen (Morris et al 1953). Since these early studies were carried out, increasing
mechanisation and automation has resulted in leisure activity becoming a major
component of total physical activity. Morris et al (1973) showed that mortality from
ischaemic heart disease was significantly reduced in London civil servants who had
taken part in physical activity. Many studies have shown an increased risk of coronary
heart disease associated with a lack of physical activity in leisure time (Kannel et al
1979a, Morris et al 1973, Paffenbarger et al 1978, Morris et al 1980). More recently
Zimmet et al (1991) showed that physical activity in Mauritians improved their
cardiovascular risk factor profiles, in that HDL cholesterol was significantly higher,
while fasting triglyceride levels, uric acid, 2-hour plasma glucose concentration were
significantly lower among more active subjects. In addition, lifelong physical activity
has been shown to reduce the risk of stroke (Shinton and Sagar 1993).
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4.1.2 Physical Activity and Peripheral Arterial Disease
Few studies have concentrated on peripheral arterial disease and it has
generally only been mentioned in studies where the main concern was ischaemic heart
disease. In the Framingham Study (Kannel et al 1979a) an association was found
between low levels of physical activity and the development of intermittent
claudication, which became non-significant on adjustment for age. Levels of physical
activity decline with increasing age. Hence the Edinburgh Artery Study represents the




4.2.1 Physical activity vs Physical Fitness
The distinction between physical fitness and physical activity should be made.
Physical fitness is a biological marker of the ability to perform physical activity and
so is the outcome of participation in activity and not the process. Most
epidemiological surveys have been concerned with measuring physical activity,
although it has been suggested that physical fitness is a more powerful predictor of
disease (Sobolski et al 1987). In a study of coronary heart disease risk factors Lochen
et al (1992) found that physical fitness was more closely related to other risk factors
but also found physical fitness to be significantly correlated with physical activity.
They suggested that fitness and activity may be two different dimensions with largely
related but independent information. It is also more difficult to measure physical
fitness with suitable precision in population surveys compared to activity. In any case
it is physical activity which promotes fitness and studies have shown activity to be
protective against coronary heart disease (Morris et al 1990).
4.2.2 Measurement of Physical Activity
The usual method of measuring physical activity in large population studies is
through recall questionnaires. These are simple to administer in epidemiological
studies but the grading is crude and can result in over and under-estimation. Among
the other methods which show promise is telemetry which measures the heart rate
response minute by minute (Armstrong et al 1990), although this presents problems
for analysis, with large numbers of correlated observations. There have also been
attempts to measure activity with a single question (Shectman et al 1991) but this has
not been sufficiently validated. Recall questionnaires have been shown to be reliable
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(Blair et al 1991). A recent study (Jacobs et al 1993) showed good correlation between
the Minnesota leisure time physical activity questionnaire and nine other
questionnaires with treadmill estimation of oxygen uptake and body composition, both
of which are gold standard measures of physical activity. They found poor agreement
between the questionnaire and occupational activity.
4.2.3 Statistical Methods
The Edinburgh Artery Study used an adapted version of the questionnaire
employed in the Welsh Heart Health Study (1985 a), which had been validated against
measures of cardiovascular fitness (Welsh Heart Health Study 1985 b). This consisted
of three broad classifications of activity into light, moderate and strenuous (Appendix
1). Respondents were asked to assess the number of twenty minute periods of activity
in the summer and winter in the last year and when aged 35-45 years old. This last
category is important to obtain some measure, albeit crude, of past physical activity
which can be related to present disease status. The summer and winter responses were
then combined and classified into a single measure of leisure activity aged 35-45 with
the following categories; 0 = no leisure activity; 1 = maximum of light activity; 2 =
maximum of moderate activity; 3 = maximum of strenuous activity. Three dummy
variables were created representing each of these categories relative to no activity for
the purposes of multiple regression analyses. The measure of leisure activity at the
time of the survey was correlated (r = 0.56) with leisure activity when aged 35-45 but
present activity was not used in the analysis because of the methodological difficulties
of interpretation in a cross-sectional survey. Present activity would be reduced because
of symptomatic disease. Occupational activity was assessed by two questions for
present activity and for activity aged 35-45. There was no significant association
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between occupational activity and the ABPI and so this was also not explored further.
The analysis concentrates on the ABPI as a continuous outcome which gave
greater power to detect associations. Spearman rank correlations of the ABPI (Chapter
2) which is an indicator of peripheral arterial disease with leisure activity were
calculated and the mean ABPI levels across leisure activity categories was tested for
linear trend. The independent relation between leisure activity and peripheral arterial
disease was assessed using multiple linear regression with the ABPI as the dependent
variable, adjusting for age, sex, BMI, cumulative lifetime smoking as measured by the
packyears and alcohol, lifestyle variables which have been shown to be related to the
ABPI (Fowkes et al 1991). Square root transformed variables for smoking and alcohol
were used in the regression analyses because of positive skewness. Tests for
interaction between other risk factors and leisure activity were also carried out. It has
been shown that social class is related to leisure activity at age 36 (Kuh and Cooper
1992) and so the effect of social class was also assessed in the multiple regression
model. A more thorough analysis of the relationship between lifestyle factors and
social class is discussed in chapter 9.
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4.3 Results
A greater proportion ofmen (65.7%) indulged in moderate or strenuous leisure
activity when aged 35-45 years (table 4.1), compared to women (39.7%).
Table 4.1 Percentages (n) of men and women taking part in leisure activity when aged
35-45 years in the Edinburgh Artery Study
Leisure Activity aged 35-45 years
None At most At most At most
Light moderate Strenuous
Females 11.9% (93) 48.5% (379) 36.6% (286) 3.1% (24)
Males 8.0% (65) 26.3% (213) 48.0% (388) 17.7% (143)
The Spearman Rank Correlations show a positive relationship between leisure
activity aged 35-45 and the ABPI, alcohol intake and being male (Table 4.2). High
social class is associated with greater leisure activity. Leisure activity in females is
associated with low BMI and high alcohol intake while in males leisure activity is
associated with low smoking. A leisure activity by sex interaction is suggested by the
differing correlations with the ABPI in males compared to females.
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Table 4.2 Spearman Rank Correlations of leisure activity aged 35-45 years with the
ABPI and risk factors for Peripheral Arterial Disease in males and females








( n = 1591)
ABPI 0.02 0.13*** 0.13***
Sex(l=F,2=M) - - 0.28***







Social Class* -0.32*" -0.23*** -0.27***
# 1= I, 2 = n, 3 = HI Non-manual, 4 = III Manual, 5 = IV, 6 = V, VI
*
p < 0.05, ** p < 0.01, *** p < 0.001
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This is reinforced by the significant positive linear trend (p = 0.0004) in the mean
ABPI with increasing leisure activity in males but not in females (table 4.3).
Table 4.3 Mean (se) ABPI by degree of leisure activity aged 35-45 years




None 0.99 (0.02) 0.98 (0.02)
At most light 1.01 (0.01) 1.04 (0.01)
At most moderate 1.01 (0.01) 1.06 (0.01)
At most strenuous 0.99 (0.03) 1.09 (0.02)
Test for trend p = 0.41 p = 0.0004
Table 4.2 showed a significant relationship between smoking and leisure activity in
males and figure 4.1 suggests that the strongest linear relationship between the ABPI
and leisure activity is amongst males who ever smoked. Note also that the mean levels
of the ABPI are higher in the never smoked in both males and females, so that
although the greatest increase in the mean ABPI with leisure activity is in the ever
smoked these mean levels never reach the mean ABPI levels found in the never























Ever Smoked p = 0.45
Never Smoked p = 0.38
None Light Moderate















Ever Smoked p = 0.0002
Never Smoked p = 0.78
None Light Moderate
Maximum Leisure Activity(aged 35-45)
Strenuous
Figure 4.1 Trends in mean(± 2 se) ABPI by degree of leisure activity
aged 35 - 45 in (a) females (b) males
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In the multiple regression analysis with the ABPI as the dependent variable a
significant leisure activity by sex by smoking (ever vs never) interaction was found
(p = 0.02). Consequently twelve dummy variables were created for each of the leisure
categories relative to no activity separately for males and females in the ever and
never smoked categories. When this model was fitted adjusting for age, BMI, sex,
smoking (ever vs never) and alcohol, increasing leisure activity was significantly
associated with higher ABPI only in males who ever smoked (table 4.4). A dose
response is indicated by the increasing size of the regression coefficients with
increasing degree of activity.
Table 4.4 Results of multiple regression of leisure activity aged 35-45
on the ABPI





Ever Never Ever Never
smoked smoked smoked smoked
Light 0.04 0.01 0.06* 0.05
(0.03) (0.03) (0.03) (0.04)
Moderate 0.03 0.01 0.08*** 0.03
(0.03) (0.03) (0.03) (0.04)
Strenuous 0.07 -0.07 0.10*** 0.05
(0.05) (0.06) (0.03) (0.04)
*
Adjusted for age, sex, smoking, BMI and alcohol.
There is some indication of a similar positive effect of activity in females, especially
strenuous in the ever smoked, but this does not reach statistical significance perhaps
because of the low numbers of women who indulged in moderate or strenuous activity
aged 35-45, compared to males and hence the larger standard error. On adding social
class to this model it just failed to reach statistical significance (p = 0.06) and the
regression coefficients for leisure activity did not change.
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4.4 Discussion
Although the questionnaire was relatively crude for measuring leisure activity
it did show relationships between the degree of leisure activity aged 35-45 and arterial
disease, as indicated by the ABPI. This was consistent with multiple regression
analyses of ischaemic heart disease in which it has been shown that physical activity
was an independent risk factor, mainly in men (Kannel et al 1979a). A meta-analysis
of 27 cohort studies showed a reduced summary risk of coronary heart disease for
those who were physically active compared to those who were more sedentary (Berlin
and Colditz 1990).
Relatively few women indulged in moderate and strenuous activity when aged
35-45 (39.7% ) compared to men (65.7 %), which was consistent with other findings
(Kuh and Cooper 1992), although a possible contributing factor is that the Edinburgh
Artery Study scale emphasised competitive sport especially in the strenuous category,
which may be more relevant to males than to females. In the list of items for moderate
or strenuous activity, exercise to music, housework and childminding were not listed,
activities which a high proportion of females carry out compared to males (Kuh and
Cooper 1992). In addition horse riding and sailing, for example, in the light category
could be described as moderate or strenuous depending on their intensity and duration.
The other main problem is that of recall bias but it is difficult to assess how important
this could be in the present study. A recent study suggested that the validity of recall
of previous activity over a ten year period was satisfactory, and independent of recall
interval and age (Blair et al 1991).
Despite these drawbacks there is a highly significant linear increase in the
mean ABPI with leisure activity in males (p = 0.0004). The multiple regression
analysis showed that this increase was most marked amongst those who had ever
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smoked. It seems that exercise aged 35-45 goes some way to ameliorate the drawbacks
of smoking in terms of the ABPI, but cannot compensate completely. For those who
never smoked there is a weak positive relationship between leisure activity and the
ABPI but the increase does not reach statistical significance. Clearly, smoking remains
one of the strongest risk factors for peripheral arterial disease and the risk is increased





Since Friedman and Rosenman (1974) identified an excess of what later
became known as Type A behaviours in their patients controversy has raged over the
possible role of personality in the pathogenesis of atherosclerosis. They found that
certain types of individuals seemed to be oveirepresented in their patients. These
Type A individuals (as opposed to Type B) tended to have a competitive craving for
achievement and recognition, a tendency towards hostility and aggression, and a sense
of extreme time urgency and impatience. They tended to act and speak quickly,
interrupt more often in conversation, show impatience, show little interest in the
aesthetic aspects of life and measure success in quantitative terms rather than the
quality of goals. It has been pointed out that this is a very broad categorisation and
more tried and tested personality measures (Eysenck 1985) could have been studied
in relation to coronary heart disease. Nevertheless, it is the Type A construct which
has entered the medical consciousness.
Friedman and Rosenman (1974) originally measured Type A using a structured
interview, in which Type A behaviour was deliberately evoked and characteristics such
as the tone of voice and speed of reply were noted. The structured interview is
considered the 'gold standard'. However, reliable self-report measures have been
developed such as the Jenkins Activity Survey (JAS, Jenkins et al 1974). Later there
were calls to abandon self-report measures, especially as they do not contain items
relevant to anger and hostility (Friedman and Booth-Kewley, 1988). Other
conventional behavioural measures such as anxiety and depression were found to be
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as good as the Type A construct in predicting coronary heart disease (Booth-Kewley
and Friedman 1987). Behavioural factors have been studied extensively in relation to
coronary heart disease (Rosenman et al 1975, Haynes et al 1980, and Shekelle et al
1985b) and showed that in general Type A individuals have a greater tendency to
develop coronary heart disease. These studies were all based on US populations where
the type A construct originated and the results in Europe have not been so consistent.
For example, the Regional Heart Study found no association between Boitner Type
A scores and myocardial infarction in 45-59 year old men over a 5 year period
(Johnstone et al 1987).
A recent review (Evans, 1990) suggests that a core part of this relationship
may be concerned with hostility. On the other hand peripheral arterial disease,
although another manifestation of the process of atherosclerosis, has been less
thoroughly explored. One exception by Cottier et al (1983) on a relatively small
sample, found no significant association but intermittent claudicants were poorer at
controlling expressions of anger compared to normal controls, suggesting that large
scale research in this area would be fruitful.
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5.2 Methods
5.2.1 Measurement of Personality
All the 1592 participants in the Edinburgh Artery Study (Chapter 2) completed
a self-reported personality questionnaire which had been used by Cottier et al (1983).
This was the Bortner Personality Inventory consisting of 14 items, each item relating
to different aspects of Type A behaviour (Appendix 1). Each item consisted of a
visual analogue scale from low Type A activity to extreme activity, the scores (1-24)
being assessed after completion using an overlay. The Type A Bortner score was then
calculated as the sum of the scores over all items. In the questionnaire the individual
components of the Bortner were laid out so that the extremes of Type A behaviour did
not always appear on the same side of the page.
Since hostility and anger seem to be important factors in atherosclerosis
(Booth-Kewley and Friedman, 1987), subjects were also asked to complete the
Personality Deviance Scale (Bedford-Foulds, 1978). This reliable and validated
questionnaire consisted of three major scales - extrapunitiveness (blame others),
intropunitiveness (self-blame) and dominance. Each major scale is the sum of two
subscales which in turn consist of six items from the questionnaire; extrapunitiveness
= hostile thoughts + denigratory towards others; intropunitiveness = lack of self-
confidence + dependency; dominance = hostile acts + domineering attitude. Each
question was worded to elicit responses referring to 'most of their life' in order to
reduce the problem of measuring disease status and risk factor at the same time,
inherent in cross-sectional methodology. The whole questionnaire was checked by a
research nurse and advice given on how to complete any missing items. Peripheral
arterial disease was measured using the WHO questionnaire, the ankle brachial
pressure index (ABPI) and a reactive hyperaemia test. Subjects were classified into
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four categories as follows : 1) intermittent claudication if positive to the WHO
questionnaire; 2) major asymptomatic disease if the ABPI < 0.7 or a hyperaemic
reduction in ankle pressure > 35%; 3) minor asymptomatic disease if the ABPI < 0.9
or a hyperaemic reduction > 20% ; and 4) normal , if none of the above. Mean
personality scores were compared across these categories of disease severity using
tests for trend.
52
5.2.2 Statistical Methods - Principal Components Analysis
As the Bortner inventory is composed of 14 items each potentially a factor in
relation to peripheral arterial disease, one means of reducing the dimensionality of the
problem is through the use of principal components analysis. This procedure
transforms the observed correlated variables into a smaller number of uncorrelated
linear combinations of the original variables, which account for a large proportion of
the variation. No statistical model is assumed and the distribution of the variables does
not have to be approximately Normal.
If we let XT = [Xl5 X2, Xp] for p random variables with
mean = p and variance-covariance matrix 2.
Then we wish to find new Yls Y2, Yp which are uncorrelated with variances
decreasing from first to last and the Y; are linear combinations of the X's , that is,
Yj = a^ + a^ + + a^Xj = aj1X
where a^ = [ a^, a^, ...., a^] is vector of constants
The condition = 2 akj2 = 1 is imposed, that is, the transformation is orthogonal.
The 1st principal component Yx is found by choosing a.x so that Yj has the largest
variance. In other words, the procedure maximises Varta^X) subject to the constraint
that a/aj = 1 and this is repeated for a^ a3,
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Vai^a^X) = a^Xaj = f(x)
Maximise by Lagrange multipliers, with one constraint
Let L(x) = f(x) - X [g(x) - c]
where f(x1,...,xp) is differentiable function of p variables subject to constraint
Then 3L/3X = 0 can be written as
3f/9xi - X 0g/dx; = 0 [i=l,2,...p]
L (aj) = a^Zax - X (a^ - 1)
SL/Saj = 2Eaj ~ 2Xaj
Then 3L/8a1 = 0 implies (2 - XI) a! = 0
If (X - XI) aj = 0 has other than 0 as a solution then (X - XI) must be singular
We can choose X, such that IX - Xil = 0
A solution existing implies the X, are the eigenvalues of X and are all
positive since X is positive semidefinite
Then Xj > Xj > Xj, > 0
and Var ( a^X) = a^Xaj = a/Xaj = Xj
The 1st principal component ax is eigenvector of X corresponding to the largest
eigenvalue X1. This is then repeated for and so on.
The eigenvectors A where A = [a^, ...ap]
Y = AtX
Then X Var (Y;) = XX; = trace (A)
= trace (ATXA) = trace (XAAT) = trace (X) = X Var (Xj)
In other words, the sum of the variances of the original variables =
the sum of variances of the principal components. So we can say that the ith PC
accounts for Xj / ^2 Xj of the total variation in the original data.
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The Varimax method was used which took the first few components (say m)
and rotated these as a linear combination of the eigenvectors to obtain a new set of
components. The loadings for each of the variables was then as close to 1 or 0 as
possible to make identification of important variables easier.
Logistic regression was used to analyse the relationship between intermittent
claudication (yes/no) and personality scales in the Edinburgh Cross-sectional study.
In addition multiple linear regressions with the ABPI as a continuous outcome were
carried out for the total cross-sectional data and for males and females separately.
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5.3 Results
5.3.1 The Bortner Inventory
The principal components analysis carried out on the 14 items of the Bortner scale
identified 4 principal components which accounted for 50% of the total variation in
the original 14 items (Table 5.1). This is not a particularly high percentage and it
could be that the 14 items have already been selected by principal components
analysis from a much larger Type A inventory. The first component was highly
correlated with the original Bortner score which is the sum of the 14 items.
Table 5.1 Principal components analysis and relationship to the Bortner scale
Principal Cumulative Correlation* with Correlation* with
Component Percentage Bortner the ABPI
1 21.9 0.80 0.02
2 33.6 0.40 0.07
3 42.9 0.21 0.11
4 50.1 0.14 -0.06
*
Spearman Rank correlation
The four principal components identified could be characterised as time pressure,
competitiveness, speed, and emotional expression/job recognition (table 5.2), although
there is an element of subjectivity in these descriptions. The important factors for each
principal component are highlighted in bold in table 5.2 represented by 'large'
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component loadings.The Varimax rotation produces extremes of loading for each item,
that is close to 0 or 1 to make identification of important items easier and aid
interpretation.
Table 5.2 Varimax rotated principal component loadings and correlations with the
ABPI
Trait PCI PC2 PC3 PC4 Correlation with
ABPI
A 'never late' -0.06 -0.37 0.50 -0.29 0.03
B 'very competitive' -0.06 0.71 0.27 -0.06 0.06
C 'interrupt' 0.40 0.11 0.11 0.44 -0.01
D 'always
rushed'
0.74 -0.11 0.07 -0.03 0.01
E 'impatient' 0.57 0.26 -0.21 0.05 0.01
F 'go all
out'
0.49 0.15 0.49 0.07 0.07
G 'do many
things at once'
0.67 0.04 0.07 0.03 0.05
H 'emphatic
in speech'
0.45 0.14 0.17 0.53 0.01
I 'job
recognition'
0.25 0.32 0.14 -0.64 0.08
J 'fast eat
/talk'
0.26 -0.11 0.64 -0.01 0.06
K 'hard
driving'
0.44 0.47 0.09 0.30 0.03
L 'express
feelings'
0.03 0.32 -0.05 0.46 -0.01
M 'few
interests'
0.16 -0.27 ■0.64 -0.08 -0.10
N 'ambitious' 0.17 0.70 -0.18 0.10 0.05
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Apart from the fourth principal component there is a positive relationship
between the constructed dimensions and the ABPI. When considering the correlations
of the individual components of the Bortner with the ABPI, it is notable that only one
item 'few interests apart from work' is significantly associated with low levels of the
ABPI while the remaining items, as with the first three principal components are
generally positively associated with the ABPI.
The change in Bortner scores and first four principal components across
categories of peripheral arterial disease are shown in table 5.3. With decreasing
severity of disease to normal there are significant linear trends of increasing scores on
the Bortner scale, time pressure, competitiveness, and speed which is in the opposite
direction to that expected. In other words, type A characteristics are associated with
a lack of disease. For the fourth principal component; emotional expression/job
recognition, although there is a slight suggestion of a positive association, that is, in
the expected direction, this is not significant.
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Table 5.3 Mean (se) Bortner scores and first four Principal Components in











Bortner 146.7 150.4 151.1 157.6 0.001
Mean (se) (5.4) (3.7) (2.4) (1.1)
Time pressure 44.4 45.1 46.5 48.5 0.02
Mean (se) (2.3) (1.7) (1.1) (0.5)
Competitiveness 16.5 17.1 16.5 19.3 0.007
Mean (se) (1.8) (1.3) (0.8) (0.4)
Speed 16.9 19.6 20.9 23.3 0.001
Mean (se) (1.3) (1.1) (0.7) (0.32)
Emotional 3.2 2.6 2.9 3.1 0.87
expression (1.1) (1.1) (0.6) (0.3)
Mean (se)
In analysing the relationship between the ABPI and individual items of the
Bortner scale in multiple linear regression, males and females were treated separately,
as the univariate relationships differed between males and females. In a stepwise
regression procedure item M was significant (p=0.005) in females after adjusting for
smoking (square root transformation of packyears), age, HDL and nonHDL
cholesterol, and BMI. This negative association remained on adding known diabetes.
This suggested an independent relationship between low ABPI and having few
interests outside work in females. In males item M was not significant while item G,
'go all out' was significant (p = 0.01) after adjusting for age, smoking, diabetes, HDL
and nonHDL Cholesterol and BMI.
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5.3.2 Bedford-Foulds Questionnaire
The Bedford-Foulds measures are generally higher for cases of intermittent
claudication compared to others. It is notable that dominance and its subscale
components hostile acts and domineering attitude are higher in claudicants (table 5.4),
although only reaching statistical significance for hostile acts. In addition, males have
significantly higher levels of hostility compared to females (p < 0.0001).












12.6 (0.3) 12.4 (0.1) 0.69
Hostile
thoughts




12.1 (0.4) 11.8 (0.1) 0.51
Dependency 13.5 (0.3) 13.6 (0.1) 0.82
DOMINANCE
Hostile acts 14.6 (0.4) 13.9 (0.1) 0.03
Domineering
attitude
15.0 (0.4) 14.8 (0.1) 0.55
In the logistic regression of hostile acts on intermittent claudication a
significant interaction (p = 0.01) was found for sex and hostile acts and so the analysis
was carried out separately for males and females. After adjusting for age and smoking
the odds ratio was 1.40 ( 95% C.I. = 1.01, 1.95 ) for hostile acts in males, while the
odds ratio for females was 1.18 which was not significant. Hostility is related to
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lifetime cigarette smoking as measured by packyears (r = 0.19), but after adjusting for
cumulative smoking the odds ratio for hostile acts in males hardly changed to 1.42 and
remained statistically significant (Table 5.5). The odds ratios were obtained from
standardised coefficients (frs^ to indicate that hostile acts in males were of comparable
importance as smoking as a risk factor for intermittent claudication. On adding item
M in the Bortner inventory to this model hostile acts in males remained significant,
while the odds ratio for item M in females was 1.50 (95% C.I. = 1.06, 1.73) and was
not significant in males.
Table 5.5 Logistic regression on Intermittent Claudication
Variables (+1 SD)
Females
Odds Ratio (95% C.I.)
Males
Odds Ratio (95% C.I.)
Hostile acts 1.08 (0.78, 1.51) 1.42 (1.01, 2.00)
Item M
'few interests'
1.50 (1.06,1.73) 1.07 (0.76, 1.51)
Packyears
(Square root)
1.70 (1.24, 2.34) 1.34 (0.94, 1.93)
Age 1.41 (1.01, 1.99) 1.52 (1.06, 2.19)
It might be thought that increased hostility and dominance may be a
consequence of illness rather than antecedents. In order to address this question the
asymptomatic cases were selected, that is, those cases without intermittent claudication
or angina (n = 94) and compared to the controls who were free from disease (n =
149). After adjusting for age and sex, the odds ratios were for dominance (OR=1.37
, 95% CI = 1.04,1.79 , p = 0.02), for hostile acts (OR=1.24, 95% CI = 0.95,1.61 , p
= 0.07), and for domineering attitude (OR=1.39, 95% CI 1.06,1.82 , p = 0.02).
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5.4 Discussion
These results represent the first large scale study of personality traits and peripheral
arterial disease. It was surprising that the Bortner scale and most of the individual
items showed significant trends in the opposite direction to that which might be
expected. Subjects with disease had lower Type A scores and lower scores on the
principal components compared to normals. The most likely explanation is that the
instructions for completion of the Type A inventory relate to the present and so
disease status could influence responses. This is supported by the significant
association of competitiveness and 'going all out' with absence of disease, aspects
which would be reduced by disease. Also, it is debatable whether many of the items
are relevant to a retired population of this age range. The significant finding of having
'few interests outside work' associated with disease in females could be the result of
social isolation as a consequence of curtailed mobility. The Type A inventory also
suffers from being self-completed since in a structured interview Type A behaviours
are elicited. However, in a large cross-sectional study the cost of structured interviews
for all subjects would be prohibitive. The 14-item inventory did not contain items on
hostility and this is a major drawback, especially as it has been suggested (Booth-
Kewley and Friedman 1987) that the expression of hostility lies at the core of the
relationship between atherosclerosis and personality (Evans 1990).
The results do support the association of hostility as measured by the Bedford-
Foulds Personal Deviance Scales and peripheral arterial disease. Male subjects with
disease have a tendency to be more domineering and act in a hostile manner in
interpersonal situations. This is consistent with the finding of aggressiveness being
related to coronary heart disease (Booth-Kewley and Friedman 1987). The instructions
for completion of the Bedford-Foulds questionnaire emphasised the retrospective
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nature of actions, that is, respondents were asked to assess how they would behave
'over most of your life'. Respondents could then disregard present aspects such as
disease status and so these scales would more likely represent trait measures. In
addition, when the angina cases and intermittent claudicants were excluded from the
analysis, there was still a significant relationship between hostility and major
asymptomatic disease. This suggests that the personality deviance is unlikely to be a
consequence of disease and so hostility may be an independent risk factor for





Blood rheology is the study of the deformation of blood and its resistance to
flow or viscosity and this chapter will consider Theological factors as risk factors for
peripheral arterial disease. Resistance to flow is measured by whole blood viscosity
and important components of this are plasma viscosity, haematocrit and fibrinogen.
Atherosclerosis tends to predominate at certain sites, with lesions occurring at
bifurcations and bends, areas where flow is altered and so haemodynamic factors may
play a part in atherogenesis.
Of all the Theological factors, fibrinogen has been shown to be a major
cardiovascular risk factor (Wilhelmson et al 1984, Stone and Thorpe 1985, Meade et
al 1987), although it is important to assess whether this is independent of smoking as
smoking is known to increase fibrinogen level (Lee et al 1990).
Other important factors are leucocyte elastase, urinary fibrinopeptide A and
uric acid. Leucocyte elastase, a measure of blood leucocytes, is released during early
events in coagulation or other pathways that occur in parellel with coagulation (Plow
1982) and in a small hospital based study was shown to be elevated in patients with
ischaemic heart disease (Dawes 1987).
Fibrinopeptide A is a measure of activation of blood coagulation. It is released
from fibrinogen on conversion to fibrin and so urinary concentration reflects that of
plasma (Alkjaersig and Fletcher 1982).
Plasma uric acid is thought to be related to platelet function which in turn
affects thrombus formation (Winocour 1977) and hence may be a risk factor for
atherosclerosis.
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Previous studies have suggested that patients with intermittent claudication may
have activation of blood coagulation (Donaldson et al 1987, Al-Zahrani et al 1992);
increased blood viscosity due to elevation of haematocrit and plasma fibrinogen
(Dormandy et al 1973, Stormer at al 1974, Blunt et al 1980), and increased leucocyte
activation and rigidity (Ciuffetti et al 1988, Nash et al 1988). However these factors
have not been related to peripheral arterial disease in epidemiological studies in the
general population, nor have relationships with other cardiovascular risk factors, such
as smoking, been taken into account.
The Edinburgh Artery Study (Fowkes et al 1991) enables study of the
relationships of whole blood viscosity and its major determinants; haematocrit, plasma
viscosity, and fibrinogen as well as measurements of activation of blood coagulation
such as urinary fibrinopeptide A (Dawes et al 1987) and of blood leucocytes such as
plasma leucocyte elastase (Greer et al 1989) to symptomatic and asymptomatic
peripheral arterial disease in the general population aged 55 - 74 years.
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6.2 Methods
6.2.1 Measurement of Rheological Factors
Details of the study population and recruitment are described in chapter 2.
Peripheral Arterial disease was measured by the WHO questionnaire identification of
intermittent claudication (Rose 1962) and the ankle brachial pressure index.
From a fasting blood sample which was taken on each patient at about 9 am,
serum uric acid was estimated on a Cobas Bio analyser, using a standard kit.
Fibrinogen was measured in citrated plasma by a thrombin-clotting turbidometric
method in a centrifugal analyser (Lowe et al 1991a). Haematocrit was measured using
a Hawksley microcentrifuge and reader. Blood viscosity was corrected to a standard
haematocrit of 45%. This was calculated using the formula of Matrai et al (1987) as
follows:
Corrected Blood vis. = ( bl°°dvis) HaeJtocnt (plasvis)
plasvis
Relative blood viscosity, which is corrected blood viscosity/plasma viscosity, was
calculated to give a measure of red cell deformability (Chien 1975). Urinary
fibrinopeptide A was measured by radioimmunoassay (Dawes et al 1987) as was
plasma leucocyte elastase (Greer et al 1989). Quality control was monitored by means
of blind duplicate samples taken intermittently throughout the study.
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6.2.2 Statistical Methods
Tests for linear trends in the mean levels of the rheological factors across four
categories of peripheral arterial disease were carried out. The categories of disease
have been described in chapter 2, and the results of studies comparing the ABPI and
reactive hyperaemia separately with arteriography (Fowkes 1988d) suggest that this
classification has some validity. The main analysis as in previous chapters concentrates
on the ABPI as a continuous measure of peripheral arterial disease giving greater
power to detect associations.
Multiple linear regression was used to investigate the relationships between the
ABPI and age, sex, height, blood and plasma viscosity, haematocrit, fibrinogen,
leucocyte elastase and urinary fibrinopeptide A, uric acid and alcohol and smoking.
The log transformed data for leucocyte elastase and urinary fibrinopeptide A were
used in the analysis because of the positive skewness of their distributions. Height was
included in the regression analysis because it had a positive association with the ABPI
(Fowkes et al 1991). Exclusion of height affected the association with sex, tending to
increase the adjusted ABPI in males. The multiple linear regressions were carried out
with all of the above factors entered simultaneously, and with the subsequent insertion
of total cholesterol, HDL cholesterol, triglycerides (log transformed) and diabetic
status (Known vs non-diabetic). Tests for sex by rheological factors were carried out
as well as a test of the three way interaction of sex by smoking by fibrinogen.
The association with smoking was modelled using the number of packyears as
described in chapter 2. The distribution of packyears was highly skewed with a few
very heavy smokers, and so a square root transformation was used in all the analyses.
The smoking histories were considered valid because stated consumption was related
to mean thiocyanate levels.
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Multiple logistic regressions of age, sex, height, smoking and the rheological




Table 6.1 shows the correlations between the rheological variables. In
particular, haematocrit and blood viscosity are highly correlated ( r = 0.70), as are
fibrinogen and plasma viscosity (r = 0.46) and blood viscosity and plasma viscosity
(r = 0.45).

































































Fibrinogen increased markedly with age from a mean (se) of 2.52 (0.03) g/1 in those
aged 55-59 years to 2.90 (0.04) g/1 in those aged 70-74 years. There were many
differences between the levels of rheological variables in men and women (table 6.2),
blood viscosity, haematocrit, leucocyte elastase and urinary fibrinopeptide A were
significantly higher in males (p < 0.001) while fibrinogen was significantly higher in
women (p < 0.001). Mean plasma viscosity did not differ significantly between men
and women. The trends in rheological factors in relation to severity of peripheral
arterial disease are shown in table 6.3 and 6.4.
69
Table 6.2 Differences in mean (se) levels of rheological variables






















Haematocrit % 44.11(0.12) 47.39(0.13) <0.001







Uric acid pmol/1 287.4(2.5) 344.3(2.6) <0.001
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Table 6.3 Trends in mean (se) of Rheological variables in females across categories
of peripheral arterial disease.
IC Major Minor Normal Missing Total
Rheological (n=73) (n=106) (n=228) (n=1071) (n=l 14) (n=1592 P-
factor ) value*
Mean Mean Mean Mean Mean Mean
(se) (se) (se) (se) (se) (se)
Blood viscosity 3.63 3.38 3.38 3.31 3.58 3.37 0.0003
mPa.s (0.06) (0.07) (0.04) (0.02) (0.07) (0.02)
Corrected blood 3.55 3.45 3.44 3.37 3.60 3.42 0.004
viscosity (0.05) (0.07) (0.03) (0.02) (0.06) (0.01)
Relative blood 2.55 2.54 2.60 2.55 2.64 2.56 0.74
viscosity (0.03) (0.03) (0.02) (0.01) (0.03) (0.01)
Plasma viscosity 1.39 1.37 1.33 1.32 1.37 1.33 <0.001
mPa.s (0.01) (0.03) (0.01) (0.004) (0.01) (0.004)
Haematocrit % 45.6 44.5 44.2 43.9 44.1 44.1 0.004
(0.45) (0.70) (0.28) (0.14) (0.37) (0.12)
Fibrinogen 313.9 304.2 2112 270.8 303.8 279.4 <0.000
g/1 (12.1) (9.6) (5.6) (2.9) (8.6) (2.5) 1
Leucocyte 3.74 3.47 3.36 3.39 3.44 3.41 0.009
elastase(ln) (0.11) (0.11) (0.06) (0.03) (0.07) (0.02)
ng/ml
Uric acid jimol/1 314.7 301.3 294.9 279.2 306.6 287.4
(13.1) (10.9) (7.5) (2.8) (8.1) (2.5) 0.0001
Urinary (ng/ml) 2.3 1.9 1.5 1.7 1.7 1.7 0.17
fibrinopeptide A (0.74) (0.41) (0.09) (0.07) (0.10) (0.07)
* Test for linear trend in means; missing excluded.
There were highly significant linear trends (p < 0.001) in males of increasing
blood viscosity, corrected blood viscosity, plasma viscosity, and fibrinogen with
severity of peripheral arterial disease. There were also significant trends in haematocrit
and leucocyte elastase with severity of disease. The results were similar in females
except that there was a significant linear trend in uric acid in females (table 6.3) but
not in males (table 6.4).
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Table 6.4 Trends in mean (se) of Rheological variables in males across categories of
peripheral arterial disease.
IC Major Minor Normal Missing Total
Rheological (n=73) (n=106) (n=228) (n=1071) (n=114) (n=1592 P-
factor ) value*
Mean Mean Mean Mean Mean Mean
(se) (se) (se) (se) (se) (se)
Blood viscosity 4.03 3.94 3.93 3.73 3.75 3.78 <0.0001
mPa.s (0.13) (0.08) (0.06) (0.03) (0.10) (0.02)
Corrected blood 3.75 3.65 3.65 3.53 3.57 3.57 0.0001
viscosity (0.08) (0.06) (0.04) (0.02) (0.08) (0.01)
Relative blood 2.75 2.68 2.71 2.67 2.63 2.68 0.07
viscosity (0.05) (0.03) (0.02) (0.01) (0.05) (0.01)
Plasma viscosity 1.36 1.36 1.35 1.32 1.36 1.33 0.0001
mPa.s (0.01) (0.01) (0.01) (0.004) (0.01) (0.003)
Haematocrit % 47.8 48.9 47.6 47.2 47.7 47.4 0.003
(0.52) (0.58) (0.41) (0.14) (0.71) (0.13)
Fibrinogen 291.8 302.8 264.4 258.6 268.8 264.2 <0.0001
g/1 (13.5) (10.1) (5.7) (2.9) (11.7) (2.5)
Leucocyte 3.57 3.74 3.74 3.55 3.55 3.59 0.03
elastase(ln) (0.11) (0.09) (0.06) (0.03) (0.07) (0.02)
ng/ml
Uric acid 349.3 363.6 343.9 342.7 335.7 344.3 0.13
}imol/l (13.6) (11.1) (6.8) (2.9) (17.2) (2.6)
Urinary (ng/ml) 3.62 1.64 1.75 2.14 2.02 2.11 0.55
fibrinopeptide A (1.37) (0.11) (0.12) (0.24) (0.29) (0.18)
* Test for linear trend in means; missing excluded.
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Age (+10 years) -4.2(0.8) < 0.0001
Sex 34.5(6.8) < 0.0001
Height ( + 10 cm) 1.3(0.7) 0.05
Packyears (square root trans.) -1.2(0.3) 0.0001
Alcohol units (square root) 0.6(0.3) 0.03
Fibrinogen:
Males, ever smoked(+ 100g/l) -4.85(1.13) <0.0001
Males, never smoked(+ 100g/l) -3.93(1.20) 0.001
Females, ever smoked(+100g/l) -1.71(1.15) 0.14




Plasma viscosity(mPa.s) -2.1(6.1) 0.73
Haematocrit( + 10%) -1.7(1.9) 0.70
Leucocyte elastase(ln) (+1 ng/ml) -0.9(0.76) 0.24
Uric acid (+ 100 pmol/1) -1.08(0.68) 0.11
Known diabetic vs non (Males) - 13.0(4.3) 0.002
Known diabetic vs non (Females) -3.2(4.6) 0.49
There was a significant three way interaction (p = 0.01) of sex by smoking
(packyears) by fibrinogen adjusting for all two-way interactions and so separate terms
were entered in the regression model for fibrinogen in males and females who ever
smoked and who never smoked. This classification of smoking was used for simplicity
as any cut-off point for packyears would be arbitrary. The results of the multiple linear
regression on the ABPI (table 6.5) show that although univariately there were
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significant relationships between rheological variables and peripheral arterial disease
in women (table 6.3), these were not independent of smoking. On the other hand, in
men, both fibrinogen and blood viscosity (p = 0.003) were significant independently
of smoking, and due to a significant interaction with smoking, fibrinogen was related
to a greater reduction in the mean ABPI in ever smokers (p < 0.0001) compared to
never smokers (p = 0.001, table 6.5). Even in females, although fibrinogen was not
significant after adjusting for smoking, the differences in the regression coefficients
indicate a weak multiplicative effect of fibrinogen with smoking (table 6.5). On adding
HDL (p = 0.009) and non-HDL cholesterol (p = 0.002) there was little change in the
significance of the regression coefficients of blood viscosity and fibrinogen for males.
There was almost a significant sex by diabetes (known vs non) interaction (p = 0.10)
and consequently separate terms were entered for males (p = 0.003) and females (p
= 0.96).
When considering the presence of intermittent claudication as the outcome
many of the rheological variables were univariately related to peripheral arterial
disease. There were no significant interactions of sex or smoking with rheological
variables. There were also no independent significant rheological factors (table 6.6),
when adjusting for age, sex, height, smoking and all other rheological factors
simultaneously. Age and smoking were the only significant factors independently
associated with the odds of intermittent claudication.
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Age( +10 years) 2.26(1.38,3.70)** 2.18(1.30,3.70)**
Female ( vs male) 0.96(0.56,1.65) 0.81(0.35,1.89)
Height ( + 10 cm) 0.77(0.57,1.03) 0.77(0.50,1.16)
Blood viscosity(+ 1 mPa.s) 1.80(1.20,2.70)** 1.26(0.65,2.43)
Haematocrit( + 10%) 2.19(1.05,4.60)* 1.58(0.53,4.76)
Plasma viscosity(+ 0.1 mPa.s) 1.62(1.23,2.13)*** 1.23(0.85,1.78)




Urinary fib. A(>1 ng/ml) 0.95(0.55,1.64) 0.88(0.50,1.55)
Uric acid ( + 10 pmol/1) 1.00(0.97,1.04) 0.94(0.98,1.02)
Packyears(square root) 1.18(1.08,1.29)*** 1.16(1.03,1.31)*
+ p < 0.1 * p < 0.05 ** p < 0.01 *** p < 0.001
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6.4 Discussion
The results in the Edinburgh Artery Study support the hypothesis that
Theological factors were independently related in an older male population aged 55-74
years to both atherosclerotic peripheral arterial disease as measured by the ABPI and
to leg ischaemia, as measured by the presence of intermittent claudication on
questionnaire.
Blood viscosity and its major determinants, haematocrit, plasma viscosity and
fibrinogen as well as leucocyte activation as measured by plasma leucocyte elastase
were found to be significantly related to increasing severity of peripheral arterial
disease in males and females (tables 6.3 and 6.4). Activation of blood coagulation as
indicated by urinary fibrinopeptide A showed no relationship to peripheral arterial
disease. This was surprising as other studies had suggested that plasma fibrinopeptide
A levels were related to several major cardiovascular risk factors (Lowe et al 1991a)
as well as to angiographic coronary artery disease (Small et al 1988). However, in the
Edinburgh Artery Study the assay may have been insensitive as 38% of the population
had levels < lng/ml.
The relationship between Theological factors and the extent of atherosclerotic
narrowing in the arteries to the lower limbs was assessed using the ABPI, which has
been shown to be up to 95% sensitive in detecting angiogram positive peripheral
arterial disease (Bernstein et al 1982) and in the Edinburgh Artery Study has been
shown to be related to the severity of disease on duplex scanning (Fowkes et al
1992b). The ABPI was significantly associated with blood viscosity in men, and
plasma viscosity and fibrinogen in men and women. The relationships with blood
viscosity and fibrinogen were still significant after adjustment for age, sex, height and
smoking in men but not significant for women. These findings suggest that blood
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viscosity and fibrinogen may each have an independent role in atherogenesis in men.
Several biologically plausible mechanisms have been suggested, including an effect
of blood viscosity on the localisation of atherosclerotic lesions (Lowe 1987). The
association between fibrinogen and the ABPI was strongly related to the amount of
cigarette smoking. The significant (p = 0.02) smoking by fibrinogen by sex interaction
may be explained as a synergistic effect of smoking predominantly in males which
disturbs endothelial cells and activated platelets, and fibrinogen infiltrates the arterial
wall through damaged endothelium which then promotes platelet aggregation (Lowe
1987). The result that fibrinogen became non-significant in women on adding
smoking to the regression model suggested that smoking was the strongest risk factor
in women which may operate via the plasma fibrinogen level.
In the logistic regression model adjusting for age, sex and cigarette smoking,
the associations between the rheological variables and intermittent claudication became
non-significant (table 6.6). There were no significant sex or smoking by rheological
interactions. This may be related to the small number of claudicants, and also does not
exclude the possibility that increases in viscosity, fibrinogen and leucocyte activation
may be mechanisms whereby age and smoking promote development of peripheral
arterial disease.
The results suggested that blood viscosity and fibrinogen were independently
associated with the severity of atherosclerosis as measured by the ABPI in the older
population of men but not independently of smoking in women. Smoking appears to




ARTERIAL BLOOD PRESSURE AND RHEOLOGICAL FACTORS
7.1 Introduction
Arterial blood pressure is a risk factor for arterial disease (MacMahon et al
1990) but it cannot be directly assessed in the same way as other risk factors. Arterial
blood pressure as well as a risk factor is also a component of the outcome measure,
directly in the case of the ABPI, and indirectly as indicated by the presence of
intermittent claudication measured by the WHO questionnaire (Rose 1962). Hence it
was not possible to enter blood pressure as a variable in regression analyses with these
measures of peripheral arterial disease as outcomes.
Peripheral resistance is one of the main determinants of arterial pressure and
is affected by vasoconstriction of the arterioles and blood viscosity. It is not surprising
then that blood viscosity has been found to be increased in patients with hypertension
(Tibblin et al 1966, Letcher et al 1981, Dintenfass 1981, Isles et al 1984). This
elevated blood viscosity may be due partly to haematocrit and plasma fibrinogen
concentration which are also increased in hypertension (Letcher et al 1981). In the
general population, arterial pressure has been shown to be related to fibrinogen levels
(Karsen-Bengtsen et al 1972, Kannel et al 1985a) and to haematocrit (Mc Donough
et al 1965, Kannel et al 1972, Sorlie et al 1981) but the relationship with blood
viscosity is not well established, having been studied only recently in one population
aged 25-64 years of age (Smith et al 1992). Thus the Edinburgh Artery Study
facilitates the study of the relationship between blood viscosity and its components,
plasma viscosity, haematocrit and fibrinogen, and arterial pressure in the general
population aged 55-74 years.
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7.2 Methods
Multiple linear regression was used to assess the independence of relationships
between rheological variables and systolic and diastolic arterial pressure separately.
As significant sex by blood viscosity and sex by fibrinogen interactions were found
in relation to peripheral arterial disease in the previous chapter , males and females
were analysed separately. In addition each regression model was adjusted for BMI,
smoking as measured by packyears and alcohol. Square root transformations were used
for the latter two variables because of the skewed nature of their distributions.
A generalisation of multiple linear regression is the procedure of canonical
correlation analysis, originally used by Hotelling (1936). It consists of considering
linear combinations of one set of Y variables with linear combinations of another set
of X's. In this case diastolic and systolic blood pressure form one set while the
rheological variables along with age, BMI, smoking and alcohol form the second set.
The linear combinations of the X variables are known as canonical variables and the
correlation between these and the linear combinations of the Y's, the second set of
canonical variables, are the canonical correlations.
The procedure involves finding a linear combination of Y's -
Ci(y) = &1 yi + a2 y2 + + aq yq i = 1 q
and a linear combination of the X's -
Cj(x) = bj xx + b2 Xj + + bp Xp i = 1, ,p
The first canonical variables cx(y) and cx(x) are chosen such that the first canonical
correlation is a maximum. The next set of canonical variables c^y) and c2(x) are
chosen to maximise the correlation between them, and also to be uncorrected with the
first canonical variables. The process is repeated until Bartlett's (1947) test is
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nonsignificant for one of the eigenvalues.
The correlation matrix between the X's and the Y's can be partitioned thus :
R= ^XX ^XY
Ryx Ryy
where Rxx is the p x p correlation matrix of the X's and Ryy is the qxq correlation
matrix of the Y's.
The next step is to solve the eigenvalue problem :
RxyRyy 1^ktP
for eigen values Xx > > > > 0
and Pj, .... Pm are the corresponding eigenvectors where m is the effective rank of the
two sets of variables.
The canonical correlations are given by
pi=v/X7
i = l,....,m
Initially a test of whether the two sets of variables are independent is carried out using
Bartlett's (1947) test. The test statistic is
m
<1>02 = - [n-l/2 (p+g+1) ] ]JT In (1-A.j) ~ xpg2
1=1
where p is the number of X's , q is the number of Y's and m is the number of
eigenvalues.
The number of canonical variables of practical value is less than or equal to
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the smallest number of eigenvalues for which Bartlett's (1947) test for the remaining
eigenvalues is nonsignificant. The test statistic for the remaining correlations after the
first j have been removed is given by :
m
<f>/ = - [72-1/2 (p+g+1) ] Yj ln(l~X1) ~ X(p-J> (<7-J)2
i=j+l
The standardised coefficients (mean 0, variance 1) are used to interpret the results (see
for example, Chatfield and Collins 1984), large values indicating the importance of
these variables to the canonical variable compared to those with low coefficients.
However, this is difficult if the X's or the Y's or both are highly correlated with each
other. A better procedure is to consider the correlations of each canonical variable
with its component X's or Y's (Manly 1991).
In the canonical correlation analysis systolic and diastolic blood pressure were
treated as the first set of variables while the second set consisted of the rheological
variables plus age, BMI, smoking and alcohol. Natural logarithms or square root
transformations of some variables were used in the analysis as approximate





The results in table 7.1 indicate few significant relationships between systolic
blood pressure and rheological factors. Increasing age was significantly related to
systolic pressure, while BMI was just significant at the 5% level (table 7.1). In
general, high levels of the rheological factors were associated with high systolic
pressure, but only uric acid reached statistical significance (p = 0.04). Blood viscosity
was not significantly related to systolic pressure univariately.
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Table 7.1 Multiple regression of Theological factors on systolic blood pressure in
females (Adjusted R2 = 16.5%)




Packyears (square root) -1.09(0.96) 0.26
Alcohol(square root) -0.58(0.97) 0.55
BMI 2.19(1.03) 0.03
Blood viscosity 0.35(1.29) 0.79
Fibrinogen 1.09(1.09) 0.29
Leucocyte elastase(ln) 0.72(0.92) 0.44
Plasma viscosity 0.89(1.14) 0.43
Haematocrit -0.75(1.14) 0.51
Uric acid 2.07(1.03) 0.04
Urinary fib. A(ln) -0.21(0.96) 0.82
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In contrast, with diastolic pressure as outcome, uric acid was highly
significantly associated with high pressure(table 7.2). Age was again strongly related
to arterial pressure while high levels of smoking were associated with lower arterial
pressure. BMI and Blood viscosity were highly significantly related to diastolic
pressure adjusting for smoking but only approached significance at the 5% level
whenever uric acid was added to the model.
Table 7.2 Multiple regression of rheological factors on diastolic blood pressure in
females (Adjusted R2 = 6.8%)
Factor(+ 1 S.D.) Regression coefficient(se) p-value
Age 1.49(0.51) 0.003
Packyears(square root) -1.25(0.51) 0.01
Alcohol(square root) 0.57(0.52) 0.26
BMI 0.94(0.54) 0.09
Blood viscosity 1.27(0.69) 0.07
Fibrinogen 0.14(0.54) 0.77
Leucocyte elastase(ln) 0.86(0.50) 0.08
Plasma viscosity -0.19(0.61) 0.76
Haematocrit 0.61(0.62) 0.32
Uric acid 1.52(0.55) 0.006
Urinary fib. A(ln) -0.06(0.51) 0.90
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Males
In males as for females, age and BMI were significantly related to systolic
pressure (table 7.3). Alcohol was also positively related to systolic pressure (p = 0.02).
Among the rheological variables, blood viscosity was highly significantly related to
systolic pressure, which was not the case for females.
Table 7.3 Multiple regression of rheological factors on systolic blood pressure in
males (Adjusted R2 = 16.4%)
Factor(+ 1 S.D.) Regression coefficient(se) p-value
Age 7.07(0.90) <0.0001
Packyears(square root) -1.24(0.89) 0.16
Alcohol(square root) 2.10(0.88) 0.02
BMI 4.66(0.89) <0.0001
Blood viscosity 4.37(1.33) 0.001
Fibrinogen -0.07(1.04) 0.93
Leucocyte elastase(ln) -1.33(0.90) 0.14
Plasma viscosity 1.36(1.06) 0.20
Haematocrit -1.91(1.27) 0.13
Uric acid -0.22(0.87) 0.79
Urinary fib. A(ln) -0.07(0.88) 0.94
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The results for diastolic pressure were very different in males to systolic; age
was not significant while smoking was strongly related to lower pressure (table 7.4).
Blood viscosity was highly significantly associated with diastolic pressure adjusting
for smoking but only approached significance at the 5% level when uric acid was
added (p = 0.03). As for systolic pressure, BMI was highly significantly related to
high arterial pressure. The results of the multiple linear regressions were summarised
in table 7.5
Table 7.4 Multiple regression of rheological factors on diastolic blood pressure in
males (Adjusted R2 = 13.3%)





Alcohol(square root) 0.59(0.47) 0.21
BMI 3.25(0.46) <0.0001
Blood viscosity 1.06(0.70) 0.06
Fibrinogen -0.42(0.54) 0.46
Leucocyte elastase(ln) 0.27(0.48) 0.57
Plasma viscosity 0.54(0.56) 0.34
Haematocrit 0.53(0.67) 0.44
Uric acid 1.02(0.44) 0.03
Urinary fib. A(ln) 0.05(0.47) 0.91
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Table 7.5 Summary of Multiple Linear Regressions on systolic and diastolic pressure
in males and females
Regression coefficient (s.e.)
P-value
Arterial Pressure Arterial Pressure
Variable
FEMALES MALES
Systolic (Adj Diastolic (Adj Systolic (Adj Diastolic (Adj
R2=16.5%) R2=6.8%) R2=16.4%) R2=13.3%)
Age 8.69(0.95) 1.49(0.51) 7.07(0.90) 0.46(0.46)
<0.0001 0.003 <0.0001 0.32
BMI 2.19(1.03) 0.94(0.54) 4.66(0.89) 3.25(0.46)
0.03 0.09 <0.0001 <0.0001
Smoking -1.09(0.96) -1.25(0.51) -1.24(0.89) ■1.33(0.47)
0.26 0.01 0.16 0.004
Alcohol -0.58(0.97) 0.57(0.52) 2.10(0.88) 0.59(0.47)
0.55 0.26 0.02 0.21
Blood 0.35(1.29) 1.27(0.69) 4.37(1.33) 1.06(0.70)
viscosity 0.79 0.07 0.001 0.06
Uric acid 2.07(1.03) 1.52(0.55) -0.22(0.87) 1.02(0.44)




Bartlett's (1947) test showed that two canonical variables (CV) were sufficient
to describe the relationships between the two sets of variables.
Table 7.6 Standardised coefficients for canonical variables for systolic and diastolic
blood pressure in females
1st CV 2nd CV Adjusted
R2
P
Systolic 1.09 -0.568 0.168 <0.0001
Diastolic -0.187 1.22 0.068 0.006
In females the first canonical variable reflects mainly systolic blood pressure. The
second CV represents mainly diastolic blood pressure, and to some extent the
difference between diastolic and systolic pressure, although this was difficult to
interpret.
The adjusted R2 values (table 7.6) show that 17% of the information in the
variable systolic can be accounted for by a combination of the risk factors in females
while only 7% of the diastolic variable is represented. Although somewhat arbitrary,
high values for the standardised coefficients of the risk factors have been highlighted
in table 7.7, showing that the first canonical variable represents mainly age, BMI, and
uric acid. Systolic and diastolic blood pressure represent 15% of the information in
age while their combination represents 4% of uric acid. Thus systolic is mainly related
to age, BMI and uric acid, while the combination of diastolic and systolic pressure as
represented by the second canonical variable is related to blood viscosity, uric acid
and smoking in females.
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Table 7.7 Standardised coefficients of canonical variables for risk factors in females
1st CV 2nd CV Adjusted
R2
P
Fibrinogen 0.103 -0.033 0.02 0.003
Haematocrit -0.113 0.339 0.01 0.003
Plasma
viscosity(ln)
0.085 -0.164 0.01 0.003
Blood
viscosity(ln)
0.009 0.448 0.02 0.0003
Leucocyte
elastase(ln)
0.046 0.280 0.00 0.12
Uric acid 0.164 0.400 0.04 <0.0001
Urinary
fib. A
-0.022 -0.010 0.00 0.94
Age 0.851 0.205 0.15 <0.0001
BMI 0.193 0.167 0.02 0.0003
Packyears
(square root)
-0.067 -0.405 0.00 0.09
Alcohol
(square root)
-0.081 0.290 0.01 0.009
In - Natural logarithm
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Males
As with females there were two canonical variables necessary to describe the
relationships between the two sets of variables.
Table 7.8 Standardised coefficients for canonical variables for systolic and diastolic
blood pressure in males
1st CV 2nd CV Adjusted
R2
P
Systolic 0.95 -0.80 0.165 <0.0001
Diastolic 0.09 1.24 0.136 <0.0001
The first canonical variable represents mainly systolic blood pressure , while the
second although mainly diastolic, also represents the difference between systolic and
diastolic pressure.
From table 7.9 systolic (1st CV) is related to age, BMI, and blood viscosity
while the second CV (mainly diastolic, but also to some extent reflecting systolic
pressure) is related to age, BMI, uric acid and haematocrit.
The results are consistent with the multiple linear regressions shown earlier
(table 7.5) especially for the regressions on systolic pressure compared to the first
canonical variable. It is more difficult to compare the second canonical variable which
represents the difference between the measures of arterial pressure, although with
greater weight towards diastolic pressure.
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Table 7.9 Standardised coefficients of canonical variables for risk factors in males
1st CV 2nd CV Adjusted
R2
P
Fibrinogen -0.008 -0.109 0.016 0.002
Haematocrit -0.205 0.311 0.02 0.0005
Plasma
viscosity(ln)
0.101 0.026 0.026 0.0001
Blood
viscosity(ln)
0.499 -0.057 0.047 <0.0001
Leucocyte
elastase(ln)
-0.117 0.205 0.00 0.11
Uric acid -0.005 0.320 0.036 <0.0001
Urinary
fib. A
-0.011 0.042 -0.002 0.85
Age 0.693 -0.547 0.119 <0.0001
BMI 0.517 0.496 0.106 <0.0001
Packyears
(square root)
-0.147 -0.258 0.004 0.09
Alcohol
(square root)
0.217 -0.026 0.00 0.42
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7.4 Discussion
The Edinburgh Artery Study was the first study which related arterial pressure
to blood viscosity in a random sample of a population aged 55 - 74 years. The results
showed a strong relationship between systolic blood pressure and age, BMI, and blood
viscosity in males. The results of the canonical correlation were similar to those of the
simpler multiple linear regression, although more difficult to interpret. Canonical
correlation is a useful technique when multiple outcomes are present, but in this case,
the results of the multiple regression were preferable as they were consistent with the
more sophisticated analysis and easier to interpret. Diastolic blood pressure was
mainly related to age and uric acid in both males and females, but more strongly in
females. Diastolic pressure was significantly related to blood viscosity adjusted for
smoking in males and females, but not independently of uric acid.
The overall results were consistent with results from the Scottish Heart Health
study (Smith et al 1992) and case-control studies on patients with hypertension
(Tibblin et al 1966, Letcher et al 1981, Isles et al 1984). Although plasma viscosity,
fibrinogen and haematocrit are principal determinants of blood viscosity (Lowe GDO
1987), blood viscosity made a significant contribution to systolic blood pressure in
males independently of these components. Letcher et al (1981) also found that high
blood viscosity in hypertensives was due only in part to increases in fibrinogen and
haematocrit. Age, alcohol, and BMI were also related to systolic blood pressure. Age
increases arterial pressure as does BMI.
The fact that the relationship between systolic and blood viscosity was only
significant in males is difficult to explain. However, other studies (Lee et al 1990) and
the previous chapter showed that there were male-female differences in the
relationship of rheological factors and atherosclerotic disease and hence males and
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females have been analysed separately. Almost all the women were over 55 years and
so would have been post-menopausal when male/female differences in cardiovascular
disease are thought to diminish, although Isles et al (1992) found that protection from
coronary heart disease mortality persisted after the menopause.
Fibrinogen was not independently related to arterial pressure. Other studies
(Karsen-Bengtsen et al 1972, Kannel et al 1985a) have suggested that fibrinogen is
related to systolic pressure in the general population but often on adjustment for other
factors the relationship became nonsignificant (Karsen-Bengtsen et al 1972). Overall,
the evidence suggests that fibrinogen does not have an independent relationship with
blood pressure in the general population. In a similar manner, haematocrit has been
shown to be related to arterial pressure in community studies (McDonough et al 1965,
Kannel et al 1972, Sortie et al 1981). In the Edinburgh Artery Study, haematocrit was
related only to diastolic pressure and was not independently related after adjustment
for other risk factors and rheological variables.
The relationship between systolic blood pressure and blood viscosity in males
cannot solely be explained by an increased haematocrit in which the contracted plasma
volume is known to be directly related to arterial pressure and to the associated
transcapillary shift of extracellular fluid (Kobrin et al 1984). Nor is it likely to be
related to elevations of plasma proteins which occur in hypertensives because these
increases mirror those of haematocrit and are probably due simply to plasma volume
contraction (Letcher et al 1981).
The pathophysiological significance of increased blood viscosity in
hypertension is also not clearly known. In theory, it should contribute to increased
peripheral resistance, and this is supported by correlations with haemodynamics in
vivo (Devereux et al 1984). Furthermore, the increased blood viscosity might increase
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cardiac afterload and promote left ventricular hypertrophy; this is supported by a
stronger correlation of left ventricular hypertrophy to blood viscosity than to any other
haemodynamic factor (Chien et al 1985). This effect is however unlikely to explain
the association of viscosity and systolic hypertension in the general population in
which relatively few people have left ventricular hypertrophy (less than 1% of the
subjects in the Edinburgh Artery study had good electocardiogram evidence in the
form of large R waves and left axis deviation.)
Although blood pressure itself cannot be used as a risk factor for peripheral
arterial disease as indicated by the ABPI, blood viscosity in males along with age and
BMI could act as markers. In males these were strongly related to systolic pressure,
17% of the variability of which could be explained by rheological factors. Thus
through the analysis in the previous chapter it can be postulated that systolic pressure
was related to peripheral arterial disease through the rheological factors and especially
through blood viscosity in males. In females systolic blood pressure was mainly






The main aims of genetic analyses are to identify whether genes are associated with
the occurrence of disease and if so, which genes are involved. The development of
polymorphic DNA markers or restriction fragment length polymorphisms (RFLPs) has
led to the identification of all chromosomal regions, which has furthered these aims.
One approach is to compare the frequency of a particular genetic marker between
cases of disease and matched controls. The DNA polymorphisms within a tightly
linked cluster of genes show the phenomenon of linkage disequilibrium (Bodmer
1987). Crossing over within the cluster is infrequent and so DNA markers in the group
tend to be inherited en bloc as a haplotype. New markers or disease causing mutations
arising within the cluster thus are associated with the haplotype of origin and only
slowly over many generations lose this association. Thus it would be expected that a
case-control study would reveal an excess of a particular haplotype amongst the cases
of disease compared with the general population. The drawback of all such genetic
analyses is that as multiple markers are usually studied, the chance of reaching
statistical significance is high when multiple tests are carried out.
Genes are known to contribute to variation in populations in the levels of
fibrinogen, lipids, and other risk factors, sometimes known as 'level' genes. In
addition, they also contribute to setting the framework within which lifestyle or dietary
factors can cause variation, known as 'variability' genes (Berg and Kerulf, 1989).
Restriction fragment length polymorphisms (RFLP) allow the study of genetic
variation at the fibrinogen locus in relation to plasma fibrinogen concentrations.
Increased levels of plasma fibrinogen have been shown in longitudinal studies
95
to be associated with an increased risk of CHD and stroke (Meade et al 1986,
Wilhelmson et al 1984, Kannel et al 1987) and in epidemiological studies to be
associated with peripheral arterial disease (Kannel et al 1990, Lowe et al 1991b).
Plasma fibrinogen increases with age and cigarette smoking (Meade et al 1979,1987)
but when corrected for these factors still emerged in the above studies as an
independent risk factor. Other factors associated with high levels of plasma fibrinogen
were social class (Markowe et al 1985), diabetes mellitus (Fuller et al 1979), and low
alcohol consumption (Lee et al 1990). In women the use of oral contraceptives and
post-menopause were associated with raised plasma fibrinogen (Lee et al 1990).
It might be expected that genetic variation would be involved in elevated levels
of plasma fibrinogen which have been shown to be associated with peripheral arterial
disease (chapter 6). However, controversy surrounds the role of genetic variation in
affecting plasma fibrinogen levels.
Fibrinogen is synthesised in the liver from three polypeptide subunits ; alpha,
beta and gamma, which occur as a linked cluster of genes on the long arm of
chromosome 4. Humphries et al (1987) compared levels of fibrinogen (adjusted for
age, sex and smoking) in 91 healthy volunteers genotyped at the fibrinogen alpha and
beta loci and estimated that genetic variation at these loci accounted for 15% of the
total variation. This is lower than the finding by Hamsten et al (1987) who, on the
basis of path analysis, found that 50% of the variation of plasma fibrinogen was due
to genetic factors. On the other hand, Berg and Kerulf (1989) found low heritability
of levels of fibrinogen in a Norwegian twin study and found no association between
fibrinogen levels and fibrinogen alpha and beta genotypes.
One drawback of these studies was that they did not examine the relationship
between fibrinogen genotype and atherosclerotic disease. Genetic information was
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collected in the Edinburgh case-control study, described in chapter 2, allowing the role
of fibrinogen haplotytpes as risk factors for peripheral arterial disease to be examined.
In addition, the role of genetic variation at the fibrinogen loci in determining the level
of plasma fibrinogen was assessed.
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8.2 Methods
8.2.1 Measurement of fibrinogen and fibrinogen haplotypes
Details of the methods of the case-control study are described in chapter 2.
Following invitation all subjects who attended the clinic had blood samples taken in
the morning in the fasting state. Samples of plasma, white blood cell pellets and DNA
preparations were obtained. Plasma fibrinogen levels were measured in two ways;
firstly in citrated plasma by a thrombin-clotting turbidometric method in a centifugal
analyser (Lowe et al 1991b). Secondly, fibrinogen levels were assayed by heat
precipitation using a nephelometric method (Stone et al 1985). Details of how DNA
was extracted are described in Connor et al (1992). The DNA probes used were alpha,
beta, and gamma which detect polymorphic fragments of 2.4kb and 1.6kb (TaqI),
5.3kb and 4.2kb (Bell), and 14kb and 1 lkb (KpnI/SacI) respectively (the appropriate
restriction enzymes indicated in parentheses in each instance). Gene frequencies were
calculated by gene counting and compared to Hardy-Weinberg frequencies by chi-
squared tests. The expected frequencies of genotypes are x2, 2x (1 - x), and (1 - x)2




As the fibrinogen concentrations measured by the clotting methods were
positively skewed, a logarithmic transformation was used yielding geometric means
and their confidence intervals as summary measures. Cumulative smoking was
expressed in terms of packyears, that is, the average number of packs of 20 cigarettes
smoked per day multiplied by the number of years of smoking. Analysis of
covariance was used to assess differences in fibrinogen between genotypes or
haplotypes adjusting for age, sex, and cumulative smoking. One way analysis of
variance was carried out on the adjusted fibrinogen values to assess the phenotypic
variability. The percentage of phenotypic variability (PV) in fibrinogen values
associated with RFLP genotypes was estimated as described by Sing and Davignon
(1985).
The formula used was PV = 100 x genotype variance/(genotype variance + within
genotype variance), where the within genotype variance is obtained from the one way
analysis of variance and the genotype variance ( aG2 ) is estimated as the sum of the
observed relative frequency of the genotype multiplied by the square of the deviation
of the mean of the genotype from the grand mean. This assumes that the observed
relative frequency does not differ from the expected Hardy-Weinberg frequency.
The estimate of between genotype variability (aB2) was also expressed as a
percentage of the total variability (cw2 +oB2) obtained from the one way analysis of
variance.
The between group variability was calculated as :
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where sB = between group mean square;
sw = within group mean square; and
1 ,
*~TRl JTnn=
k = number of groups; N = total = E rij for unequal n; (i = 1, ,k). This is sensible
as long as the n; are not very different (Armitage 1971).
As well as genetic factors determining the level of plasma fibrinogen it is
possible that specific haplotypes or genotypes may be more associated with disease
than others, the so-called 'variability' genes (Berg and Kerulf, 1989). In order to
assess this, dummy variables were created which represent each haplotype with
reference to the most common haplotype (2.4/2.4, 5.3/5.3, 11/11). These were added
in a multiple logistic regression model on peripheral arterial disease with adjustments
for smoking as measured by packyears and current and ex-smokers, and level of
clotting fibrinogen. Hence, one aim of this model is to assess the possible association
of haplotypes at fibrinogen loci and peripheral arterial disease, irrespective of the level
of plasma fibrinogen. Since the cases and controls were frequency matched, all
analyses were adjusted for age and sex (Schlesselman , 1982). In addition, two dummy
variables for the beta-locus were used to assess whether particular genotypes were
associated with disease as found by Humphries et al (1987).
The main drawback of the haplotype analysis is the multiple testing involved.
Humphries et al (1987) had drawn attention to a possible association of the (3
genotypes with fibrinogen level. Two dummy variables were created for the 5.3/4.2
and 4.2/4.2 genotypes relative to the 5.3/5.3 genotype at the (3 polymorphism and the
100




8.3.1 Plasma fibrinogen and fibrinogen haplotype
Out of the 306 subjects invited to the clinic 121 cases and 126 controls
attended giving an overall response rate of 81%. Of the attenders, 3 individuals did
not have blood taken and a further 11 had at least 1 missing allele and so could not
be classified according to haplotype. In both the cases and control groups, the
attenders did not differ significantly from non-attenders in terms of age, sex, cigarette
smoking, prevalence of intermittent claudication and mean ABPI. Smoking in terms
of packyears was higher in the cases, while the mean age of both cases and controls
was 69 years and there were no differences in the proportions of males and females
(Table 8.1).
Table 8.1 Characteristics of Cases and Controls
Cases (n=114) Controls (n=119)
Variable
Mean (s.e.) Mean (s.e.)
Packyears
(Square root)
4.80 (0.25) 1.92 (0.22)
Age 69.2 (0.5) 69.2 (0.5)
Sex : Females 56 (49%) 56 (47%)
Males 58 (51%) 62 (52%)
The overall frequencies for each polymorphic allele in the 247 subjects were 0.75 for
the 2.4kb allele and 0.25 for the 1.6 kb allele at the alpha fibrinogen locus; 0.85 for
the 5.3 kb allele and 0.15 for the 4.2 kb allele at the beta fibrinogen locus; and 0.24
for the 14 kb and 0.76 for the 11 kb alleles at the gamma fibrinogen locus. The
frequencies of allele combinations (genotypes) were not significantly different from
Hardy-Weinberg frequencies for all three loci (Table 8.2).
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Table 8.2 Comparison of observed genotype numbers to those


















X2! = 0.128 (N.S.)
Of the 27 possible combinations of genotypes only 13 haplotypes were observed
(Table 8.3).
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Table 8.3 Combinations of genotypes to form haplotypes in cases and controls
combined
a - locus P - locus y - locus
enzyme enzyme enzyme
Haplotype Taq I BCL I KPN n(% )
1 2.4/2.4 5.3/5.3 11/11 87 (37)
2 2.4/1.6 5.3/5.3 14/11 57 (24)
3 2.4/2.4 5.3/4.2 11/11 37 (15)
4 2.4/1.6 5.3/5.3 11/11 10(4)
5 2.4/1.6 5.3/4.2 14/11 16(7)
6 1.6/1.6 5.3/5.3 14/14 12(5)
7 2.4/2.4 4.2/4.2 11/11 4(2)
8 2.4/2.4 5.3/5.3 14/11 6(3)
9 1.6/1.6 5.3/4.2 14/14 1 (0.4)
10 2.4/1.6 5.3/4.2 11/11 1 (0.4)
11 2.4/2.4 5.3/4.2 14/11 1 (0.4)
12 1.6/1.6 5.3/5.3 14/11 2 (0.8)
13 2.4/1.6 4.2/4.2 14/11 2 (0.8)
236*
*
5 subsets with at least 1 missing allele
Table 8.4 shows the mean fibrinogen levels adjusted for age, sex, and smoking
according to the RFLPs. The fibrinogen values were calculated by analysis of
covariance adjusting for age, sex, and packyears. There were no significant differences
in plasma fibrinogen levels between genotypes for the RFLPs. The genotypes with the
highest fibrinogen levels were 2.4/1.6 at the a-polymorphism and 5.3/4.2 at the (3-
polymorphism for fibrinogen measured by the clotting method.
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Alpha-locus Geometric Mean(95%C.I.) Mean (95% CJ.)
2.4/2.4 2.89 (2.76,3.00) 4.06 (3.92,4.22)
2.4/1.6 3.02 (2.88,3.16) 4.32 (4.13,4.51)
1.6/1.6 2.86 (2.56,3.21) 4.33 (3.88,4.78)
p -value 0.43 0.12
Beta-locus Geometric mean(95%C.I.) Mean (95% CJ.)
5.3/5.3 2.90 (2.81,3.01) 4.13 (3.99,4.26)
5.3/4.2 3.04 (2.86,3.22) 4.34 (3.60,5.07)
4.2/4.2 2.82 (2.36,3.38) 4.39 (3.65,5.12)
p-value 0.32 0.30
Gamma-locus Geometric Mean(95%C.I.) Mean (95% CJ.)
14/14 2.91 (2.58,3.29) 4.41 (3.92,4.90)
14/11 2.95 (2.81,3.09) 4.28 (4.09,4.47)
11/11 2.93 (2.82,3.04) 4.09 (3.95,4.25)
p-value 0.98 0.23
*
Adjusted by age, sex, and smoking as measured by packyears 95% confidence
intervals based on pooled standard deviation
The three loci were combined to form the 13 haplotypes (Table 8.3)and comparison
of fibrinogen level (adjusted for age, sex, and smoking) according to haplotype
showed no significant association (Table 8.5). The between haplotypes variability
explained a negligible percentage of the total variability.
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Table 8.5 Plasma fibrinogen level(adjusted by age, sex and smoking) by haplotype
Fibrinogen-Clotting Method Fibrinogen-Nephelometric Method
Haplotype Geometric Mean
(95%CJ.)*
n Mean(95% C.I.)* n
1 2.89 (2.75,3.03) 81 4.01(3.82,4.21) 85
2 2.90 (2.73,3.08) 52 4.19 (3.94,4.44) 54
3 2.97 (2.75,3.20) 34 4.18 (3.87,4.48) 36
4 3.32 (2.83,3.89) 10 4.39 (3.75,5.04) 10
5 3.22 (2.86,3.64) 15 4.64 (4.15,5.14) 15
6 2.97 (2.49,3.54) 11 4.39 (3.79,4.99) 12
7 2.64 (1.85,3.78) 4 4.25 (2.80,5.69) 4
8 2.65 (2.09,3.35) 6 4.04 (3.07,4.97) 6
9 2.52 1 4.63 - 1
10 3.21 1 4.38 - 1
11 4.04 1 4.38 - 1
12 2.71 (1.37,5.36) 2 3.82 (1.06,5.57) 2
13 3.03 (1.53,5.99) 2 4.61 (1.86,7.36) 2
Total 2.93 (2.91,2.96) 220 4.19 (4.15,4.23) 229
p-value 0.52 0.71





95% confidence interval based on pooled standard deviation
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8.3.2 Fibrinogen haplotypes as risk factors
The proportions of genotypes 2.4/1.6 for the a-locus and 5.3/4.2, 4.2/4.2 genotypes
for the P-locus were higher in the cases compared to the controls (Table 8.6). The
differences in proportions were only significant for the j3-locus (p = 0.01).
Table 8.6 Distribution of genotypes in cases and controls
Controls Cases
Alpha-locus Number ( % ) Number ( % )
2.4/2.4 71 ( 59) 64 ( 56)
2.4/1.6 38 ( 32) 47 ( 41)
1.6/1.6 11 ( 9) 4 ( 3)
p = 0.11
Beta-locus Number ( % ) Number ( % )
5.3/5.3 97 ( 81) 74 ( 65)
5.3/4.2 21 ( 18) 35 ( 31)
4.2/4.2 1 ( 1) 5 ( 4)
p = 0.01
Gamma-locus Number ( % ) Number ( % )
14/14 9 ( 8) 4 ( 4)
14/11 40 ( 33) 43 ( 37)
11/11 71 (59) 68 ( 59)
p = 0.37
The frequency of haplotypes show some differences between cases and controls, with
haplotype 3 (2.4/2.4, 5.3/4.2, 11/11), haplotype 4 (2.4/1.6, 5.3/5.3, 11/11), haplotype
5 (2.4/1.6, 5.3/4.2, 14/11) and haplotype 7 (2.4/2.4, 4.2/4.2, 11/11) occurring more
frequently in cases of peripheral arterial disease compared to the controls (Table 8.7).
Overall, the differences in distribution of haplotypes between cases and controls was
not significant (p = 0.14).
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Table 8.7 Distribution of haplotypes by cases and controls
Haplotype Controls n ( % ) Cases n ( % )
1 49 (57) 37 (43)
2 30 (55) 25 (45)
3 16 (43) 21 (57)
4 4 (40) 6 (60)
5 4 (25) 12 (75)
6 8 (67) 4 (33)
7 1 (25) 3 (75)
8 4 (67) 2 (33)
9 1 (100) 0
10 0 1 (100)
11 0 1 (100)
12 2 (100) 0
13 0 2 (100)
When the haplotype dummy variables were added in the logistic regression
model, adjusting for age and sex alone (Table 8.8), haplotype 3 (at 10% level) and
haplotype 5 (5% level) relative to haplotype 1 were significant predictors of disease.
An increase in log fibrinogen units of 0.2 was associated with an odds ratio of disease
of 1.82 (95% C.I. 1.38,2.41) (Table 8.8), when adjusted for age and sex alone. On
adding the haplotype dummy variables the odds ratio for fibrinogen reduced to 1.77
showing little change. Clotting fibrinogen remained highly significant (p<0.001), and
haplotypes 3 and 5 were significant predictors of disease (10% level). Smoking was
positively associated with peripheral arterial disease, while haplotype 3 had the lowest
proportion of smokers relative to other haplotypes. When smoking as packyears and
current and ex-smokers (less than 5 years) were added to this model the odds ratio for
clotting fibrinogen was reduced to 1.52 (95% C.I. 1.08,2.14)(Table 8.8), although
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remaining significant. The odds ratios for haplotypes 3 and 5 increased and were
significant predictors (5% level) of disease. Further analyses adjusting additionally
for BMI, alcohol and social class did not alter the significance of the haplotype
variables and none were independently associated with disease.
Table 8.8 Univariate and Multivariate logistic regressions of fibrinogen haplotypes,



























(2.5 ,7.2 )*** (2.43,8.22)***
Current 0.9 1.27
(0.3 ,2.3 ) (0.42,3.85)
Ex-Smokers 0.56 0.56
(0.2 ,2.2 ) (0.13,2.36)
$ change in packyears in one standard deviation on square root
scale; current and ex-smokers < 5 years are compared to non-
smokers adjusted for packyears
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On repeating the analyses for the two dummy variables (Table 8.9) for the (3-
polymorphism, the odds ratio was 3.67 (95% C.I. 1.60, 8.40) after adjusting for
clotting fibrinogen, smoking and age and sex for the 5.3/4.2 genotype relative to the
5.3/5.3 genotype (p = 0.003). In addition, the dummy variable representing the 4.2/4.2
genotype relative to the 5.3/4.2 genotype was just significant at the 5% level, although
the confidence interval was wide reflecting the low number of this particular genotype.
Table 8.9 Univariate and Multivariate logistic regressions of fl-fibrinogen genotypes,
cigarette smoking and plasma fibrinogen, adjusted for age and sex on peripheral
arterial disease
Genotype Univariate Multivariate
(relative to Odds Ratio Odds Ratio












(2.5 ,7.2 )*** (2.42,7.51)***
Current 0.9 1.12
(0.3 ,2.3 ) (0.40,3.11)
Ex-Smokers 0.56 0.62
(0.2 ,2.2 ) (0.16,2.43)
$ change in packyears in one standard deviation on square root scale; current and ex-
smokers < 5 years are compared to non- smokers adjusted for packyears
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8.4 Discussion
These results tend to agree with those of Berg and Kerulf (1989) who found
no relationship between genotype in two polymorphisms (alpha and beta) and plasma
fibrinogen level. This population differs from that of Berg and Kerulf (1989) and
Humphries et al (1987) which consisted of 91 healthy volunteers, so it is difficult to
make comparisons. It is noticeable that the results of Humphries et al (1987) who
found a significant association between plasma fibrinogen and the polymorphism
detected at the beta locus were mainly due to two individuals with very high plasma
fibrinogen levels. The number of key homozygous subjects in this study was small and
this along with the within person variation of plasma fibrinogen level over time are
the main problems in such studies. This suggests that further studies are required
where a large random sample of the general population is taken rather than volunteers
and followed up over a suitable period of time. On the basis of the results in the
Edinburgh case-control study it appeared that genetic factors did not greatly affect the
level of plasma fibrinogen.
The analysis was taken a stage further by examining the influence of fibrinogen
haplotype and genotype on the odds of peripheral arterial disease. The logistic
regression results are consistent with the idea of 'variability' genes (Berg and
Kerulf,1989). Despite little relationship between plasma fibrinogen level and genotype,
there were significant univariate associations between disease and haplotypes 3 and
5 relative to haplotype 1. This relationship was also independent of fibrinogen level,
smoking, alcohol, social class and BMI which are all associated with plasma
fibrinogen level. Caution should be applied in interpreting these two significant results
at the 5% level with multiple dummy variables in the regression model. By
concentrating on the ^-polymorphism as highlighted by Humphries et al (1987), the
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problem of multiple tests is reduced and a highly significant relationship (p = 0.003)
was found. An increased odds for peripheral arterial disease of approximately three
and a half times was found for the genotype 5.3/4.2 relative to the genotype 5.3/5.3,
adjusting for plasma fibrinogen, smoking and age and sex. The genotype 4.2/4.2 was
also found to be significantly associated with peripheral disease although there were
low numbers of this genotype. This was the genotype found by Humphries et al
(1987) to be associated with the highest fibrinogen levels in their study and so there
was some consistency with this finding. However, the Edinburgh case-control study
found the genotype 5.3/4.2 to be associated with the highest fibrinogen level and a
significant independent risk factor for peripheral arterial disease Hence, the results
suggested that genes at the fibrinogen loci may indicate a predisposition to peripheral
arterial disease or operate on lifestyle risk factors independently of the risk factors of
plasma fibrinogen level and smoking.
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CHAPTER 9
LIFESTYLE AND INTERMEDIARY RISK FACTORS
9.1 Introduction
This chapter will assess combinations of the risk factors which were considered
separately in the previous chapters. Social class or the closely related measure, social
deprivation (Carstairs and Morris 1991), has been shown to be related to ischaemic
heart disease (Pocock et al 1987, Rose and Marmot 1981) and so may be an important
factor for peripheral arterial disease. Hence social class will also be considered as a
risk factor and its relation to other risk factors will be discussed in this chapter.
It is useful to consider the risk factors as roughly forming two clusters which
could be thought of as elements in a causal chain, that is, 'Lifestyle' factors which are
related to the 'Intermediary' factors which in turn are more directly related to
peripheral arterial disease. The lifestyle factors consist of diet, leisure activity,
smoking, and alcohol along with personality, while the rheological variables and HDL
and nonHDl cholesterol, along with triglycerides form the 'intermediary' grouping. In
all the analyses adjustment for age has been carried out, and height and indication of
known diabetes has been assessed initially with the second grouping. This is a
tentative network which does have some face validity as lifestyle factors can be seen
as preceding the more immediate blood risk factors which to a large extent they help
to determine. For example, lack of exercise is associated with higher blood viscosity
(Ernst 1985) which in turn is associated with higher risk of coronary heart disease
(Kannel and Sorlie 1979a) and peripheral arterial disease (chapter 6). The Lifestyle
factors are all related to social class, as are many of the intermediary factors.
As fibrinogen haplotype was only available for the case-control study and the
power to detect associations with disease when a large number of variables is
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considered is low, the analysis of fibrinogen haplotype will not be explored further.
This chapter will then assess the independence of all risk factors for peripheral
arterial disease, as measured in the cross-sectional part of the Edinburgh Artery Study




Many sex by risk factor interactions have been found in previous analyses
(chapters 3-7) , and consequently the results have been presented for males and
females separately. Lifestyle and personality factors were considered first followed by
the rheological and lipids and finally all factors were analysed simultaneously.
The relationship between risk factors considered in previous chapters and social
class was initially assessed by tests for linear trend in mean levels for continuous
variables or proportions for categorical variables across social class. The classification
of social class was I - Professional, II- Intermediate, in - Non-manual/clerical, Ill-
Skilled, manual, IV - Semi-skilled manual, V-Unskilled, manual , VI and VII -
Unknown/unclassified according to the classification of occupations (OPCS 1980). The
unemployed and retired were classified according to longest held occupation, and
married women were assigned to their husband's social class. The independence of
risk factors was assessed using multiple linear regression with the ABPI as an
indicator of peripheral arterial disease.
As there was a danger of multiple testing with such a large number of
variables which can undermine statistically significant results, the regression analyses
were restricted to those variables which were either approaching statistical significance
or significant at the 5% level in analyses in previous chapters. Nevertheless the
problem still remains and so marginally significant results were treated with caution.
Since smoking as indicated by packyears has been shown to be one of the strongest






Social class was strongly linearly related to many dietary variable intakes with
significantly lower intake of energy adjusted vitamin C, [3-carotene and cereal fibre
in lower social classes (Table 9.1). A similar trend is shown for a-tocopherol but this
did not reach statistical significance at the 5% level. Height and alcohol intake were
significantly lower in lower social classes while BMI was higher in lower social
classes (all p < 0.0001). Cigarette smoking was also significantly (p = 0.02) higher in
lower social classes, although not in a strongly linear fashion. Social class was
significantly related to leisure activity with greater prevalence of strong/moderate
activity aged 35-45 in higher social classes. Most importantly social class was not
significantly related to the ABPI. This suggested that social class was not a true
confounder of the relationships between other risk factors and peripheral arterial
disease in females.
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Table 9.1 Trend in mean (se) ABPI and lifestyle risk factors for peripheral arterial
















ABPI 1.02 1.00 1.00 1.01 1.00 1.02 0.89
(0.02) (0.01) (0.01) (0.01) (0.02) (0.03)
P-carotene 8.41 8.17 8.10 8.02 8.03 7.51 <0.0001
(0.07) (0.05) (0.06) (0.06) (0.06) (0.10)
Vitamin C 83.7 80.4 73.2 76.9 72.9 62.1 0.0001
(3.3) (1.7) (1.8) (2.2) (3.6) (4.0)
Cereal Fibre 2.52 2.39 2.25 2.40 2.23 2.14 0.0001
(0.04) (0.03) (0.03) (0.04) (0.06) (0.07)
a-tocopherol 2.43 2.35 2.28 2.40 2.28 2.20 0.06
(0.06) (0.03) (0.03) (0.04) (0.06) (0.06)
Height(cm) 161.9 160.4 157.7 159.7 156.7 155.1 <0.0001
(0.8) (0.4) (0.4) (0.5) (0.7) (1.1)
Alcohol 1.89 1.63 1.00 1.04 1.02 0.77 <0.0001
(0.17) (0.09) (0.08) (0.09) (0.16) (0.20)
Packyears 1.92 1.94 2.38 2.18 2.85 2.35 0.02
(0.27) (0.15) (0.18) (0.20) (0.39) (0.47)
Leisure 62.2 % 55.0% 23.7 % 39.6 % 24.3 % 9.4 % <0.0001
activity(n) (46) (132) (49) (63) (17) (3)
Str/Mod.
Males
Unlike in females, there was a significant linear trend of mean ABPI across
social class categories in males (table 9.2), and so social class could be considered a
true confounder in males. As with females, vitamin C and cereal fibre showed strong
linear trends with significantly lower mean levels in lower social classes while a-
tocopherol was also highly significant (p = 0.003) with p-carotene, only just
significant (p = 0.02). Height had a similar relationship in males compared to females;
shorter mean height in lower social classes (table 9.2). Alcohol has a similar
relationship as in females, while the actual intake is much greater in males compared
to females for all social classes. Similarly, smoking levels are higher in males
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compared to females and showed a stronger linear trend with higher mean packyears
in lower social classes (p < 0.0001). Another lifestyle factor which shows a strong
relationship is leisure activity with greater percentages indulging in strenuous or
moderate activity aged 35-45 years in higher social classes. Mean overt hostile acts
is lowest in social class I but there was no significant trend across social class
categories. Hostile acts was not assessed for females as previous analyses (chapter 5)
had shown no significant relationship to peripheral arterial disease.
Table 9.2 Trend in mean (se) ABPI and lifestyle and hostility risk factors for
















ABPI 1.11 1.07 1.03 1.04 1.03 1.06 0.004
(0.02) (0.01) (0.01) (0.02) (0.03) (0.03)
P-carotene 8.1 8.0 7.9 7.9 7.9 7.6 0.02
(0.07) (0.05) (0.06) (0.09) (0.12) (0.23)
Vitamin C 69.3 66.4 58.7 58.9 57.5 50.9 <0.0001
(2.5) (1.5) (1.6) (2.2) (2.4) (3.6)
Cereal Fibre 2.46 2.42 2.25 2.29 2.22 2.13 <0.0001
(0.05) (0.03) (0.03) (0.05) (0.05) (0.07)
a-tocopherol 2.30 2.38 2.20 2.27 2.14 2.21 0.0003
(0.04) (0.03) (0.03) (0.05) (0.05) (0.07)
Hostile Acts 13.4 14.2 14.9 14.2 14.2 14.3 0.06
(0.2) (0.2) (0.2) (0.3) (0.4) (0.6)
Height (cm) 175.9 173.9 170.3 171.6 167.8 167.1 <0.0001
(0.7) (0.4) (0.4) (0.7) (0.8) (1.4)
Alcohol 3.12 2.72 2.90 2.50 2.69 1.76 0.01
(0.17) (0.13) (0.14) (0.23) (0.27) (0.31)
Packyears 2.95 3.34 4.17 3.93 4.47 4.32 <0.0001
(0.29) (0.18) (0.18) (0.31) (0.36) (0.62)
Leisure 79.8% 80.0% 57.6% 58.9% 46.2% 34.4% <0.0001




Previous analyses in chapter 4 had shown a significant (p = 0.02) three way
interaction of sex by smoking by leisure activity. Consequently, multiple linear
regressions were carried out separately for males and females. Smoking was the
strongest lifestyle risk factor along with age in females. There were no significant
smoking by lifestyle factor interactions in females.
In males there was a significant smoking by hostile acts interaction(p = 0.008)
but this became non-significant on adding a leisure activity by smoking interaction.
Leisure activity was strongly correlated with hostile acts in males (p = 0.03) and also
vitamin C intake (p <0.001). Vitamin C intake was significantly higher in males
(p<0.001) and females (p<0.001) in those who indulged in strenuous/moderate leisure
activity aged 35-45. As shown in tables 9.1 and 9.2 the prevalence of taking part in
leisure activity was lower in lower social classes, showing significant linear trends (p
< 0.0001) in proportions of strenuous/moderate activity aged 35-45. In other words
leisure activity may be a marker for various lifestyle, personality and social class
characteristics and hence if added to a multiple linear regression model other lifestyle
and personality factors to which it was related became non-significant. Hence hostile
acts was not a risk factor independently of leisure activity and social class.
Leisure activity showed a significant increase in the ABPI for
strenuous/moderate activity relative to none only in those who ever smoked. Hence
it appears that taking part in leisure activity aged 35-45 goes some way to ameliorate
the cumulative effects of cigarette smoking but does not compensate completely.
Amongst those who never smoked there were associations also with leisure activity
but these did not reach statistical significance, presumably because the benefit of
119
activity is relatively smaller as non-smokers already had high levels of the ABPI.
Alcohol was positively related to the ABPI in males but not in females, suggesting a
possible beneficial effect of alcohol.
Table 9.3 Multiple regression of Lifestyle factors on the ABPI in males and females











(Square root) (0.51) (0.59)
Age -3.15*" -3.20***
(0.57) (0.67)
Alcohol units 0.48 1.87*
(Square root) (0.61) (0.80)
Leisure Activity:
Ever smoked
Light activity 0.9 4.5
vs. none (2.2) (2.8)
Moderate activity 0.5 5.8*
vs none (2.3) (2.6)
Strenuous activity 1.8 7.1*
vs. none (4.6) (3.0)
Never smoked
Light activity 2.2 3.7
vs none (2.2) (3.8)
Moderate activity 2.1 2.5
vs. none (2.3) (3.3)
Strenuous activity -6.0 4.8
vs. none (5.3) (4.0)
120
Social class was shown to be significantly related to the ABPI in males on
simple linear regression (p = 0.002) but on progressively adding height, age, leisure
activity and smoking it became non-significant (table 9.4), indicating that social class
was an important risk factor but was not independendy related to the ABPI.
Table 9.4 Relationship between Social Class and Lifestyle factors in males in multiple






Social Class - 1.7 0.002
Social Class + Age - 1.6 0.002
Social Class + Age + Height - 0.5 0.017
Social Class + Age + Height + Leisure
activity
- 0.9 0.11
Social Class + Age + Height + Smoking - 0.7 0.19




9.3.2 Intermediary Risk Factors
As with the lifestyle factors there were many strong relationships between
intermediary risk factors and social class. In females blood viscosity and fibrinogen
were significantly higher in lower social classes (table 9.5). Among the lipid measures,
HDL cholesterol was highly significantly lower in lower social classes while
triglycerides were significantly higher. BMI showed a highly significant trend with
higher mean levels in lower social classes.
In males there was a similar picture, in that, blood viscosity and fibrinogen
showed significant linear trends with higher mean levels in lower social classes. On
the other hand, unlike in females, there was no significant linear trends of lipids across
social class categories (table 9.6).
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Table 9.5 Trend in mean (se) ABPI and intermediary risk factors for peripheral arterial
















ABPI 1.02 1.00 1.00 1.01 1.00 1.02 0.89
(0.02) (0.01) (0.01) (0.01) (0.02) (0.03)
Blood 3.23 3.31 3.40 3.43 3.39 3.50 0.001
viscosity (0.06) (0.03) (0.04) (0.04) (0.06) (0.10
(mPa.s)
Uric acid 288 279 293 288 285 303 0.18
(jimol/1) (7.8) (4.1) (5.1) (5.8) (8.6) (13.1)
Fibrinogen 264 275 281 282 290 293 0.008
(g/1) (6.8) (4.3) (5.0) (5.8) (7.9) (12.6)
BMI (kg/m2) 24.9 24.8 26.2 25.5 26.6 28.8 <0.0001
(0.5) (0.2) (0.3) (0.3) (0.6) (1.2)
Known 0 % 0.8 % 1.4 % 3.1 % 7.1 % 0 % 0.01
diabetic(n) (0) (2) (3) (5) (5) (0)
HDL (mmol/1) 1.74 1.68 1.58 1.57 1.53 1.52 <0.0001
(0.05) (0.02) (0.03) (0.03) (0.06) (0.08)
NonHDL 5.59 5.84 5.95 5.76 5.93 5.45 0.93
(mmol/1) (0.15) (0.08) (0.10) (0.11) (0.16) (0.24)
Triglyceride 0.17 0.23 0.38 0.29 0.38 0.40 0.0006
(In) (mmol/1) (0.05) (0.03) (0.03) (0.03) (0.06) (0.09)
In -Natural logarithm
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Table 9.6 Trend in mean (se) ABPI and intermediary risk factors for peripheral arterial
















ABPI 1.11 1.07 1.03 1.04 1.03 1.06 0.004
(0.02) (0.01) (0.01) (0.02) (0.03) (0.03)
Blood 3.65 3.74 3.79 3.86 3.95 3.93 0.0002
viscosity (0.05) (0.04) (0.04) (0.07) (0.08) (0.16)
(mPa.s)
Uric acid 344 345 344 346 343 336 0.60
(pmol/1) (7.3) (4.2) (4.5) (7.9) (9.8) (16.1)
Fibrinogen 236 253 279 275 268 273 <0.0001
(g/1) (6.3) (4.0) (5.0) (6.7) (6.8) (13.1)
BMI (kg/m2) 175.9 173.9 170.3 171.6 167.8 167.1 <0.0001
(0.7) (0.4) (0.4) (0.7) (0.8) (1.4)
Known 2.1 % 3.0 % 3.7 % 2.1 % 5.1 % 6.3 % 0.25
Diabetic(n) (2) (8) (9) (2) (4) (2)
HDL (mmol/1) 1.34 1.27 1.21 1.33 1.27 1.26 0.46
(0.04) (0.02) (0.02) (0.04) (0.04) (0.06)
NonHDL 5.32 5.44 5.29 5.45 5.37 5.47 0.86
(mmol/1) (0.14) (0.07) (0.07) (0.12) (0.14) (0.22)
Triglyceride 0.37 0.40 0.41 0.31 0.40 0.44 0.93
(In) (mmol/1) (0.05) (0.03) (0.03) (0.05) (0.06) (0.06)
In - Natural logarithm
In the multiple linear regressions there were significant fibrinogen by sex (p
= 0.02) and blood viscosity by sex (p = 0.0007) interactions. Both these variables had
significantly stronger relationships in males compared to females (table 9.7). There
was also a suggestion of an HDL cholesterol by sex interaction with a highly
significant positive association only in males but this did not reach statistical
significance at the 5% level. Both BMI and age were significantly associated with the
ABPI in males and females.
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Social class in males became non-significant as soon as blood viscosity,
fibrinogen and smoking were added to the model; because of the strong correlations
between social class and these variables (table 9.6)
Table 9.7 Multiple regression of Intermediary factors on ABPIxlOO in males and
females (adjusted for all intermediary factors)
Factor
(+ 1 S.D.)





Age (years) -2.06" -3.2*** 0.16
(0.63) (0.72)
BMI (kg/m2) 2.69*" 2.07" 0.91
(0.72) (0.75)
Fibrinogen -1.97" -3.93*** 0.02
(g/1) (0.72) (0.83)
Blood 0.83 -2.24* 0.0007
viscosity (0.89) (1.09)
(mPa.s)
HDL 0.91 2.15" 0.07
Cholesterol (0.73) (0.76)
(mmol/1)
NonHDL -1.07 -1.42+ 0.56
Cholesterol (0.77) (0.79)
(mmol/1)
Known -7.4* -16.0" 0.10
diabetic (4.4) (4.5)
vs. non
# test of difference between unstandardised regression coeffficients for males and
fenales
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9.3.3 Lifestyle and Intermediary Factors
Females
There were significant sex by smoking (packyears) by fibrinogen (p = 0.01)
and sex by blood viscosity (p = 0.01) interactions and sex by leisure activity by
smoking (p = 0.02) interactions. However, if the blood viscosity three way interaction
was added along with the fibrinogen and leisure activity three way interactions, it
became non-significant. Consequently, to aid interpretation, the analysis of all factors
was split according to sex and ever/never smoked in males. In females a test for a
fibrinogen by smoking interaction was not significant.
When the lifestyle and intermediary factors were combined the most striking
change was that fibrinogen was no longer significant for females (table 9.8) suggesting
that smoking in terms of the packyears may be the source of the raised fibrinogen
levels in women, while fibrinogen remained an independent risk factor in males
Table 9.8 shows that age and smoking in terms of packyears were the most
significant factors, especially smoking and these were the only independent risk factors
in women. NonHDL cholesterol approached significance at the 5% level. Figure 9.1
shows a similar trend in blood viscosity with leisure activity aged 35-45 years in
females and in males, although leisure activity was not significantly raited to the ABPI
in females.
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Table 9.8 Multiple regression of all factors on ABPIxlOO in females (n = 783)





Age (years) -2.57 0.0001
(0.63)
Height (cm) 0.30 0.65
(0.65)
Fibrinogen (g/1) 0.49 0.49
(0.71)
Blood viscosity 0.59 0.38
(mPa.s) (0.67)





Known diabetic -2.0 0.66
vs. non (4.4)
Leisure activity
Strenuous vs none -1.2 0.75
(3.9)
Moderate vs none 0.40 0.86
(2.1)


























Males p = 0.007
in
cvJ Females p = 0.0001
None Light Moderate
Leisure Activity (aged 35-45)
Strenuous
Figure 9.1 Relationship between blood viscosity and extent of leisure activity
aged 35-45
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Males who had ever smoked
Whenever risk factors in men who had ever smoked were considered, it was
clear that smoking had a synergistic effect on many of the risk factors' associations
with the ABPI (table 9.9). Smoking and age were both highly significantly related to
the ABPI as were fibrinogen and blood viscosity. In fact fibrinogen appeared to be the
most important risk factor (p < 0.0001) for men who smoke. HDL cholesterol and
nonHDL cholesterol were both significant at the 5% level with independent
associations with the ABPI in opposite directions. The positive association of alcohol
and the ABPI found when only lifestyle factors were considered disappeared, probably
due to the high correlation between alcohol and HDL cholesterol in men (r = 0.30).
Subjects who were known diabetic had significantly lower mean ABPI relative to non-
diabetics (table 9.9). Strenuous activity relative to none and moderate activity relative
to none were shown to be significantly related to higher mean ABPI in those males
who ever smoked when lifestyle factors were considered alone (table 9.3). On adding
the intermediary factors, the leisure activity variables became less significant, although
still remaining significant at the 10% level. This was mainly due to the strong
relationship between leisure activity and blood viscosity in males (figure 9.1).
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Table 9.9 Multiple regression of all factors on ABPIxlOO in males who ever smoked
(n = 568)





Age (years) -2.99 0.0008
(0.89)
Height (cm) 1.01 0.22
(0.77)
Fibrinogen (g/1) -4.26 <0.0001
(0.95)
Blood viscosity -3.42 0.0002
(mPa.s) (0.89)





Known diabetic -14.5 0.01
vs. non (5.6)
Leisure activity
Strenuous vs none 6.7 0.05
(3.5)
Moderate vs none 5.2 0.09
(3.1)
Light vs none 3.7 0.25
(3.3)
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Males who never smoked
Although the power was now low to detect associations in the group of men
who never smoked, table 9.10 shows that many of the risk factors were very non¬
significant in this group, and so could not be dismissed on that account. The strongest
risk factor amongst males who had never smoked was nonHDL cholesterol (p =
0.009), while being a known diabetic was also significantly associated with lower
mean ABPI (table 9.10). It is notable that age was not significantly related to the
ABPI in male non-smokers. On removing nonHDL cholesterol from this model, of all
the dietary factors dietary cholesterol approached significance (p = 0.07).
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Table 9.10 Multiple regression of all factors on ABPIxlOO in males who never
smoked (n = 224)
Factor ( + 1 s.d.) Mean ABPIxlOO
(se)
p- value
Age (years) -1.20 0.29
(1.08)
Height (cm) 1.87 0.08
(1.02)
Fibrinogen (g/1) 0.83 0.46
(1.13)
Blood viscosity -1.46 0.20
(mPa.s) (1.15)





Known diabetic -13.7 0.01
vs. non (5.6)
Leisure activity
Strenuous vs none -3.3 0.48
(4.7)
Moderate vs none -5.8 0.19
(4.4)





Age and smoking were the most important risk factors for females, with nonHDL
approaching statistical significance.
The significant relationships between the ABPI and blood viscosity and fibrinogen
could be 'explained' by cigarette smoking
Social Class and leisure activity were not significantly related to the ABPI in females
Males
Age and cigarette smoking were strongly significant in males as in females.
There were significant interactions with smoking for blood viscosity and fibrinogen.
In fact, in those who never smoked fibrinogen and blood viscosity were not
significantly related to the ABPI. In those who ever smoked, blood viscosity and
fibrinogen were significantly related to the ABPI independently of smoking.
Leisure activity factors (Strenuous and Moderate relative to none) were significantly
related to the ABPI. They also had significant interactions with cigarette smoking with
the greatest relative benefit to those who had ever smoked, although this may not be
independent of blood viscosity.
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HDL and nonHDL cholesterol were significantly related to the ABPI, nonHDL
especially in male non-smokers, where it was the most important risk factor.
Social class was strongly related to the ABPI but not independently of the lifestyle
factors of height, leisure activity, smoking and dietary factors, and not independendy
of the intermediary factors of blood viscosity and fibrinogen.
Diabetes was only a significant risk factor for males.
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CHAPTER 10
POWER AND SAMPLE SIZE ESTIMATION IN EPIDEMIOLOGICAL
STUDIES
10.1 Introduction - Terminology
This chapter addresses two main questions. Firstly, what is the power of tests
to detect a given effect size with a fixed type I error and sample size? This question
will be considered in the context of analyses of The Edinburgh Artery Study data
presented in previous chapters. Secondly, at the design stage of a study, what is the
required sample size to detect a given effect, with fixed type I error and power?
Before discussing the methods which have been proposed to answer such questions
some terminology is required.
The purpose of a statistical test is to assess the evidence against a stated null
hypothesis, Ho which it is hoped can be rejected in favour of an alternative hypothesis,
Hp In carrying out hypotheses tests there are two main types of error which can be
made. The type I error (a) is the probability of achieving statistical significance
(rejecting the null hypothesis) when the null hypothesis is, in fact, true. This is equal
to the significance level. The type II error ((3) is the probability that the null
hypothesis is not rejected when it is, in fact, false. This can be summarised as follows:
Hq true Hj true
Reject type I Correct
Ho error decision
Accept Correct type II
Ho decision error
The type I error by convention is taken to be 5%, while l-(3 the power of the
test is more often considered than the type II error {3. The power of a test l-(3 is the
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probability of rejecting the null hypothesis when the null hypothesis is false. It would
be ideal to minimise both errors but a decrease in one results in an increase in the
other. Low power is a problem in studies where a medically interesting effect is
missed because of low sample size. Hence the need to assess the required sample size
at the design stage. This will be addressed in the second part of this chapter.
10.2 Power - Continuous outcomes
10.2.1 Pearson correlation coefficient
The simplest relationship between a continuous risk factor and outcome can
be described by the Pearson correlation coefficient, p. The sample correlation





r=cov(x,y) /Jvai (x) vai (y)
A test of Ho : p = 0 is given by
r_r y/{n-2)
V (1-r2)
which follows a t-distribution with n-2 degrees of freedom. This assumes that the risk
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factor and outcome have a joint normal distribution. This is equivalent to testing the
simple linear regression coefficient ((3) under Hq : (3 = 0. Assuming n is large and
T ~ N (0,1) the power of this test is estimated by
n
(1-r2) zi-a/2
and from standard normal tables
Power=l-$=j' Zl~pf(x) dx
where f follows N (0,1).
Table 10.1 shows the correlation of various risk factors from the Edinburgh Artery
Study as described in earlier chapters with one continuous measure of peripheral
arterial disease, the ABPI.
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Table 10.1 Pearson Correlations of the ABPI and Smoking with Risk Factors




Age - 0.18 0.03 1582
Smoking (Packyears) - 0.22 - 1550
Alcohol (Square root) 0.12 0.25 1582
Fibrinogen -0.23 0.15 1538
Blood viscosity - 0.11 0.23 1390
In (Triglycerides) - 0.12 0.15 1563
HDL 0.05 - 0.14 1557
NonHDL - 0.15 - 0.04 1557
In (Cereal fibre) 0.04 -0.19 1579
a-tocopherol 0.02 -0.15 1578
Vitamin C 0.03 - 0.19 1578
Hostile acts -0.01 0.16 1579
Dominance -0.01 0.17 1579
The power based on equation 4 to detect various population correlations (p) with a
set of sample sizes with two-sided significance level of 5% are shown in table 10.2
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Table 10.2 Power (%) to detect p with sample size n at a = 0.05
Ipl n=100 n=250 n=500 n=1000 n=1500
0.05 7 12 20 36 49
0.075 11 22 39 66 83
0.10 17 36 61 89 97
0.15 48 67 92 99 *
0.20 53 90 99 * *
0.25 73 98 * * *
0.30 88 * * * *
* Power > 99.5%
The values in table 10.2 agree with those in Cohen (1988). From table 10.2 it can be
seen that the Edinburgh Artery Study can detect individual r>0.07 with power > 80%.
Where the associations are weak (table 10.1) such as r = 0.05, power is inadequate
with this sample size, although it is debatable whether such low correlations would be
worth detecting.
10.2.2 Partial Correlation Coefficient
Table 10.1 also shows that smoking in terms of packyears is highly correlated
with many other risk factors for peripheral arterial disease such as alcohol intake and
blood viscosity. Clearly, smoking is a confounder of the relationship between many
risk factors and the ABPI. The effect that this has on the simple correlation coefficient
can be seen by consideration of the partial correlation coefficient (see for example,





From table 10.2 using some interpolation, the power to detect a population correlation
coefficient of p = -0.11 is approximately 96% with n = 1400 and two-sided a. In the
Edinburgh Artery Study the correlation coefficient of blood viscosity with the ABPI
is -0.11. If smoking is included as a covariate (x^ then r^ = -0.22 and rxlX2 = 0.23
and
rYxux2 - " 0-06 compared with rYX1 = -0.11
and so the power is lower for a given sample size to detect an association between the
ABPI and blood viscosity after adjusting for smoking. In fact, using the methods
described later (Cohen 1988) the power is 66% with the presence of this covariate. On
the other hand, the Pearson correlation of alcohol and the ABPI was r = 0.12, while
the partial correlation adjusting for smoking was ^11x2 = 0.18, assuming the sample
correlations represent the population values. Thus the effect of adjusting may also be
to increase the power to detect associations depending on the direction of the
association between risk factors and outcome and between risk factors. This can be
summarised as follows
Correlation outcome Correlation risk










It is more usual to find a reduction in power after adjusting for a covariate
such as in the blood viscosity example above and in most of the factors in table 1 and
when adjusting for more than one covariate. The preceding results in terms of
correlations are equivalent to tests of regression coefficients in simple linear regression
and when adjusting for covariates in multiple linear regression.
10.2.3 Multiple linear regression
One way of dealing with more than one covariate is to consider the multiple
correlation coefficient of Y with Xx, ..., Xp. Assuming that the p+1 variables have a
multivariate normal distribution (MVN) with a positive definite covariance matrix of
E-
The population multiple correlation coefficient (Anderson 1984) between Y and X,
is estimated by
y/ y -iyi 1/2
vi A2 "i
°r
The test statistic for Hq : = 0 is
t 1 -tiyX)
where N is the number of subjects and p is the number of variables.
Gatsonis and Sampson (1989) present a method of estimating power and sample size
with two approaches: conditional and unconditional. The unconditional approach
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assuming the p+1 variables have a MVN distribution is relevant to epidemiological
studies where the independent variables are not fixed in advance. The unconditional
power of the test is given by
[p-%+2JC2]prohT7 rri i-P
where k has a negative binomial distribution. Under Hq : = 0 the random variable
k = 0.
The exact power calculations require tables of the noncentral F distribution of the
sample multiple correlation coefficient (MCC) but Gatsonis and Sampson (1989)
provide tables based on an approximation which is very accurate. They also found
reasonable agreement between their results and those of Cohen (1988). Table 10.3
shows the power of the test for various values of pyx, n and a=0.05 based on some
interpolation of the tables of Gatsonis and Sampson (1989)
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Table 10.3 Approximate power (%) with number of variables p=4 from
tables of Gatsonis and Sampson (1989) at 5% significance level
Pyx
n
100 250 500 1000 1500
0.10 < 10 20 40 70 89
0.15 20 40 77 98 *
0.20 30 74 96 * *
0.25 50 92 * * *
0.30 70 98 * * *
0.35 85 * * * *
0.40 94 * * * *
* Power > 99.5%
From table 10.3 it is clear that the Edinburgh Artery Study has adequate power
(>80%) to detect a pyx > 0.10. The value of R for the ABPI as outcome with age, sex,
alcohol and smoking in terms of packyears was R = 0.35 and on the face of it power
is more than adequate. However, epidemiological studies are generally not designed
to test Ho :pYX= 0.
A more interesting question is a test of Hq : flj = 0 adjusting for a number of
covariates where is the adjusted regression coefficient of the variable of interest.
This is equivalent to testing whether the multiple partial correlation coefficient is zero.
Gatsonis and Sampson (1989) handle this by partitioning the p independent variables
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into groups of size px and p - px denoted by Xx and X2 respectively. The appropriate
test is of an association between Y and Xx adjusting for X2. The simplest case is
where px=l , the effect of one variable adjusting for p-1 covariates. The test is then
Ho' PyxilX2 = 0.
In terms of the sample partial multiple correlation coefficient squared
p2 _d2
v2 _ YX1\X2 Y\X2
-1- ■" Y\X2
where R2 is the percentage of variance explained by the regression model.
Using the tables of Gatsonis and Sampson (1989) with various values of the partial
multiple correlation coefficient table 10.4 shows the power with px = 1.
Table 10.4 Power (%) for partial multiple correlation coefficient with px = 1
PYX1IX2
n
100 250 500 1000 1500
0.10 18 40 61 88 97
0.15 29 67 91 * *
0.20 51 90 * * *
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In the Edinburgh Artery Study the following results were obtained formultiple
linear regression of age, sex, smoking, and alcohol on the ABPI and the same model
with fibrinogen added.
Model R2 R
Age, sex, smoking, alcohol Xj 0.126 0.355
Age, sex, smoking, alcohol X1
+ fibrinogen
0.142 0.377
The multiple partial correlation coefficient for fibrinogen is thus r^^ = 0.14. From
table 10.4 and with a sample size of 1500, the power is greater than 99% for the case
of a partial multiple correlation coefficient = 0.14. For Pyxim < 0.1 , power would be
inadequate.
Cohen (1988) also gives power tables for this case by calculating X which is
a function of the squared multiple partial correlation coefficient. In addition the
number of variables of interest (u) and the number of covariates (w) need to be
specified. Then
v = N- u- w- 1 and X = f (u + v + 1)
where fz= r








Note that this implies that w is swamped by N whenever N is large and w the number
of covariates is really only a problem when N and w are of comparable size, for
example, 50 covariates with 100 subjects.
It would be useful to look at power for a range of partial multiple correlation
coefficients and table 10.5 shows this for the case of adding one variable adjusting for
4 covariates.
Table 10.5 Power (%) for partial multiple correlation coefficient for u=l variable
of interest adjusting for w=4 covariates from the tables of Cohen (1988)
Pyx iix2
n
100 250 500 1000 1500
0.025 <10 <10 <10 <10 12
0.05 <10 <10 18 34 50
0.075 10 20 37 65 81
0.10 14 34 61 89 97
0.15 31 65 92 * *
0.20 51 90 * * *
* Power > 99.5%
The results in table 10.5 are similar to those in table 10.4, so there is consistency in
the results of Cohen (1988) and Gatsonis and Sampson (1989), although the latter do
not give tables for values < 0.1. In addition, the results in tables 10.4,10.5 for partial
correlations are also similar to those for the simple Pearson correlation coefficient
(table 10.2).
Using Cohen's tables (1988) the power of the test of fibrinogen on addition to
a model containing age, sex, smoking and alcohol is also greater than 99%.
However, fibrinogen is strongly related to the ABPI and it is not surprising that the
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power is adequate in the Edinburgh Artery Study. When considering dietary risk
factors (chapter 3) variables were entered into the regression model adjusting for age,
sex, smoking and height and it would be instructive to consider the power in the case
of adding vitamin C (energy adjusted), for example, to this basic model. The change
in R2 on adding vitamin C was 0.0025 or 0.25% and the partial multiple correlation
coefficient was 0.053. The power from table 5 at the 5% level to detect such an effect
size with 1592 subjects is 56%. The power to detect such relatively small population
partial correlations is inadequate with this sample size. The question then arises as to
whether such small effect sizes are meaningful. Gatsonis and Sampson (1989) do not
give power for coefficients <0.10, but it is obvious that the power for this case would
also be inadequate according to their method.
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10.2.4 Generalised Linear Models
The methods of Gatsonis and Sampson (1989) and Cohen (1988) only apply
to continuous outcomes. The analysis of data from case-control , cohort and cross-
sectional studies and randomised controlled trials can all be accommodated within the
framework of generalised linear models (McCullagh and Nelder 1989). Power and
sample size determination taking into account confounding variables can then be
obtained directly from the Fisher information matrix within the context of generalised
linear models (GLM). Such a method is outlined by Wilson and Gordon (1986). The
method of Wilson and Gordon (1986) assumes an approximate MVN distribution for
confounders, depends on the link function specified and does not deal with nominal
or multiple outcomes. There are tests for MVN, but Cramer and Wold state that the
distribution of a p-dimensional random variable X is completely determined by the
univariate distributions of all it's linear compounds, so that if every linear compound
of X is approximately normal <=> X has a MVN distribution (Chatfield and Collins,
1984)
Before discussing the method, some background theory is necessary. Let Y be
the dependent variable and xv x2 ,Xp the independent variables of which xl5 say,
is ofmost interest and the rest of the x's are covariates. The independent variables can
be binary, nominal, ordinal, or continuous, although the method ofWilson and Gordon
(1986) assumes MVN and so strictly only applies to continuous covariates. The
distribution of the random variable Y must be from the exponential family and so can
be expressed in canonical form (McCullagh and Nelder 1983).
Define (3T = (|30, pls (3p)
Then = g(pj = pTx; and g is known as the link function.
For the case of multiple linear regression the link function is the identity -
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Tli = g (ft) = Pi = E ( Y,)
For multiple logistic regression the link function is the logit, log (p/(l-p)).
If the GLM is valid, the maximum likelihood estimate (3 asymptotically has a MVN
distribution with mean (3 and variance-covariance matrix V ((3) = [I ((3)]"1
where I ((3) is the Fisher information matrix.
If Pj is the variable of interest, then Px is approximately distributed N [Pl5 Vn (P)]
Let P(k) represent the maximum likelihood estimate of P under Hk , k = 0,1.
The test of Hq : Px = px(0) against Hp px > P1(0) at a significance level.
Let £k= [NxVxl (P(Jc)) ]1/2
Vn (Pw) is expressed in terms of N so that does not involve N.
Then power is estimated from
Zr-t'-T[/W(Pil'-Pi01) -Zi-./25ol
>1
In multiple linear regression px(0) = 0 and px(1) and V ( Px(1) ) = a2 / N var (xx) are
obtained from the regression model involving xx. Returning to the power calculations
for the case of adding Vitamin C to a regression model on the ABPI, adjusting for
age, sex, smoking and height as described earlier for Cohen's method (1988). Using
the method of Wilson and Gordon (1986) gives a power of 52.8% which is very
similar to that estimated by Cohen's method (1988); a value of 54%. Post hoc power
calculations are relatively easy with this method as the values of Px and Vxx (P) would
be readily available.
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10.3 Power - Binary Outcome
In the epidemiological literature the case-control study tends to dominate
consideration in estimating sample size, even though such a design has many
methodological failings (Hennekens and Buring 1987) and other methods such as
cross-sectional surveys and cohort studies are often encountered. There is an extensive
literature dealing with the case of a binary outcome and exposure (Walter 1977,
Armstrong 1987, Schlesselman 1974, Walter 1980, Lemeshow 1988).
10.3.1 k independent 2x2 tables
The problem of confounding variables is rarely considered. One exception is
Gail (1973) who presents power and sample size for a dichotomous outcome and
exposure allowing for k strata, that is, k independent 2x2 tables. This method assumes
constant odds ratio over all k strata and that the exposure rate in controls and cases;
Poj » Pij respectively, lie in the interval (0.1, 0.9). The power is estimated by
zi-pi-,,/2
where fj is the proportion of subjects in the j th stratum and
a = (In OR)2
j (1/ (P0J (1-PoJ) ) +1/ (PiJ (1-PiJ) ) )
and OR is the odds ratio assumed constant over the k strata. If only one stratum is
considered this is equivalent to using the simple formula comparing two independent
proportions (Schlesselman 1982)
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where p0 is the proportion exposed in the controls and
Pi = p0 OR/[l + p0 (OR - 1)] and
P=-| (P0+-Pi> and G=l-P
Gail (1973) gives a table of gj for values of OR and p0j to facilitate these calculations.
Using the 8 strata from the case-control study of the Edinburgh Artery Study (Chapter
2), that is, four age groups in males and females , with the number of cases equal to
153 the estimate of power with two confounding variables can then be compared to
that obtained with one stratum, that is, in the unadjusted case. Table 6 shows an
example of the procedure with p0j for the exposure rate to smoking (ever vs never)
obtained from the case-control study of the Edinburgh Artery Study, assuming these
are likely population values.
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Table 10.6 Calculation of estimated sample size using Gail's (1973)
method with data from the Edinburgh case-control study
Stratai Eoj $ Mi &
1 0.100 0.065 0.0269 0.00175
2 0.571 0.137 0.0506 0.0069
3 0.25 0.157 0.0497 0.0078
4 0.20 0.131 0.0447 0.00586
5 0.571 0.046 0.0506 0.00233
6 0.538 0.085 0.0536 0.0046
7 0.471 0.111 0.0565 0.0063
8 0.683 0.268 0.0413 0.0111
X f- gj = 0.0465
For a= 0.05, n=153 and OR = 2.0
Zj.p = 0.707 , Power = 77.9%
Table 10.7 shows the power estimates with 8 strata and one stratum from Gail (1973)
showing the decrease in power when adjusting for two confounders.
Table 10.7 Power (%) according to Gail (1973) for 8 strata and 1 stratum (unadjusted)
Study design
Number of cases
100 150 200 300




29 41 48 69




67 83 92 98
The results in table 10.7 demonstrate that the Edinburgh Case-Control study (n = 153)
152
is just adequate with power > 70% to detect odds ratios > 2.0 when allowing for two
covariates with the 8 strata identified in this study. The reduction in power is 5-8%
allowing for age and sex compared to the unadjusted analysis. In the actual analysis
of the case-control study (chapter 2) there was adjustment for more than 2 covariates
and hence the number of strata would be greater than 8 and so the power would be
even more reduced than that shown in table 10.7. These results are based on a
particular study. In practice, the power would be calculated for a range of p0j values
and with different numbers of strata.
This method is fine for Nj > 15 and p0j and pxj lying in the interval (0.1, 0.9),
which is reasonable for the Edinburgh data. It also assumes equal subjects divided
between treatments or equal cases and controls and the confounders are categorical.
Of course continuous covariates can also be categorised but this leads to a subsequent
loss of information. This formula (Gail 1973) is based on tests such as the Mantel-
Haenszel (1959) procedure. Greenland (1985) presents a method for multiway tables
using the Wald statistic, of which Gail (1973) is a special case. Muftoz and Rosner
(1984) also tackle the problem of power estimation by using an approximation for the
asymptotic power of the Mantel-Haenszel (1959) procedure for the test of a common
odds ratio in a collection of 2x2 tables.
10.3.2 Logistic regression
Logistic regession is a more versatile alternative to the Mantel-Haenszel
procedure for the analysis of case-control studies, and is also appropriate in cohort and
cross-sectional studies with binary outcomes. In addition, the covariates can be binary,
ordinal or continuous. A more general formula for power and sample size based on
logistic regression with small response probability and n covariates was proposed by
Whittemore (1981). This approach is based on an approximation to the Fisher
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information matrix I (0) = E[ - 821/ 8080'] for the estimated parameters in a multiple
logistic regression. This means that estimates are needed for the regression coefficients
of each variable and the correlation matrix. Hsieh (1989) presents easy to use tables
derived from Whittemore (1981) and gives an extension where the regression










and p is the probability of the event at the mean values of all covariates and 0* = In
r ( r is the odds ratio of disease corresponding to an increase in x of 1 s.d. from the
mean, given the values of the remaining covariates) , that is,
p (x) = p (y=llx1...xk)
The model expresses the logit of p as a linear combination of the x's
ln[p/(l-p)] = 0O + 0j Xj + ....+ 0k xk
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The above formula only applies to the case of one covariate and Hsieh (1989)
provides an upper bound for sample size
ii.- ^m ft —r\2(1-P2)
where p is the multiple correlation coefficient of xl5 with a number of covariates x2,
...xk. Hence nx can be substituted by nm (1 - p2) in the power formula, where each of
the Xi have been normalised with mean 0 and variance 1. The tables (Hsieh 1989) are
easy to use and suitable for high or low event probabilities.
Assuming a case-control study with equal numbers of cases and controls then
the probability of being a case with a mean level of the variable of interest is 0.5.
Table 10.8 shows the power to detect odds ratios of 1.5 and 2.0 for a subject with a
1 S.D. increase in fibrinogen for various numbers of cases. In order to detect the same
odds ratios adjusting for age, sex, and smoking, which has a multiple correlation of
0.29 with fibrinogen nt is replaced with nm (1 - p2) in the power formula (table 10.8).
Table 10.8 Power (%) for odds ratios of 1.5 and 2.0 from tables of Hsieh (1989)
Model
Number of cases





48 65 78 92





84 96 99 *
80 94 98 *
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Table 10.8 shows that the power is only reduced by about 4% after adjustment for
age, sex, and smoking suggesting that the multiple correlation coefficient needs to be
relatively large to give a substantial reduction in power. As before, with many
covariates the calculations would be repeated for likely values of the population
multiple correlation coefficient between the Xj,...^ .
Whittemore (1981) showed that inclusion of covariates which are correlated
with xx but independent of the event (i.e. 02 = 03 =...=0k = 0) leads to a loss of power
when testing for association of Xj with the event. This suggests that adjustment should
only be made for true covariates, that is, factors which are related both to the
outcomes and the risk factor being considered.
An adjustment of the overall p-value for multiple significance testing may be
needed when several covariates are of interest. Having looked at the power for various
postulated population statistics for continuous and binary outcomes and with specific
examples from the Edinburgh Artery Study the next section considers the problem of
estimating sample size for a given power at the design stage of a study.
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10.4 Sample size - Continuous outcomes
10.4.1 Pearson Correlation Coefficient
As outlined earlier when considering power for continuous outcomes the test
statistic for the population Pearson correlation coefficient p is
T-r y/(t2-2)
V(l-r2)
which follows a t-distribution with n-2 degrees of freedom. Assuming n is large and
T ~ N (0,1) we can estimate sample size by
r?= (7 +7 ) 2 (4-r2)n » l-«/2 1~P' ~l
Table 10.9 shows the sample sizes required for various values of p with power from
80%-95%.
Table 10.9 Sample size estimation for Pearson Correlation Coefficient (p)
for a= 0.05 and power = 80%, 90% and 95%
p 95% 90% 80%
0.05 5171 4188 3128
0.075 2298 1856 1396
0.10 1283 1039 776
0.15 563 456 341
0.20 311 252 188
0.25 194 157 118
0.30 131 106 79
0.35 93 75 56
0.40 68 55 41
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Clearly, in cross-sectional studies where the association with a quantitative outcome
is weak, such as r = 0.05, for example, large numbers would be required, in fact 3128
to give 80% power.
10.4.2 Multiple Linear Regression
As shown when considering power, if a covariate is correlated with the
outcome and the risk factor of interest the partial correlation will generally be lower
than the Pearson Correlation Coefficient and so the sample size needed to detect
significant correlation when adjusting for covariates would be higher. With more
covariates the need for a larger sample is increased depending on the precise nature
of the relationship between the variables in terms of their correlations.
Gatsonis and Sampson (1989) present a method for assessing sample size in
multiple linear regression with tables for p independent variables, dependent variable
y and multiple correlation coefficient pyx- From tables (Gatsonis and Sampson, 1989)
with p = 20 and various values of R the sample sizes calculated are given in table
10.10







0.15 1356 1156 1020
0.20 759 648 522
0.25 482 412 334
0.30 333 285 231
0.40 183 156 130
The number of variables is important and p = 20 would not be exceptional in an
observational study. This method appears limited in that the Hq : pyx = 0 is generally
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not of great interest. The more usual case is of testing one variable while adjusting for
a number of covariates. In order to address this question Gatsonis and Sampson(1989)
partition X into two sets Xx and where Xx is the set of variables of interest and X2
is the set of covariates. By replacing pyx by Pyxido hi the tables (Gatsonis and
Sampson 1989) and pt = number of variables of interest, the appropriate sample size
can be assessed (table 11).
Table 10.11 Sample size with one variable of interest (px = 1) adjusting for




0.10 1313 1066 802
0.15 691 482 366
0.20 339 278 213
In practice partial multiple correlations < 0.10 will often be encountered but
unfortunately Gatsonis and Sampson (1989) do not give tables for this situation. In
addition, more than one test would be carried out and so the type I error would be
adjusted to a lower value a/n where n is the expected number of tests to be carried
out.
Cohen (1988) gives sample size tables in terms of the noncentrality parameter
X which is a function of the squared partial multiple correlation coefficient. The
parameters X and v are functions of n , which is to be determined, and so the
assessment involves some iteration using an initial value of v.
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The sample size is given by
« ( X YXl! x2 )N=X- YX1'f +w
r 2x YX1X2
where w is the number of covariates and r^^ is the sample partial multiple
correlation coefficient.
Table 10.12 Sample size for various Pvxim adjusting for w = 20 covariates
with u = 1 variable of interest, with significance level a.
a Power
pyxux2 95% 90% 80%
0.05 20807 16809 12492
0.025
0.01 28482 23845 18728
0.05
0.05 5207 4209 3132
0.01 7122 5965 4688
0.075
0.05 2308 1868 1393
0.01 3153 2642 2079
0.10
0.05 1307 1059 792
0.01 1782 1495 1178
0.15
0.05 579 471 355
0.01 785 660 523
0.20
0.05 332 272 207
0.01 447 378 301
The results in table 10.12 are similar to those of Gatsonis and Sampson (1989) in table
11. Cohen's method (1988) shows how the sample size increases dramatically with
Pyxiix2 <0.1 and such values are not unusual as shown by the Edinburgh Artery
Study. Of course many such t-tests of the regression coefficients would be undertaken
and one way of dealing with this is to reduce the a to 0.01, if say 5 such tests were
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carried out. Thus, the sample sizes given for a= 0.01 are probably more relevant to
the actual analysis carried out and table 12 shows that the sample size increases
considerably in this case.
10.4.3 Generalised Linear Models
Rearranging the formula for power for the method of Wilson and Gordon
(1986) sample size is estimated by
N= ^zi-q/2^0+zl-p^i^
(Pl1>-P<0))
Assuming the population regression coefficient and variance are similar to that for
vitamin C in the example used earlier the sample sizes required to give 80%, 90%,
and 95% power are 3018, 4041, and 4988 respectively. The power to detect Vitamin
C on adding it to a model with four covariates was about 53% with a sample size of
1592. Clearly, the sample size of 1592 for the Edinburgh Artery Study gives
inadequate power to detect such effect sizes as that of vitamin C, adjusting for four
covariates.
The main drawback is in specifying and the Vu (P), which is possible once
a study or pilot study is completed, but difficult at the design stage with little prior
information. The advantage of this method lies in the generalisability of linear models
for different outcomes, through the use of the link function.
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10.5 Sample size- Binary Outcome
10.5.1 k 2x2 independent tables
In case-control studies and hence binary outcomes with k strata the method of
Gail (1973) can be used to assess sample size. Rearranging the power equation given
earlier the number of cases can be estimated by
r_ (Zi-a/2+Si-p>2
where fj is the proportion of subjects in the j th stratum and
a = dn OR) 2
J (1/ (P0J (1-PoJ) ) +1/ (PiJ (1-PiJ) ) )
where OR is the odds ratio assumed constant over the k strata. The values of p0j, the
exposure rates in the controls needs to be specified for each stratum. Assuming the p0j
reflect likely population values the exposure rates to smoking (ever vs never) from the
Edinburgh case-control study from 8 strata have been used to give sample sizes for
odds ratios of 1.5 and 2.0 in table 10.13. The total sample size required is 2 x n
assuming an equal number of controls.
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Table 10.13 Comparison of estimated sample size unadjusted and adjusted for
two covariates
Power
btudy design 95% 90% 80%
8 strata 750 624 470
OR = 1.5
Unadjusted 647 522 388
8 strata 278 225 170
OR = 2.0
Unadjusted 226 183 136
The increase in sample size is approximately 100 cases and 100 controls when
adjusting for these two covariates to detect an odds ratio of 1.5. The increase when
adjusting for covariates is less when trying to detect odds ratios of 2 or greater. These
calculations were based on values from the Edinburgh case-control study and the
calculations would be repeated for different values of p0j and j.
10.5.2 Logistic Regression
Hsieh (1989) presents easy to use tables derived from Whittemore (1981) and
gives an extension where the regression coefficients for the logistic regression do not
have to be given. The estimate of sample size is given by
Be ] 2 JJki2p5)_1 1 P (p0*2)
where p is the probability of the event at the mean values of all covariates and 0* =
In r (r is the odds ratio of disease corresponding to an increase in x of 1 s.d. from the
mean, given the values of the remaining covariates).
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Hsieh (1989) provides an upper bound for sample size
where p is the multiple correlation coefficient of xl5 with x2, ...xk.
The tables (Hsieh 1989) are easy to use and suitable for high or low event
probabilities and for any type of study with a binary outcome.
Table 10.14 Estimates of sample size for logistic regression (Hsiehl989)
(a= 5% one-tailed)
Power Probability of event p
0.01 0.05 0.10 0.20
80% 18889 4086 2236 1311
OR=1.2
90% 26120 5651 3092 1813
95% 32967 7132 3903 2288
80% 3751 823 457 274
90% 5154 1131 628 376
OR=1.5
95% 6478 1421 789 473
80% 1237 285 166 106
OR=2.0 90% 1674 385 224 144
95% 2084 480 279 179
To obtain sample size for multiple logistic regression, the number in table 10.14 is
divided by a factor of 1 - p2 (table 10.15).
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Table 10.15 Estimates of sample size for logistic regression (Hsieh 1989)
with OR=1.5 and range of values of MCC of the covariates.
Power
P 80% 90% 95%
Probability of 0.25 878 1206 1516
event p 0.50 1097 1508 1895
0.05 0.75 1881 2585 3248
Probability of 0.25 487 670 842
event p 0.50 609 837 1052
0.10 0.75 1045 1435 1803
For example, fibrinogen has a multiple correlation coefficient with age, sex, and
smoking of 0.29, so that if a model is fitted with these four variables, the sample size
in the tables should be increased by a factor of 1/(1 - p2 ) = 1.092.
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10.6 Sample size and measurement error in dietary studies
As discussed in chapter 3 measurement error in assessment of dietary intake
can effect the estimates and precision of regression coefficients. An additional effect
is that measurement error leads to reduced power and the need for larger sample sizes.
This problem has been shown for cohort and case-control studies investigating diet-
cancer links (Prentice et al 1989, Freudenheim et al 1988, and Hebert et al 1988) and
suggested conventionally sized studies which show non-significant associations could
be explained in terms of loss of power. Freedman et al (1990) suggests a simple
model of measurement error could be incorporated into the calculation of sample size.
The model is :
Y = X + e where 8 follows N (0, o2)
and Y is the measured nutrient intake and X represents the true intake. If Y and X are
normally distributed then they have the same mean and the 'true' standard deviation
can be expressed as
SDX = p SDy where p is the correlation coefficient between Y and X
Under this model the measured nutrient values have no bias but greater variance than
the true value. The result of this greater variance is a reduction in power. Freedman
et al (1990) then incorporate this model into the sample size calculations for a test of
linear trend in a cohort study (Breslow and Day, 1987). For a correlation coefficient
of 0.65 between observed and true percentage fat intake the sample size was inflated
by 6-8 times compared to no measurement error in assessing the relative risk for
colorectal cancer. This method requires a validation study to be incorporated into the
overall design and in terms of nutrient intake this implies a weighed intake study for
a subsample of the full study which uses a food frequency questionnaire (chapter 3).
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10.7 Discussion
This chapter has surveyed the main methods of estimating power and sample
size for epidemiological studies. The results have shown that reliance on simple
methods for two-group comparisons underestimate the sample size and overestimate
the power for the case of numerous confounders, a situation which is often
encountered in observational studies. At the design stage the methods outlined are fine
if some information on the correlation matrix of variables involved and some idea of
the likely effect size is known. In this case the methods lend themselves to a form of
sensitivity analysis where a likely range of correlations can be imputed into the
formulae to calculate power and sample size. An example of this was outlined in this
chapter on various partial multiple correlation coefficients. However, often in a new
study prior information is sparse and it is difficult to assess the likely correlation
structure. This is another area in which a pilot study can contribute to the design of
a study.
10.7.1 Continuous outcomes
If the outcome is continuous, there is a loss of power in transforming to a
binary outcome. The method of Wilson and Gordon (1989) is initially theoretically
attractive as GLM encompass most situations, including binary outcomes. However,
it is necessary that the covariates should be MVN. In reality, binary, ordinal and
nominal data are often encountered , so this restriction is difficult to meet. Cohen's
method (1988) relies on the change in R2 on adding covariates of whatever type to the
regression model and seems simpler to use in practice. Although Cohen's tables
(1988) were based on approximations, they gave results similar to the more exact
methods and so seem adequate, especially since sample sizes are only approximate
guides in any case.
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10.7.2 Binary outcomes
For binary outcomes, the tables of Hsieh (1989) are easy to use and based on
logistic regression, which is a common form of analysis. This method allows sample
size estimates to be made for a range of multiple correlation coefficients of the
covariates and probabilities of the outcome.
10.7.3 Multiple testing
Most of the calculations assumed a single test at the 5% level whereas in
reality many tests are usually carried out. A simple way of allowing for this is to
calculate power or sample size at significance level of 0.05/k where k is the number
of tests. This gives an overall significance level of 0.05 for each test. This was
discussed for Cohen's method (1988), and the results showed a large increase in
sample size when allowing for multiple testing in this way. Even in studies which
explain their sample size calculations, these are usually based on one two-group
comparison at the 5% significance level, and then numerous tests are carried out in
the analysis (Sulaiman et al 1988).
Measurement error, especially in dietary intake studies can also reduce the
power of tests and so allowance for this can be made by incorporating a simple error
model in the sample size calculations.
10.7.4 Software
EPIINFO was designed to analyse proportions and it gives sample size and
power estimates for the estimation of a single proportion and for comparing two
proportions based on simple formulae, for example from Fleiss (1981). The programs
do not take confounding into account in the calculations or multiple testing nor for
studies involving continuous outcomes. Clearly there is scope for the development of
such power and sample size estimation packages.
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More recently, the software EGRET SIZ was launched based on the method
of Self et al (1992). This covers conditional and unconditional logistic regression
models, Poisson regression and Cox proportional hazard models. The method of Self
et al (1992) uses GLM and is based on an approximation to the distribution of the
likelihood ratio statistic. The program allows various plots and simulations to be
carried out and gives estimates of power and sample size allowing for up to 10
variables per regression with 1 exposure variable and up to 9 confounder and matching
variables. Although all the variables have to be categorical, and these are specialised
models, this software does provide a useful addition to sample size/power estimation





This chapter will summarise the analysis of individual groups of risk factors
considered in the previous chapters, followed by an assessment of all risk factors
together as described under the groupings of lifestyle factors and lipid/rheological risk
factors in chapter 9. Then, the implications for prevention and treatment of peripheral
arterial disease are discussed, based on the foregoing analysis of the Edinburgh Artery
Study and evidence from other studies. Finally, recommendations for future research
are presented.
11.2 Analysis of individual risk factors
11.2.1 Diet
Fibre
Despite the methodological drawbacks of Food Frequency Questionnaire
derived nutrient intake, significant associations were found with the ABPI. Higher
energy adjusted cereal fibre was significantly associated with higher levels of the
ABPI in men only. In general men have a lower proportion of fibre in their diet
compared to women (Gregory et al 1990), and so could benefit most from an increase
in their dietary intake. This result was also consistent with a Greek hospital based
case-control study which showed a significant association of low crude fibre with
peripheral arterial disease (Katsouyanni et al 1991).
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Alcohol
The positive association of alcohol with the ABPI in men reflects previous
results where moderate alcohol consumption was associated with a decrease in the risk
of coronary heart disease and ischaemic stroke in women (Stampfer et al 1988) and
reduced cardiovascular mortality in middle-aged men (Marmot et al 1981), which has
led to the widely held belief that moderate intake of alcohol may be protective for
atherosclerosis. Such results have led to the consideration of a U-shaped curve for
mortality from coronary heart disease and alcohol intake (Shaper et al 1988).
However, in the British Regional Heart Study of men aged 40-59, Shaper et al (1988)
concluded that the U-shaped relationship could be explained by other factors such as
social class, and the movement of ex-drinkers with pre-existing disease into the non-
drinking category. Later studies have addressed these methodological problems, such
as in a study of New Zealand men and women, which showed that both moderate
drinkers and ex-drinkers had lower risk of non-fatal myocardial infarction compared
to total abstainers (Jackson et al 1991).
The Edinburgh results suggest a linear relationship with morbidity in men
rather than a U-shaped relationship, indicating that the higher the alcohol intake the
greater the benefit in terms of the ABPI. This seems unlikely, given that high
alcohol intake is associated with increased risk of high blood pressure ( Klatsky et al
1977), along with the attendant health and social problems (Smith 1981). On adjusting
for social class and cigarette smoking in the Edinburgh Artery Study this linear
association was considerably reduced (Jepson et al in press). The higher alcohol
intake in social classes I and II was mostly due to wine rather than beer, and it has
been suggested that wine may be beneficial for coronary heart disease in France
despite high intake of saturated fat (Renaud and de Longeril 1992). In the Edinburgh
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Artery Study the wine effect could be explained by the higher alcohol intake in the
social classes I and II who tended also to have healthier diets, and smoke less than
lower social classes. There is thus little evidence from the Edinburgh Artery Study
data of a U-shaped relationship between alcohol and the ABPI and the linear
relationship that was found could be explained by cigarette smoking and social class,
so there was little evidence of any protective effect of alcohol (Jepson et al in press).
This was also the conclusion reached by Shaper et al (1988) in their assessment of the
U-shaped relationship with cardiovascular mortality. Even if alcohol were protective,
this would have to be balanced against the fact that increasing alcohol intake would
increase the mean level of intake in the population (Rose and Day 1990) and hence
increase the prevalence of problem drinkers. Further analysis considering mortality in
the follow-up of the Edinburgh population is planned and it will be interesting to
assess the possible relationship of mortality and cardiovascular events to alcohol intake
measured at the cross-sectional stage.
Vitamins
The associations of vitamins with the ABPI were consistent with previous
studies concerned with atherosclerosis. Smoking reduces plasma vitamin levels of 0-
carotene, vitamin C and a-tocopherol (Stryker 1988, Shectman 1989), so it would be
expected that smokers would benefit most from vitamin supplementation, if unwilling
or unable to give up smoking. Unfortunately in a Bristol survey it was shown that
supplements were more likely to be taken by already healthier individuals, that is,
women and social classes I and II (Gregory et al 1990). The association with a-
tocopherol, although weak, is consistent with studies showing a link between low
vitamin E and mortality from coronary heart disease (Gey and Puska 1989) and
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increased risk of angina pectoris (Riemersma et al 1991). Indeed vitamin E has been
used as a treatment for intermittent claudication (Livingstone 1958, Haegar et al 1974,
Williams et al 1971, Pinsky 1980) and angina (Gillilan et al 1977). This link is clearly
worth investigating, especially as vitamin E intake is lower in lower social classes,
who also have higher cigarette consumption and lower mean ABPI values.
11.2.2 Leisure Activity
Men
The greatest benefit of taking part in leisure time activity when aged 35-45
on present disease status (time of the survey) occurred in males, and especially in
males who had ever smoked. This does not indicate that exercise was of no benefit
to those males who never smoked, but that the relative benefit was greater in those
who had ever smoked. This is consistent with other findings, which suggest positive
associations between high risk of coronary heart disease and lack of leisure time
activity (Kannel et al 1979a, Paffenbarger et al 1978, Morris et al 1973, Morris et al
1980).
The proportions indulging in moderate/strenuous exercise were significantly
higher in higher social classes in both males and females. This was consistent with a
study of Swedish women which showed lower cardiovascular disease and total
mortality in higher socioeconomic groups who indulged in more physical activity
(Lapidus and Bengtsson 1986). Taking part in leisure activity when aged 35-45 years
was also positively related to hostile acts in males and vitamin C intake, but remained
significant after adjustment for these factors in the multiple regression analysis.
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Mechanism
The effects of exercise are well known on blood rheology and include
reduction of blood and plasma viscosity (Charm et al 1979, Ernst 1985). In one study,
exercise was shown to increase pain-free walking distances in intermittent claudication
patients (Edzard et al 1987) and this was achieved by increased 'fluidity' of blood.
Hence part of the benefit from regular exercise in the general population may be
related to increased blood fluidity indicated by lower blood viscosity. Other known
effects of physical activity are reductions of nonHDL cholesterol and increased HDL
cholesterol (Haskell 1984).
As leisure activity tends to reduce blood viscosity (Ernst 1985) so it would be
expected that when rheological factors were added, leisure activity would no longer
have a significant independent effect on the ABPI. However, in males who ever
smoked there was still some indication of a positive association for strenuous/moderate
activity at the 10% level, allowing for other lifestyle and rheological factors. So it
appeared that blood viscosity was not the sole mechanism by which leisure activity
could have had a beneficial effect on the ABPI.
Women
Although taking part in leisure activity was associated with social class in
women, it was not significantly related to the ABPI. This may in part be due to the
low number of women aged 35-45 years who took part in strenuous activity, or the
questionnaire design is biased towards activities which men are more likely to indulge
in. It was notable that activities such as childminding, gardening and general
housework were not covered by leisure activity categories or occupational categories;
and these would tend to involve many women aged 35-45 over long periods of time.
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Certainly, the questionnaire seems more likely to pick up activities involving organised
sport rather than physical activity in general. There could also be a sex difference in
the recall of leisure activity, although Blair et al (1991) found no evidence for such
a bias.
Occupational Activity
The lack of an association between occupational activity and atherosclerosis
was surprising, given that coronary heart disease has been shown to be related to
occupational activity (Morris et al 1953). However, the sample surveyed in the
Edinburgh Artery Study did not include a large proportion of manual classes, so the
occupational activity classification may have been less relevant. Also the classification
of occupational activity was relatively crude (Appendix 1).
11.2.3 Personality
The results on personality showed a weak significant relationship between
hostile acts adjusting for age and cigarette smoking and the odds of having
intermittent claudication in males but not in females. This is consistent with results
suggesting impatience and the expression of hostility are linked to atherosclerosis
(Evans 1990, Sykes et al 1992).
The weak association between hostile acts in men and the ABPI became non¬
significant on adjusting for lifestyle factors such as diet and leisure activity when
aged 35-45. Overt hostile acts in males were also highly correlated with cigarette
smoking (r = 0.14 ) and triglyceride levels (r = 0.13 ) (Fowkes et al 1992c). The
mechanism of how hostility might operate via triglyceride levels may be similar to the
hypothesis that lower serum cholesterol lowers brain serotonin which in turn reduces
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the suppression of aggressive behaviour (Engelberg 1992, Zuckerman 1991).
The Edinburgh results suggest that hostility should be assessed rather than the
type A construct which may not be as relevant to British or European populations as
the U.S population or if a type A inventory is used it should incorporate items on
hostility. A recent comparison of three European countries did show a relationship
between mortality from ischaemic heart disease and the personality dimensions of
hard-driving and impatience (Sykes et al 1992). The Edinburgh results also suggested
that hostility was related to other risk factors and may not be an independent risk
factor for peripheral arterial disease. A synergism between smoking and hostility has
also been suggested by other studies (Epstein and Perkins 1988, Grossarth-Maticek et
al 1988) and there was a significant interaction (chapter 9), although this was not
independent of the leisure activity by smoking interaction.
The Edinburgh type A inventory (Bortner 1969) did not show strong
associations with peripheral arterial disease possibly because it did not contain items
on hostility, and also it may not have been relevant to a largely retired population,
who presumably show less competitiveness and time pressure than younger
populations. It was also self-completed rather than derived from a structured interview
and hence may have been influenced by symptoms of disease. The latter explanation,
a problem of the cross-sectional methodology was suggested as a possible reason for
the association between type A behaviour and prevalent heart disease in the Caerphilly
study (Gallacher et al 1988). The Bedford-Foulds Inventory (Bedford and Foulds
1978) which assessed hostility, domineering attitude and overdependency made some
attempt to overcome this drawback by careful phrasing of the initial statement in the




Fibrinogen and blood viscosity
In men blood viscosity and its components, especially fibrinogen were
important risk factors for peripheral arterial disease in the Edinburgh Artery Study.
Plasma fibrinogen is a well known risk factor for peripheral atherosclerosis (Fowkes
et al 1991) and high levels of fibrinogen have been shown to be strongly related to
smoking (Lee et al 1990). As fibrinogen is a component of blood viscosity it was
perhaps surprising that each had strong and independent associations with the ABPI
in men. There was a synergistic effect of smoking on the relationship between
fibrinogen and the ABPI. The effect of smoking could be via damage to the
endothelial cells of arteries, which then allows fibrinogen to infiltrate the arterial wall.
This, in turn, promotes platelet aggregation a process which is consistent with raised
levels of von Willebrand factor and cross-linked fibrin degradation products which
are found in cases of peripheral arterial disease (Smith et al 1993).
In women, there were also strong associations of blood viscosity and fibrinogen
with the ABPI, but these could be explained by smoking in terms of the packyears.
This evidence suggests that raised fibrinogen and blood viscosity levels in women
with peripheral arterial disease may be largely due to heavy cigarette smoking, and
thus cigarette smoking was the main independent risk factor for peripheral arterial
disease in women.
Arterial Blood Pressure and rheological factors
The relationship of arterial pressure to peripheral arterial disease was assessed
in an indirect way, since it is a component of the ABPI, by relating rheological factors
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to both systolic and diastolic blood pressure (chapter 7). Fibrinogen was not
independently related to systolic or diastolic arterial pressure and this was consistent
with other studies in the general population (Karsen-Bengtsen et al 1972). Blood
viscosity was significantly associated with systolic blood pressure in males, so that
blood pressure can be indirectly related to peripheral arterial disease via blood
viscosity in men. In women, systolic pressure was related to uric acid, but uric acid
was not significantly related to peripheral arterial disease. This was another difference
in the role of risk factors for peripheral arterial disease between men and women.
Even though an association was found between blood viscosity and systolic
pressure and by implication to disease, it was not possible to assess whether the
relationship was causal. A longitudinal study would be necessary to distinguish
whether high systolic pressure was a risk factor for or a result of peripheral arterial
disease. The 26-year follow-up of the Framingham study (Kannel and McGee 1985b)
suggested an increased risk of intermittent claudication for systolic pressures >180
mmHg, so there is some evidence that systolic pressure is a risk factor for
atherosclerosis.
Fibrinogen Haplotype
Fibrinogen haplotype was not found to be significantly associated with plasma
fibrinogen level in the case-control study (chapter 8). Perhaps surprisingly fibrinogen
haplotype was related to peripheral arterial disease independently of fibrinogen and
smoking. Thus genetic factors are clearly worth investigating further, but it was not
possible to extend the analysis to the whole cross-sectional data at present.
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11.2.5 Diabetes
It is well known that diabetes is related to microvascular disease in the lower
limbs, although it is not clear whether it is a risk factor for peripheral arterial disease
or whether arterial disease promotes diabetes (Strandness et al 1964).
Although the test for a sex by diabetes (known vs non-diabetic) interaction was
not significant, when the analysis was split by males and females, having known
diabetes was significantly associated with a low ABPI in males only. This suggested
that diabetes increases the risk of disease, only in men. This was the opposite result
to that found for coronary heart disease in women in the Framingham Study (Kannel
et al 1985a). On the other hand, the incidence of intermittent claudication was higher
for diabetics compared to non-diabetics in the Framingham study (Kannel and McGee
1979b) and in Finland (Uusitupa et al 1990) and these were consistent with the
Edinburgh results.
11.2.6 Cholesterol
Dietary cholesterol was not significantly related to the ABPI in the total
population, which may in part be due to the underestimation of nutrients from food
frequency questionnaire data. Also dietary cholesterol was not correlated with serum
total cholesterol (r = - 0.01). However, saturated fat intake was correlated with serum
total cholesterol (r = 0.13) and nonHDL cholesterol (r = 0.11). The only link found
between dietary cholesterol and serum nonHDL cholesterol was in male non-smokers.
On removing nonHDL cholesterol from the regression model dietary cholesterol
approached significance (p = 0.07) for this group. Thus, there was a suggestion that
in male non-smokers the most important risk factor was nonHDL cholesterol which
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was influenced by dietary cholesterol intake or dietary saturated fat intake (Figure
11.1). However, caution should be exercised as this came from a subgroup analysis
with relatively weak associations.
Dietary
ChoIestero I
Figure 11.1 Relationships between Dietary Cholesterol, Saturated fat, and the ABPI
in male non-smokers
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Lowering total cholesterol has been shown to reduce risk of coronary heart
disease (Kannel et al 1971, MRFTT 1982, Frick et al 1987). Reductions of serum
cholesterol have also shown reductions in total mortality in epidemiological studies
(Anderson et al 1987), although some studies suggest an increase in mortality from
other causes (Muldoon et al 1990). The Oslo clinical trial study showed significant
reduction in mortality (Hjermann et al 1986) due to dietary lipid lowering. However,
a reduction in total mortality may not be the best indicator of the value of lowering
serum cholesterol; quality of life could be improved by a reduction of suffering for
large numbers of people with CHD, whether they live longer or not (LaRosa et al
1990). Dietary reduction of cholesterol has also been shown to reduce the risk of
coronary heart disease and total mortality, after 15 years of follow-up of the Seven
Countries Study (Keys et al 1986) and after 19 years of follow-up in the Western
Electric Study (Shekelle et al 1981). Despite these results there have also been
conflicting results and Oliver (1991) suggests that population lipid-lowering is still
controversial.
MacRury et al (1992) showed an inverse relationship between serum
cholesterol and leucocyte vitamin C. Low levels of anti-oxidants such as vitamin C
may lead to oxidative modification of LDL cholesterol by free radicals which in turn
increases the likelihood of atheromatous lesions (Steinberg et al 1989). NonHDL
cholesterol was significantly negatively associated with the ABPI in the whole
population, especially in male non-smokers where it was the strongest risk factor. This
is consistent with the results of a meta-analysis of lipid lowering trials showing that
LDL cholesterol rather than total cholesterol was the major risk factor for coronary
heart disease (Yusuf et al 1988).
The finding that nonHDL cholesterol was associated with the ABPI in women
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as well as men, although weakly, is consistent with studies on coronary heart disease.
The Edinburgh Artery Study consisted of women aged 55-74, so most would be
postmenopausal (approximately 95%). After the menopause oestrogen levels would be
reduced and this leads to an increase in nonHDL cholesterol levels. In the Edinburgh
Artery Study the mean nonHDL cholesterol level was higher in women (mean = 5.82
mmol/1 se = 0.05) compared to men (mean = 5.38 mmol/1 se = 0.04). However,
men develop atherosclerotic disease earlier in their 50s and 60s compared to women
(Lerner and Kannel 1986) and so it is perhaps not surprising that there was still
greater risk in men because of their lifetime exposure to risk factors. There were large
differences in risk factors between males and females for peripheral arterial disease
in this population, apart from nonHDL cholesterol and smoking. Indeed, cigarette
smoking in terms of packyears was the strongest risk factor for women.
HDL cholesterol was only positively significantly related to the ABPI in male
smokers but not independently of nonHDL cholesterol in other groups.
11.2.7 Social Class
In chapter 9, when social class was considered as a risk factor for peripheral
arterial disease, it was significantly related to the ABPI only in males. This was
perhaps not surprising as it has been shown that social class as determined by a
woman's occupation was not a good indicator of disease or mortality (McDowall
1983). Among the alternatives to social class, social deprivation (Carstairs and Morris
1991) is a related measure based on the area of residence rather than occupation and
may be a more appropriate measure for women. However, deprivation was highly
correlated with social class ( Males r = 0.46, Females r = 0.35) and the associations
with the ABPI were similar for males and females for both measures. Social class has
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also been shown to be a strong indicator of disease in studies of coronary heart
disease (Rose and Marmot 1981, Pocock et al 1987) and so this thesis has
concentrated on social class as a measure of socio-economic status. Of course,
individuals can change social class over their lifetimes, but this was less of a problem
in the Edinburgh Artery Study, since social class was defined by the longest held
occupation (chapter 2).
There were significant linear trends of low levels of dietary factors such as
vitamins E and C, (3-carotene and cereal fibre with lower social classes in males and
females. The lower social classes also indulged less in strenuous or moderate leisure
activity when aged 35-45 compared to higher social classes. Lower social classes were
also on average shorter which may be an indication of poorer nutrition at an earlier
age. Walker et al (1989) in the British Regional Heart Study found that the risk of
heart attack was significantly greater for shorter men compared to taller men, and this
became less significant on adjusting for social class, among other confounders. The
cumulative lifetime cigarette smoking in terms of packyears was significantly greater
in lower social classes, especially for men, while alcohol intake was greater in higher
social classes. This is consistent with a study of ischaemic heart disease where Pocock
et al (1987) found that the high risk of ischaemic heart disease events in manual
workers during 6 years of follow-up was due to cigarette smoking, higher blood
pressure, greater obesity and less physical activity in leisure time.
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11.3 Analysis of All Risk Factors
From the analyses of individual groups of risk factors, it was clear that there
were a number of significant smoking and sex interactions. Consequently, when
considering all factors it was appropriate to consider males and females separately, and
never smokers and ever smokers separately in males.
11.3.1 Females
Cigarette smoking and age were the most important risk factors for women
(figure 11.2). Although a raised fibrinogen level was significantly associated with the
ABPI, this could be explained by cigarette smoking. On adding BMI which was
surprisingly positively related to the ABPI, nonHDL was inversely related to disease.










Figure 11.2 Risk factors for women in the Edinburgh Artery Study
11.3.2 Males who never smoked
The strongest independent risk factor was nonHDL cholesterol in those who
never smoked. Known diabetes was the only other independent risk factor in this
group.
11.3.3 Males who had ever smoked
Cigarette smoking was of course an important risk factor in this group.
Synergistic effects of smoking with fibrinogen and blood viscosity were found and
these rheological factors also had significant associations with the ABPI,
independently of smoking. Thus smoking was not the only factor involved in raised
levels of fibrinogen and blood viscosity.
Leisure activity was related to blood viscosity and after adjustment for this,
moderate and strenuous activity when aged 35-45 years relative to none was only just
significant at the 10% level.
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NonHDL cholesterol and HDL cholesterol had significant independent
associations with the ABPI in opposite directions. Known diabetes was a significant
risk factor in those who had ever smoked as well as for non-smokers.
The multiple regression analysis of lifestyle and personality risk factors on the
ABPI showed that the relative benefit of moderate or strenuous leisure activity aged
35-45 years was greatest for men who had ever smoked. As leisure activity, cigarette
smoking and height were strongly related to social class in males, when these were
entered into the regression model, social class became non-significant. Also on adding
the rheological factors as well as the lifestyle risk factors, social class was not
significantly associated with the ABPI. However, social class was not a true
confounder in the sense of being only related to the outcome (ABPI) and the variables
of interest, because social class could be considered as the first component in a causal
chain linked to the lifestyle factors and the rheological factors through to peripheral
arterial disease (figure 11.3). Hence social class remains an important risk factor for
peripheral arterial disease while taking part in leisure activity aged 35-45 years, height,




Figure 11.3 Relationships between risk factors for Peripheral Arterial Disease in males
who had ever and who had never smoked
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Mechanism
It was clear that smoking was the major risk factor for peripheral arterial
disease and there was some indication that this was the main difference between risk
factors for peripheral arterial disease compared to ischaemic heart disease (Fowkes et
al 1992a). In non-smokers, nonHDL cholesterol was the strongest risk factor.
The mechanism by which smoking increases peripheral arterial disease is
complex. Evidence suggests this may be via damage to the arterial wall (Smith et al
1993) indicated by increased levels of von Willebrand factor and cross-linked fibrin
degradation products. Smoking also increased fibrinogen level and hence blood
viscosity and these were higher in subjects with peripheral arterial disease. In women
smoking 'explained' the higher levels of fibrinogen and blood viscosity while in men,
although this was also true to some extent, there remained a significant residual
relationship with disease independendy of smoking. Smoking acts in other more direct
ways which may increase the risk of arterial disease. Smoking depletes vitamin C and
E levels (Stryker 1988, Shectman 1989), both of which are antioxidants reducing
oxidation of nonHDL cholesterol involved in the growth of atheromatous lesions (Gey
et al 1989, Riemersma et al 1991). Oxidised NonHDL cholesterol has been recognised
as present in human atherosclerotic plaques (Steinberg et al 1989). These processes
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Figure 11.4 Possible mechanism of relationships between Cigarette smoking, Vitamin




The questionnaires for diet, physical activity and personality were not validated
for the Edinburgh Artery Study itself. Rather reliance was placed on validation by the
authors of these questionnaires, or on validity studies of similar questionnaires.
In studies of dietary risk factors a subsample assessed by weighed intake as
well as food frequency questionnaire is recommended, which allows measurement
error to be taken into account in the analysis (Rosner et al 1990, Rosner et al 1992).
The Edinburgh Artery Study used a Food Frequency Questionnaire (FFQ) with
decreasing frequencies of consumption of food items and with some items, portion
size was added. In a Swedish study of women attending mammography screening
different types of FFQ were compared and it was found that the reported mean
frequencies of consumption of fat, milk fat and vegetables, which are all important in
relation to atherosclerosis, were significantly reduced if portion sizes were added to
the questionnaire (Kuskowska-Wolk et al 1992). In addition, decreasing categories of
response were associated with increased responses for bread and vegetables. Thus the
design of FFQs will affect the results of dietary studies.
The physical activity questionnaire was assessed in the Welsh Heart Health
Study (1985b) against physiological measures such as forced expiratory volume. The
Edinburgh Artery Study used a similar but modified version of the questionnaire and
so a further validation study might have been appropriate.
In studies of atherosclerosis and personality one of the main problems has been
the number of different instruments used to measure Type A behaviour pattern, which
may partly explain the inconsistent results. It would be worth targeting hostility rather
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than general personality traits, as there appears to be a consensus that impatience and
hard-driving, aspects of hostility, are the core elements of the Type A behaviour which
are linked to coronary heart disease (Evans 1990, Sykes et al 1992). It would also be
worth considering structured interviews rather than self-completed questionnaires, the
former having the advantage that note can be taken of the tone and speech behaviour
of the interviewee as well as the content of the replies. Rosenman et al (1975) used
this instrument in the follow-up of the Western Electric Study and it is considered the
gold standard for measures of Type A behaviour.
11.4.2 Sample Size and Power
At the design stage sample size calculations are often based on two-sample
comparisons which may be appropriate for clinical trials, but are probably not realistic
in an observational study. For example, multiple testing will be carried out in a cross-
sectional study and therefore it would be better to calculate sample size based on a
more realistic type I error of 0.1% say, rather than 5%. Calculations should also take
into account adjustment for numerous confounders in observational studies. The
methods of Cohen (1988), Hsieh (1989), Wilson and Gordon (1986) and Self et al
(1992), could be used depending on whether the outcome was binary or continuous.
There were many differences in the relationships between risk factors and
peripheral arterial disease for males and females and this has been noted for coronary
heart disease (Lerner and Kannel 1986). Hence sub-group analyses are likely in
observational studies and the power is reduced to detect associations with disease and
sample size should be increased to compensate for this.
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11.4.3 Within-person measurement error
Measurement error in clinical factors such as serum cholesterol and serum
glucose have been shown to greatly attenuate the estimates of regression coefficients
(Rosner et al 1992) leading to underestimation of their importance in relation to
disease. Other factors such as BMI, age and smoking were relatively more accurate
and therefore less of a problem (Rosner et al 1992). The solution would be to
incorporate reproducibility substudies within the design of a study for factors which
are known to vary in time, such as dietary factors, serum cholesterol and fibrinogen,
and adjust the regression coefficients according to the degree of within-person
variability.
11.5 Future Research
11.5.1 Implications for prevention
The advice to 'stop smoking and keep walking' was offered to cases of
intermittent claudication (Housley 1988). The analysis of risk factors in the Edinburgh
Artery Study suggest that this advice should also be applied to the general population
where asymptomatic and symptomatic peripheral arterial disease was prevalent (26%).
To this advice could be added that one should also try to change social class or more
practically adopt behaviours associated with higher social class. These are reduce
cigarette smoking, reduce dietary saturated fat intake, increase vitamin intake, that is,
as fruit and vegetables or as supplements, and increase participation in leisure activity.
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Smoking
The Edinburgh Artery Study results and studies on ischaemic heart disease
(Pocock et al 1987) have implications for health education programs, in that
campaigns to reduce smoking should perhaps be targeted at manual social classes.
Although mortality from all causes and coronary heart disease and presumably
peripheral arterial disease have declined in time, the relative improvement has been
greater in non-manual social classes, and the proportionate decline in smoking has
been greater in non-manual classes (Marmot and McDowall 1986). It would appear
that these messages have already got through to higher social classes, or at least they
are in a more favourable position to act upon the message.
Since smoking appears to be the main risk factor for women and is especially
prevalent in lower social classes, this is clearly a group which could be targeted. In
the 1982 General Household Survey it was found that only 12% of women with
university degrees were smokers compared to 42% of those with no educational
qualifications (OPCS, 1990). It is known that lower social class lone mothers are well
aware of the health risks, but see their habit as a luxury and relief from stress
(Graham 1987). Hence the smoking cessation message needs to be appropriate to the
social class and gender of the recipients.
Saturated fat intake
On the other hand, in terms of Health Education programs, reduction of
nonHDL cholesterol in the whole population would be a worthwhile aim. This has
been reinforced by studies in China which suggested that even in distributions which
are shifted to lower levels than those found in the West there was still a dose-response
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relationship of coronary heart disease and plasma cholesterol (Chen et al 1991).There
was no social class gradient in the Edinburgh Artery Study for nonHDL cholesterol
unlike that found for smoking. Meta-analyses of lipid-lowering trials have suggested
an unexpected increase in deaths from accidents/suicide (Muldoon et al 1990), but
analysis of the Edinburgh Artery Study showed no significant relationship between
nonHDL cholesterol and hostility measured by the Bedford-Foulds (1978) scales but
did indicate a positive relationship between overt hostile acts and triglyceride levels
(Fowkes et al 1992c). It will be interesting to see whether high triglyceride or low
cholesterol are associated with deaths from accidents/suicide in the follow-up of the
Edinburgh Artery Study. Recent analysis of the Whitehall study (Davey Smith et al
1992) speculated that low cholesterol level was not the cause of the increased risk for
other diseases.
Thus large population programmes are indicated for some factors, such as
cholesterol, to lower the mean of the distribution of a risk factor but for other factors
such as smoking, targeting subgroups may be more appropriate. Attention needs to be
paid to 'the shape as well as the position of the distribution and how the distribution
varies among subgroups of the population' (Marmot 1993).
Of course all of these prevention programmes apply equally to reducing risk
of coronary heart disease, although smoking appears to be a stronger risk factor for
peripheral arterial disease (Fowkes et al 1992a). Although symptomatic peripheral
arterial disease was relatively rare in the Edinburgh population, secondary prevention
could relieve suffering ofmillions with coronary heart disease and/or PAD throughout
the world (LaRosa et al 1990).
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11.5.2 Implications for Treatment
In terms of evaluation of interventions the gold standard is the randomised
controlled trial (RCT). This method could be applied to smoking cessation programs,
including counselling, and nicotine patches. Cholesterol lowering trials either by drug
treatment or dietary advice would be worth exploring, although it has been suggested
that cholesterol-lowering drugs should only be used for those at high risk (Davey
Smith et al 1993). Amongst the possible trials concerned with dietary change would
be vitamin supplementation or dietary advice to increase intake of vitamin C and E
containing foods, high fibre and low saturated fat Finally, advice or programs to
increase leisure activity could be implemented and evaluated.
11.6 Summary
The results suggest that men and women should be considered separately and
possibly non-smokers/smokers in the analysis of risk factors for arterial disease. Cross-
sectional studies can demonstrate associations but there is a need for longitudinal
studies to show causative relationships. Although measures of lifetime risk such as
packyears for smoking alleviate this problem somewhat, these in turn are liable to
recall bias. Ideally intervention studies to alter risk factors are needed to demonstrate
causation.
Sample size calculations based on two group comparisons tend to give an
underestimate in epidemiological studies, where multiple confounders are likely and
multiple tests tend to be carried out. Methods which take confounding into account
would give more realistic estimates of sample size.
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APPENDIX 1 : The Edinburgh Artery Study Questionnaire
EDINBURGH ARTERY STUDY
QUESTIONNAIRE
THE INFORMATION IN THIS QUESTIONNAIRE IS HIGHLY CONFIDENTIAL AND IS PART OF
A MEDICAL RESEARCH STUDY
The information you give in this personal health record will be treated as
strictly confidential and will be available only to your own doctor and the
study team. The results of the research will appear only in the form of
general statistics from which it will be impossible to identify you as an
individual.




If you have any difficulties in answering some questions you will have a
chance to discuss these later with a member of the study team.
THANK YOU FOR YOUR CO-OPERATION IN THIS STUDY. THE FINDINGS WILL HELP TO
IMPROVE HEALTH IN SCOTLAND.
IT IS IMPORTANT TO ANSWER ALL THE QUESTIONS CAREFULLY. PLEASE TAKE YOUR
TIME.
There is some evidence of a relationship between health and other factors
such as exercise, occupation, education, diet etc. In order to compare our
data frith national figures and other research work, we are interested to
have the following details about, yourself.
PERSONAL HISTORY
1. Please tick one box:
2. Enter your date of birth: Day
Male Female




3. Please tick the box showing jour present mar ital status:
Married (or equivalent) □ 1
Single □ 2
Widowed □ 3
Divorced or serarated □ 4
EDUCATION
4. What is the HIGHEST level of education you and your spouse or




University/college degree course □ 1 □ 1
Other professional or technical
qualification after leaving school □ 2 □ 2
Secondary School □ 3 □ q
Primary School □ 4 □ 4
PAID EMPLOYMENT











Other, please specify 6
Please complete questions 6 and 7 as appropriate for yourself and your
spouse or ex-spouse.
6. YOURSPT ,F YOUR SPOUSE or EX-SPOUSE
(a) Please give the name of your present job and describe what you do as
fully as possible. If unemployed or retired, do not complete this
question, BUT PROCEED TO QUESTION 7.
(b) What business or industry is this in?
(c) In this job are you?
self-employed □ foreman □
manager □ other □
(d! In this job do you supervise/employ?
25 or more people □
fewer than 25 people □
no-one □
self-employed □ foreman □
□ other | jmanager
25 or more people





YOUR SPOUSE or EX-SPOUSE7. YOURSELF
(a) Please give the name of the job you have done for the longest period of
your life, and describe what you did as fully as possible. (If the
answer is the same as in Question 6 above, write SAME)
(b) uhat business or industry, was this in?
(c) In this job were you?
self-employed □ foreman □
manager u other p
employee —
self-employed □ foreman □
manager □ other
employee □
(d) In this job did ycu supervise/employ?
25 or more people □ 25 or more people





FOR OFFICE USE ONLY
S.C.
SMOKING
Smoking has been linked with many health problems. It is important that you
answer the following section as accurately as possible. Please tick
appropriate boxes.
(a) Do you smoke at present0




(b) What do you usually smoke now?
cigarettes Yes □ No □
pipe Yes □ No □
cigars Yes □ No □
(c) How many do you usually smoke now?
cigarettes per day
02. tobacco per week
cigars per week
(d) For how many years during your life have you
smoked cigarettes?
(e) How many cigarettes have you smoked on average
per day during the period you have smoked?








f) Have you ever smoked regularly?




g) What did you usually smoke?
cigarettes Yes □ No □
pipe Yes □ No □
cigars Yes □ No □
(h) How much did you smoke on average while you
were a smoker?
cigarettes per day
oz. tobacco per week
cigars per week





If you smoked cigareztes, how long is it
since you finally gave up? years .months
Is any other member of your household a
smoker? Yes | | No □
MEDICAL HISTORY
We should now like co ask you questions about your health, illnesses you
have had in the past, and how you are feeling now. Please tick appropriate
boxes.
9. Have you ever been told by a doctor that you have or have had anv of
the following?
Yes No
Hardening of the arteries in the legs □ □
.Angina □ □
Heart attack (coronary thrombosis, myocardial
infarction) □ □
High blood pressure □ □
Stroke □ □




Are you on any regular medical treatment from a doctor as follows?
Yes No
Drugs to lower blood pressure □ □
Diuretics (water tablets) □ □
Insulin injections □ □
Tablets for diabetes □ □
Other treatments?
Give names if possible.
□ □
CHEST PAIN
11(a) Do you ever get pain or discomfort in your chest?
IF NO, PROCEED TO QUESTION 12
Yes n >;o n
(b) Do you get this pain or discomfort when you walk uphill or hurry?
IF NO, PROCEED TO QUESTION llg
Yes Q No Q
(c) Do you get it when you walk at an ordinary pace on the level?
Yes Q No Q
(d) When you get any pain or discomfort in your chest what do you do?
stop n
Slow down □
Continue at the same pace □
(e) Does it go away when you stand still or sit down?
Yes Q No □
(f) How soon?
10 minutes or less Yes □ No □
more than 10 minutes Yes No
(g) Where do you get this pain or discomfort? Mark the place! s) with 'X'
on the diagram.
RIGHT LEFT
12(a) Have you ever had a severe pain across the front of your chest lasting
for half an hour or more?
Yes
(b) What w-as the cause? -
FOR OFFICE USE ONLY A: GRADE Ml:
□ No □
COUGH
13(a) Do you usuaiiy cougn several times rirst tnmg m tne morning m me
winter? (Ignore clearing throat or single cough)
s □ □Ye
(b) Do you usually cough during the day or night in winter? (Ignore the
occasional cough)
les □ N'o □
(ci If yes to (a) or (b), do you cough on most days for at least three
months each winter?
les □ N'° □
PHLEGM (SPIT)
14(a) Do you usually bring up any phlegm (spit) from your chest first thing
in the morning in the winter?
Yes LJ Mo □
ibi Do you usually bring up any phlegm from your chest, during the day, or
at night, in the winter?
Yes Q Mo Q]
(c) If yes to (a) or (b), do you bring up phlegm like this on most days
for as much as three months each vear?
Yes □ N'o □
RREATHLESSNESS
15(a) Are you troubled by shortness of breath when hurrying on level ground
or walking up a slight hill?
IF NO, GO TO QUESTION 16
Yes [J No □
(b) Do you get short of breath walking with other people of your own age
on level ground?
ies □ N?° □
(c! Do you have to stop for breath when walking at your own pace on level
ground?
les □ N:° □
FOR OFFICE USE ONLY
GRADE
WHEEZING
16(a) Have you had attacks of wheezing or whistling in your chest at any
time in the last 12 months?
Yes Q No |_]
(b) Have you ever had attacks of shortness of breath with wheezing?
Yes Q No Q
(o) If yes to (b), is/was your breathing absolutely normal between
attacks?
^
Yes |_J No Q
(d) Have you at any time in the last 12 months been woken at night by an
attack of shortness of breath?
Yes □ No □
LEG PAIN
l'7(a) Do you get a pain in either leg on walking?
IF NO, GO TO QUESTION 18
Yes □ No □
(b) Does this pain ever begin when you are standing still or sitting?
Yes PJJ No □
(c) Do you get this pain in your calf (or calves)?
Yes □ No □
(d) Do you get it when you walk uphill or hurry?
Yes P] No ppj
(e) Do you get it when you walk at an ordinary pace on the level?
Yes [P] No pj
(f) Does the pain ever disappear while you sure still walking?
Yes p] No j j
(g) What do you do if you get it when you are walking?
Stop 1 PJ]
Slow down 2 j j
Continue at same pace 3 pjj
(h) What happens to it if you stand still?
Usually continues for more than 10 minutes 1 | j
Usually disappears in 10 minutes or less 2 PJ
18. Have you ever had surgery on the arteries of your legs other than fc:
varicose veins?
Yes □ No □
Please specify
19. Have you ever had surgery to remove
toes? Yes I I No □
leg below the knee? Yes pj No PJ
leg above the knee? Yes □ No □
FCR OFFICE USE ONLY
I. C • GRADE
OTHER MEMBERS OF YOUR FAMILY
20. Please tick the appropriate boxes for other members of your family if
they have been diagnosed as having any of the illnesses below:






□ □ □ □
□ □ □ □
□ □ □ □
Diabetes (sugar disease) □ □ □ □
Hardening of the arteries
in the leg/claudication □ □ □ □
Thrombosis/embolism □ □ □ □
High blood pressure □ □ □ □
Heart attack □ □ □ □
If died from heart attack,
at what age?
...Yrs ....Yrs ....Yrs ....Yrs
PHYSICAL ACTIVITY
The following section gives examples of the sort of activities you might do








Walking (include to and
from work,to shops etc)
Yoga







Cycling (include to and
























21. In a t;*pical week during the last year, on how many occasions would
you take part FOR MORE THAN 20 MINUTES EACH TIME:
Insert'None'if appropriate
in LIGHT physical activity? in summer times
in winter times
in MODERATE physical activity? in summer times
in winter times
in STRENUOUS physical activity? in summer times
in winter times
22. In a typical week, when you were 35-45 years old, on how many
occasions would you take part, FOR MORE THAN 20 MINUTES EACH TIME:
Insert 'None' if appropriate
in LIGHT physical activity? in summer times
in winter times
in MODERATE physical activity? in summer times
in winter times
in STRENUOUS physical activity? in summer times
in winter times
Which of the following best describes your daily work or other daytime
activity at the present time?
Please tick one box only.
I am usually sitting during the j 1 eg. office workers,
day and do not walk about much ] | drivers
I stand or walk about quite a
lot during the day, but do not





I usually lift or carry light




I do heavy work and carry
heavy loads □ eg. building, miningworkers, agricultural
workers
Which of the following best described your daily work or other daytime
activity WHEN YOU WERE 35-45 YEARS OLD?
I usually sat during the
day and did not walk about much □ eg. office workers,drivers
I stood or walked about quite a
lot during the day, but did not





I usually lifted or carried light
loads and had to climb stairs
and/or hills often
□ eg. postmen, packers
I did heavy work and carried heavy I | eg. building, mining hea\T
loads 1 I workers, agricultural
workers
LIFE STYLE AND ATTITUDES
25. Each of us belongs somewhere along the line between two extremes. For
example, most of us are neither the most competitive nor the least
competitive person we know. What we would like you to do is to make a
vertical line where you think you belong between these two extremes.
For example:
Always tidy | Never tidy
(a) Never late
(b) Not competitive
(c) Anticipate what ethers





(f) Go "all out"
(g) Take things one at a
time
(h) emphatic in speech
(may pound desk or chair)
( i ) Have wanted good .job
recognised by others
















Try to do many things
at once, think about:












26. The next section contains descriptions of how you may have felt,
thought, or acted during most of your life. Below each statement there
are four words or phrases; choose the one which best describes you for
most of your life and draw a circle round it.
EXAMPLE
(а) I have enjoyed being with other people.
Nearly always ^Of'terT) Seldom Never
The first example would mean that most of your life you have often
enjoyed being with other people.
(1) I would have liked to get my own back on someone.
Very often Often Seldom Never
(2) I have been content to act in a very humble way.
Never Seldom Often Nearly always
(3) I have thought that people will tell the truth, even if it gets them
into trouble.
Nearly always Often Seldom Never
(4) I have felt as capable as other people.
Never Seldom Often Nearly always
(5) When I've wanted to have a row with someone, I have done so.
Nearly always Often Seldom Never
(б) I have preferred to take a lot of advice before doing anything.
Never Seldom Often Nearly always
(7) I have felt like telling people to go to blazes.
Nearly always Often Seldom Never
(8) When in a group I have been content to be led.
Never Seldom Often Nearly always
(9) When someone has been particularly helpful, I've wondered what real
reason lay behind it.
Nearly always Often Seldom Never
(10) I have had confidence in myself.
Never Seldom Often - Nearlv alwavs
(11) When I've disliked someone, I have shown it.
Nearly always Often Seldom Never
(12) I have wanted plenty of support from people.
«
Never Seldom Often Nearly always
(13) I have felt the urge to smash things.
Very often Often Seldom Never
(14) I have been content to be dominated by someone else.
Never Seldom Often Nearly always
(15) I have believed that people are pretty reliable.
Nearly always Often Seldom Never
(16) I have been very unsure of myself.
Never Seldom Often Nearly always
(17) When I've been angry with someone, I've bottled it up.
Nearly always Often Seldom Never
(18) I have liked to be told what needs doing.
Never Seldom Often Nearly always
(19) I have wanted to give someone a piece of my mind.
Very often Often Seldom Never
(20) I have preferred to let people have their own way.
Never Seldom Often Nearly always
(21) I have felt that people would tell lies to get ahead.
Nearly always Often Seldom Never
(22) I have given up doing something because I thought too little of my owi
ability.
Never Seldom Often Very Often
(23) Even when crossed, I've let people get away with it.
Nearly always Often Seldom Never
(24) I have been content to lean on other people for emotional support.
Never Seldom Often Nearly always
(25) I would have liked to pick a quarrel with someone.
Very often Often Seldom Never
(26) I have been happy to play second fiddle.
Never Seldom Often Nearly always
(27) I have felt that people are out for what they can get.
Nearly always Often Seldom Never
(28) I have felt that even when difficulties were piling up I would
overcome them.
Never Seldom Often Very often
(29) When I've thought I was justified in losing my temper, I have done so
in no uncertain terms.
Very often Often Seldom Never
(30) I have preferred to find out for myself what's to be done.
Never Seldom Often Nearly always
(31) I have felt like blaming others when things have gone wrong.
Nearly always Often Seldom Never
(32) I have preferred to stay in the background.
Never Seldom Often Nearly always
(33) I have thought one can safely trust people.
Nearly always Often Seldom Never
(34) I have felt pretty useless.
Never Seldom Often Nearly always
(35) When I've felt like blaming someone to their face for something that
has gone wrong, I have done so.
Nearly always Often Seldom Never
(36) I have needed a lot of help from other people.
Never Seldom Often Very often
DIET
The following questions are about the food that you usually eat. Please give
the number of days each week on which you usually eat the various foods.
EXAMPLE
Ring the appropriate answer like this:
If you eat a food every day, then ring
the 7:
If you eat a food 3 days each week ring
the 3:
If you eat a food less than one day a week
(but more than once a month), then
ring M (Monthly):
If you eat a food rarely, or never, then
ring R (Rarely):
Number of days each week
0654321 MR
7654(3)2 1 MR
6 5 4 1 © R
7 6 5 4 3 2 1 M (R)
Please complete every line even if you do not take the food in question.
27. BREAD
How many slices Please tick





























Rice Crispies, Special K, Sugar Puffs 7 6 5 4 3 2 M R
(b) Cornflakes, Muesli, Shredded Wheat,
Sultana Bran, Weetabix 7 6 5 4 o0 2 >1 R
(c) Bran Flakes or Puffed Wheat 7 6 5 4 3 2 M R
(d) All bran or Wheat Bran 7 6 -\ 4 3 2 M R
(e) Other cereals. 7 6 5 4 3 2 M R
Please specify
29. MEAT
(a) Beef (including minced beef,
beefburgers) 7 6 5 4 3 o 1 M R
(b) Lamb 7 6 5 4 3 2 1 M R
(c) Pork, bacon or ham 7 6 5 4 3 2 1 M R
(d) Chicken, Turkey,, or other poultry 7 6 5 4 3 2 1 M R
(e) Tinned meat (all types, eg.corned beef) 7 6 5 4 3 2 1 M R
(f) Pork sausages 7 6 5 4 3 2 1 M R
(g) Beef sausages i 6 5 4 3 2 1 M R
(h) Meat pies or pasties 7 6 5 4 3 2 1 M R
(i) Liver or kidney or heart 7 5 5 4 3 2 1 M R
CO o FISH
(a) White fish (cod, haddock, hake, plaice,
or fish fingers etc.) 7 6 5 4 3 2 1 M R
(b) Kippers, herrings, pilchards, tuna,
sardines, salmon or mackerel (including
tinned) 7 6 5 4 3 2 1 M R
31. VEGETABLES
(a) Potatoes:boiled, baked or mashed 7 6 5 4 3 2 i_ M R
(b) Potatoes:(a) chips or fried (from shop) 7 6 5 4 3 2 1 M R
(b) chips or fried (cooked at
home) 7 6 5 4 3 2 1 M R
(c) Green vegetables or salad 7 6 5 4 3 2 1 M R
(d) Carrots 7 6 5 4 3 2 1 M R
(e) Parsnips, swedes, turnips, beetroot,
and other root vegetables *71 6 5 4 3 2 1 M R
(f) Baked or butter beans, lentils, peas,
sweer.com 7 6 5 4 3 2 1 M R
(g) Onions, (cooked, raw or pickled) 7 6 5 4 3 2 1 M R
(h) Spaghetti and other pasta 7 6 5 4 3 2 1 M R
(i) Rice (all types except pudding rice) 7 6 5 4 3 2 1 M R
32. BISCUITS/PUDDINGS
(a) Digestive biscuits or plain biscuits 7
(b) Sweet biscuits, sweeties, or jellies 7
(c) Ice cream, sweet yoghurts or chocolate 7
(d) Fruit cake, sponge cake, scones or buns 7
(e) Fruit tart, jam tart, fruit crumble,
trifle 7
(f) Milk pudding(eg. rice, tapioca custard) 7
(g) Tinned fruit 7
6 5 4 3 2 M R
6 5 4 3 2 M R
6 5 4 3 2 M R
6 5 4 3 O{* M R
6 5 4 3 2 M R
6 5 4 3 2 M R
6 5 4 OvJ 2 M R
33. FRESH FRUIT
(a) Number of apples eaten per week
(b) Number of pears eaten per week
(c) Number of oranges or grapefruit eaten per week
(d) Number of bananas eaten per week
34. EGGS










Between half and one pint
More than one pint
What kind of milk do you usually use?
(Please tick one)
Full-fat milk, fresh or dried
Semi-skimmed milk
Fully-skimmed milk, fresh or dried




















What do you usually eat on bread?
(Please tick one or more)
Butter





How often do you eat home-fried food (including chips) cooked with:
765432 LMR






How many cups of coffee do you have per day?
How many teaspoons of sugar do you take per cup?
How many cups of tea do you have per day?
How many teaspoons of sugar do you take per cup?
7 6 5 4 3 2 1 M R
How many days each week do you drink
fruit juices and squashes?




6 5 4 3 2 1 M R
□ i
□ ^




Lard and solid vegetable oil
Liquid vegetable oil


















(a) How much salt is added in your cooking? (please tick one)
None 1 | |
A little 2 □
A lot 3 Li
(b) Do you add salt to your meals at the table? (please tick one)
No i n
When the food is not salty enough 2 i I
Almost always before tasting 3 (^]
(c) Is, in your opinion, ready-made food compared to home-marie food?
(please tick one)
Less salty than at home 1
As salty as at home 2 [^]
More salty than at home 3 Qj
40. How many persons normally eat in your household?
Number of adults (including yourself)
Number of children 5 to 16 years
Number of children 1 to 4 years
Number of babies under 1 year of age
41. Are you on a special diet? (Please tick one)
None 0 j j
Slimming diet suggested by your doctor 1 □
SI ironing diet prescribed by yourself 2 [ ;
Diabetic diet 3 | 1





42(a) Think back carefully over the last seven 'days. Please write in each
column exactly the number of alcoholic drinks you have consumed on
each day during the past week. If none consumed write 'O' in the
boxes.
Try to remember where you were and who you were with on each day. This
may help you remember what you had to drink.
Pints of Single Glasses Single Glasses
beer, lager of whisky,vodka of martini,
cider, etc gin etc. sherry, etc.
Monday □ □ □
Tuesday □ □ □
Wednesday □ □ □
Thursday □ □ □




Sunday □ □ □
(b) Would you say that last week was fairly typical of what you usually
have to drink in a week?
Yes □ N° □
(c) If last week was not typical, would you normally drink more or less in
a week?
i □ More 2 □ Less
43. Think about the last time you had a drink. Exactly how- much did you
drink on that occasion? Please insert the numbers in the boxes.
How many pints of lager, cider, shandy,
stout etc. did you drink? Pints
How many single glasses of whisky, vodka,
gin, rum or other spirits did you drink? Glasses
How many single glasses of Martini, port,
sherry or wine did you drink? Glasses
THANK YOU VERY MUCH FOR YOUR CO-OPERATION IN COMPLETING THIS QUESTIONNAIRE.
YOU WILL HAVE .AN OPPORTUNITY* TO DISCUSS ANY PROBLEMS WITH THE QUESTIONNAIRE
WITH A NURSE AT THE END OF THE MORNING.
APPENDIX 2: Published Papers
(Permission to reproduce the papers has been
obtained from each relevant journal)
Diet as a risk factor for peripheral arterial disease in the
general population: The Edinburgh Artery Study1-3
Peter T Donnan, Marjory Thomson, F Gerald R Fowkes, Robin J Prescott, and Edward Housley
ABSTRACT The Edinburgh Artery Study included a cross-
sectional survey of 1592 men and women (aged 55-74 y). One
aim was to examine relationships between an indicator of pe¬
ripheral arterial disease, the ankle brachial pressure index (ABPI),
and dietary factors. Nutrient intake was derived from a food-
frequency questionnaire. Higher frequency of consumption of
fiber-containing foods was associated with greater mean ABPI
in males and higher consumption of meat and meat products
were significantly associated with low mean ABPI in males and
females. In a multiple linear regression with ABPI as outcome
and energy-adjusted nutrients as predictors, cereal fiber (P
= 0.02) and alcohol (P = 0.04) were positively associated with
the ABPI in males but not in females. Dietary vitamin E(a-
tocopherol) intake was positively associated with ABPI (P = 0.04)
independently of smoking and other nutrients. Dietary vitamin
C intake was significantly related to ABPI (P = 0.006) only
among those who had ever smoked. Am J Clin Nutr 1993;57:
917-21.
KEY WORDS Atherosclerosis, peripheral arterial disease,
diet, dietary fiber, vitamin E, vitamin C
Introduction
The underlying mechanism of peripheral arterial disease and
coronary heart disease is atherosclerosis and similarities in dietary
risk factors for these two conditions would be expected. Most
research has concentrated on the relationship between diet and
coronary heart disease.
Epidemiological evidence suggests that high consumption of
fish oil (1) and dietary fiber (2) reduces the risk ofcoronary heart
disease, whereas smoking is associated with a higher incidence
of coronary heart disease (3). Dietary interventions to reduce
cholesterol have been shown to lower the risk of coronary heart
disease and cardiovascular mortality (4).
In contrast to coronary heart disease the relationship between
diet and peripheral arterial disease has not been studied exten¬
sively. In a hospital-based case-control study in Greece (5) dietary
intake of saturated fatty acids, proteins, and cholesterol were
associated with increased risk of peripheral arterial disease,
whereas a high intake of polyunsaturated fatty acids and crude
fiber reduced risk. In dietary-intervention studies on patients
with peripheral arterial disease, clinical improvement has been
demonstrated in patients on low-fat, high-fiber diets (6-8). Fish-
oil (eicosapentaenoic acid) supplementation produced a reduc¬
tion in blood viscosity (9).
This limited research on diet and peripheral arterial disease
has been conducted only on hospital patients. In this study our
aim was to determine the relationships between diet and a wide
spectrum of peripheral arterial disease in a representative sample
from the general population of men and women aged 55-74 y
surveyed in the Edinburgh Artery Study.
Methods
The Edinburgh Artery Study carried out in 1988 consisted of
a cross-sectional survey of 1592 men and women aged 55-74
y, randomly selected from the age-sex registers of 10 general
practices. These general practices had catchment populations
spread geographically and socioeconomically throughout the city.
The subjects were invited to a university clinic to complete a
questionnaire and have a comprehensive medical examination.
This examination included measurement of the left and right
ankle brachial pressure index (ABPI), which is the ratio of the
ankle systolic pressure to the brachial systolic pressure. The ABPI
is related to the extent of peripheral arterial disease in the general
population (10), low values being indicative of more extensive
disease.
The response rate to the invitation to participate in the study
was 65% and follow-up of a sample of nonresponders did not
show any significant bias in terms of age, sex, smoking, and
extent of peripheral arterial disease. Details of the study popu¬
lation, recruitment, and prevalence of peripheral arterial disease
were described previously (11). The questionnaire included val¬
idated questions on social class, cardiovascular history, inter¬
mittent claudication and angina [World Health Organization
questionnaire (12)], smoking history, and alcohol consump¬
tion (13).
In the Edinburgh Artery Study, a version of a food-frequency
questionnaire used in a previous study (14) was used to obtain
nutrient information. This consisted of a list of «60 food items
and respondents were asked to rate the frequency ofconsumption
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(rarely/monthly or 1-7 times/wk) for each item. This was com¬
pleted by all who attended the clinic, and a nurse was available
to go through the questionnaire if there were any problems of
interpretation. Calculation of energy and nutrient intakes for
individuals was estimated by multiplying the nutrient content
of a typical portion size of the specified food item by the fre¬
quency of consumption and summing over all food items. Even
if participants failed to complete all questions, nutrients were
still calculated, provided a response had been given regarding
those foods that are major sources of a specific nutrient. Con¬
sequently, some nutrients may have been slightly underesti¬
mated.
The study was approved by the National Health Service Loth¬
ian Health Board Committee on Ethics ofMedical Research.
Statistical methods
The results of the food-frequency questionnaire in terms of
nutrients have been expressed as medians along with the upper
and lower quartiles because many of the nutrients had positively
skewed distributions. The Mann-Whitney test was used to com¬
pare differences in absolute nutrient intakes between males and
females. In addition, the relationships between the frequency of
consumption of individual foods and peripheral arterial disease
were explored by testing for linear trends in the mean ABPI by
using analysis of variance across the food-frequency categories:
rarely/monthly, 1-3 times/wk, and 4-7 times/wk. These analyses
were carried out for males and females separately and were ad¬
justed for age.
Multiple linear regression was used to assess the independence
of associations between dietary factors and the minimum ABPI
of the two limbs, expressed as a continuous outcome. Tests of
sex by nutrient and smoking by nutrient interactions were carried
out. The statistical package BMDP was used for all analyses
(15). The proportion of diabetics, known and positive after a
glucose tolerance test, was small (5.7%) and were excluded from
all regression analyses. Subjects with symptomatic coronary heart
disease were not excluded because this would have also excluded
many subjects with peripheral arterial disease, resulting in a
nonrepresentative sample and a reduction in power.
It is important in epidemiological analyses to use measures
of nutrient intake that are independent of total energy intake,
especially whenever energy is related to disease (16). Conse¬
quently, energy-adjusted nutrient intakes were obtained from
the residuals of the regression of each of the nutrients with total
energy intake as predictor, applying the usual assumptions of
regression. The residuals were added to the expected nutrient
intake for the mean total energy intake of the population to give
more meaningful measures of nutrient intake. This procedure
gave relatively uncorrelated measures ofnutrient intake, allowing
easier interpretation of the results of multiple-linear-regression
models, with the ABPI as a continuous outcome.
Initially, a regression model for each energy-adjusted nutrient
was used to assess the independent association of each dietary
factor from other factors known to be associated with the ABPI,
such as age, sex, height, and cigarette smoking. Height was used
rather than body mass index (BMI) because it was found that
the measurement of the ABPI was related to height, whereas
BMI was not significantly associated with the ABPI. Smoking
history was defined in two ways. First, consumption was esti¬
mated in terms of pack-years, which is a measure of the amount
smoked and the number of years as a smoker. A square-root
transformation of pack-years was used in the models to give a
more symmetrical distribution for the analyses. Second, when
interactions with smoking were found, the population was di¬
vided into those who had never smoked and those who were
ex-smokers or current smokers (ever smokers).
Finally, a regression model with all the energy-adjusted nu¬
trients, allowing for age, sex, height, total energy, and smoking,
was used to assess the independent effect of each nutrient, al¬
lowing for all other nutrients in relation to the ABPI.
Results
The absolute values of nutrient intakes and as a percentage
ofenergy for men and women in the population of the Edinburgh
Artery Study are shown in Table 1. Most amounts of nutrient
consumption were higher in males, except for vegetable fiber
and vitamin C, which were significantly higher in females. In
addition, females had significantly greater intakes ofprotein and
polyunsaturated fatty acids as a percentage of total energy com¬
pared with males. Table 2 shows the trend in mean ABPI in
females across three categories of frequency of food consumption:
rarely/monthly, 1-3 times/wk, and 4-7 times/wk. There were
significant reductions in mean ABPI in females, with increasing
consumption of low-fiber breakfast cereals, meat pies and pas¬
tries, and pork, bacon, and ham, and significant trends in mean
ABPI with increasing frequency of consumption of onions and
biscuits/sweets. Among males there were significant linear re¬
ductions in mean ABPI with increasing consumption of white
bread and meat pies and pastries, whereas significant increases
in mean ABPI were associated with increasing consumption of
whole-meal bread, high-fiber breakfast cereals, and pears (Table
3). Increased consumption of lard in males and females was
associated with lower mean ABPIs, but not significantly lower.
Caution should be applied in interpreting these results because
with many tests at the 5% level, 1 in 20 would be expected to
be significant by chance alone. In fact the number of significant
tests is greater than would be expected by chance. The significant
linear trends (Tables 2 and 3) provide stronger evidence of cause
and effect than do the more general tests for association.
In the multiple-linear-regression models with ABPI as a con¬
tinuous outcome, the core model consisted of age, height, sex,
smoking, and total energy, to which each energy-adjusted nu¬
trient was added separately (Table 4).
Finally, to assess the independent effects of nutrients, all nu¬
trients were added simultaneously to this core model. The results
for the nutrients did not differ greatly for these two procedures,
the main difference being that cereal fiber in males was less sig¬
nificant (Table 4) when other nutrients were not adjusted for
compared with when all nutrients were simultaneously adjusted
for (Table 5).
For the variables in the core model (Table 5) there were sig¬
nificant relationships between the ABPI and age (P < 0.001),
height (P = 0.08), and smoking (ever vs never, P < 0.001). Sex
[P = 0.71) and total energy intake were also added to this model
(P = 0.69).
The energy-adjusted intake of alcohol had the strongest as¬
sociation with the ABPI, and a significant interaction with sex
was found in the regression analysis at the 10% level. Alcohol
was positively associated with the ABPI in males (P - 0.04)
when all variables were adjusted for (Table 5), whereas there
was no significant association in females. Similarly, cereal fiber
intake had a significant interaction with sex (P = 0.05) and was
significantly related to the ABPI in males (P = 0.02) but not in
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TABLE 1
Medians and upper and lower quartiles of absolute nutrient intake and as a percentage of energy in males and females aged 55-74 y in the
Edinburgh Artery Study
Females (n = 783) Males (n = 809)
Lower Upper Lower Upper
Median quartiles quartiles Median quartiles quartiles
Total energy (kj) 7425 6245 8748 8538* 7245 10 250
Total fat (% energy) 38.1 34.4 42.0 38.0 33.6 44.6
Carbohydrate (% energy) 44.2 40.3 47.8 45.2* 41.5 49.5
Protein (% energy) 17.4 15.9 19.1 16.8* 15.5 18.3
Saturated fatty acids (% energy) 16.5 14.0 19.5 16.2 13.9 18.8
Polyunsaturated fatty acids
(% energy) 4.9 3.7 6.7 4.5t 3.5 6.4
P:St 0.31 0.20 0.46 0.30 0.19 0.44
Alcohol (g) 1.2 0.0 6.2 9.5* 1.2 21.9
Cereal fiber (g) 8.9 6.2 12.8 9.7* 6.9 14.0
Vegetable fiber (g) 12.2 9.5 15.0 10.5* 7.8 13.7
Vitamin C (mg) 63.5 46.3 85.4 48.3* 35.0 67.5
Cholesterol (mg) 309.4 238.2 396.4 328.2* 258.8 433.6
Retinol (jig) 646.7 404.6 956.9 657.9 427.3 985.3
/3-Carotene (mg) 3.3 1.8 5.8 3.3 1.8 4.8
a-Tocopherol (mg) 8.1 6.1 12.2 8.2 6.1 12.7
Linoleic acid (g) 7.2 5.1 11.7 7.7§ 5.4 11.9
*f§ Significantly different from females (Mann-Whitney test): *P < 0.001, tP < 0.01, §P < 0.05.
j: Ratio of polyunsaturated to saturated fatty acids.
females. A highly significant interaction (P = 0.006) was found
between vitamin C and smoking (ever vs never). In ex-smokers
and current smokers vitamin C was significantly related to the
ABPI (P = 0.006) but this association was not significant in
lifelong nonsmokers (Table 5). There were no other significant
sex-by-nutrient or smoking-by-nutrient interactions. Finally, a-
tocopherol (vitamin E) intake was significantly associated (P
= 0.04) with an increase in the ABPI, after adjustment for all
variables. Vegetable fiber and /3-carotene were univariately re¬
lated to high ABPIs (P < 0.1), although not significantly so. In
the multiple-regression analysis these along with the other non¬
significant nutrients were not independently related to the ABPI.
Discussion
Although food-frequency questionnaires have often been used
in epidemiological studies of cardiovascular disease, few vali¬
dation studies have been carried out. Nevertheless, those few
attempts at validation (17, 18) on questionnaires similar to the
one used in the present study have shown reasonable agreement
between nutrient intakes, especially when expressed as a per¬
centage of total energy, derived from food-frequency question¬
naires and weighed intake. In particular, good agreement has
been shown for alcohol, when expressed as a percentage of total
energy.
TABLE 2
Age-adjusted ankle brachial pressure index, by frequency of individual food consumption in females in the Edinburgh Artery Study*
Rarely/monthly 1-3/wk 4-7/wk Pf
White bread 1.00 + 0.01 1.01 + 0.02 1.01 + 0.01 0.91
Whole-meal bread 1.01 + 0.01 1.01 + 0.01 1.01 + 0.01 0.93
Low-fiber breakfast cereals (eg, porridge) 1.02 + 0.01 0.98 ± 0.02 0.98 + 0.02 0.04
High-fiber breakfast cereals (eg, bran flakes) 1.01 ± 0.01 1.01 + 0:03 1.01 + 0.02 0.75
Pork, bacon, ham 1.03 + 0.01 1.00 + 0.01 0.94 + 0.03 0.002
Meat pies and pastries 1.01 + 0.01 0.98 ± 0.01 0.84 + 0.24 0.03
Kipper, herrings, tuna, mackerel 1.02 ± 0.01 1.00 + 0.01 0.94 + 0.06 0.06
Carrots 0.99 + 0.02 1.02 + 0.01 0.99 + 0.01 0.71
Onions (raw, cooked) 1.00 + 0.01 1.00 + 0.01 1.03 + 0.01 0.04
Sweets, biscuits, jellies, etc 0.99 ± 0.01 1.01 + 0.01 1.04 + 0.01 0.002
Lard, drippings, solid vegetable oil 1.01 ± 0.01 1.00 + 0.01 0.97 0.04 0.09
Apples 0.99 ± 0.01 0.99 + 0.01 1.03 ± 0.01 0.11
Pears 1.01 ± 0.01 1.01 + 0.01 1.02 ± 0.03 0.46
* x ± SE; n = 783.
t Linear trend.
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TABLE 3
Age-adjusted ankle brachial pressure index, by frequency of individual food consumption in males in the Edinburgh Artery Study*
Rarely/monthly 1-3/wk 4-7/wk Pf
White bread 1.08 + 0.01 1.05 + 0.02 1.04 + 0.01 0.0008
Whole-meal bread 1.05 + 0.01 1.08 ± 0.02 1.07 + 0.01 0.03
Low-fiber breakfast cereals (eg, porridge) 1.06 ± 0.01 1.04 + 0.02 1.06 + 0.02 0.97
High-fiber breakfast cereals (eg, bran flakes) 1.05 ± 0.01 1.08 ± 0.03 1.10 + 0.02 0.02
Pork, bacon, ham 1.05 ± 0.01 1.05 ± 0.01 1.06 + 0.03 0.80
Meat pies and pastries 1.07 ± 0.01 1.04 ± 0.01 1.05 ± 0.07 0.03
Kipper, herrings, tuna, mackerel 1.05 ± 0.01 1.04 ± 0.01 0.99 + 0.09 0.29
Carrots 1.03 ± 0.02 1.05 ± 0.01 1.07 + 0.01 0.07
Onions (raw, cooked) 1.04 ± 0.01 1.06 ± 0.01 1.08 + 0.02 0.08
Sweets, biscuits, jellies, etc 1.05 ± 0.01 1.06 ± 0.01 1.07 + 0.01 0.22
Lard, drippings, solid vegetable oil 1.07 ± 0.01 1.04 ± 0.01 1.04 + 0.03 0.06
Apples 1.05 ± 0.01 1.05 ± 0.01 1.08 + 0.01 0.14
Pears 1.05 ± 0.01 1.08 + 0.01 1.13 + 0.03 0.004
* x ± SE; n = 809.
t Linear trend.
There were many cases (n = 297) of symptomatic coronary
heart disease in the study sample, which if excluded would have
also excluded many subjects with peripheral arterial disease. We
included all cases of peripheral arterial disease in the analysis,
thus our results are representative of the general population.
Exclusion of cases ofsymptomatic coronary heart disease would
also unduly reduce the power to detect dietary associations with
the ABPI.
The total energy intake and nutrient intakes (Table 1) in males
were slightly lower than might be expected from a previous survey
in Edinburgh (19), although time trends in consumption indicate
some consistency with this finding (20). The exception to
TABLE 4
Multiple linear regressions of age, sex, height, smoking, total energy,
and each energy-adjusted nutrient separately on the ankle brachial
pressure index (ABPI) in the Edinburgh Artery Study*
Energy-adjusted nutrients (+1 unit) Valuef P
Vitamin C
Never smoked -0.02 (0.03) 0.53
Ever smoked 0.08 (0.02) 0.000-,
Cereal fiber (In)
Males 2.43 (1.40) 0.08
Females 0.37 (1.40) 0.79
Alcohol (In)
Males 1.00(0.48) 0.04
Females 0.02 (0.59) 0.97
Retinol (In) 0.10(0.82) 0.90
a-Tocopherol (In) 1.85 (0.97) 0.05
/3-Carotene (In) 0.69 (0.54) 0.20
Carbohydrate (In) -0.02 (0.01) 0.17
Vegetable fiber 0.16(0.11) 0.14
Protein (In) 0.13 (3.26) 0.97
Saturated fatty acid (In) 1.96(1.90) 0.30
Polyunsaturated fatty acid (In) 0.48 (1.15) 0.67
Linoleic acid (In) 0.48 (0.99) 0.63
* In, Natural logarithm. Diabetics excluded from the analysis, n =
1501.
t Change in ABPI X 100; SEE in parentheses. Adjusted for age, sex,
height, smoking, and total energy.
the general decrease is a slight increase in cereal fiber in the
Edinburgh Artery Study. However, comparisons are difficult be¬
cause the Edinburgh Artery Study population is older.
When the frequencies ofconsumption of individual foods were
considered, low ABPI was significantly associated with high fre¬
quency of consumption of low-fiber-containing foods (white
bread in males, low-fiber breakfast cereals in females) and high
frequency of consumption of meat and meat products in both
TABLE 5
Multiple linear regression of age, sex, height, smoking, total energy,
and all energy-adjusted nutrients simultaneously on the ankle brachial
pressure index (ABPI) in the Edinburgh Artery Study*
Valuef P
Sex (1 = female; 2 = male) -1.91 (5.19) 0.71
Age (+10 y) -4.87 (0.83) < 0.001
Height (+10 cm) 1.21 (0.70) 0.08
Cigarette smoking (ever vs never) -14.10(2.64) < 0.001
Total energy intake (+1000 kJ) 0.31 (0.79) 0.69
Energy-adjusted nutrients (+1 unit)
Vitamin C
Never smoked -0.02 (0.03) 0.57
Ever smoked 0.07 (0.03) 0.006
Cereal fiber (In)
Males 3.79 (1.61) 0.02
Females 1.10(1.52) 0.47
Alcohol (In)
Males 1.22 (0.59) 0.04
Females 0.05 (0.63) 0.94
Retinol (In) -0.79 (0.98) 0.42
a-Tocopherol (In) 4.27 (2.17) 0.04
6-Carotene (In) 0.24 (0.69) 0.73
Carbohydrate (In) -0.02 (0.02) 0.50
Vegetable fiber 0.01 (0.17) 0.95
Protein (In) -1.66 (3.96) 0.67
Saturated fatty acid (In) 2.42 (3.13) 0.44
Polyunsaturated fatty acid (In) -2.64 (8.62) 0.76
Linoleic acid (In) -1.48 (7.76) 0.85
* In, natural logarithm; diabetics excluded from the analysis, n = 1501.
t Change in ABPI X 100; SEE in parentheses.
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males and females. The significant tests for trend indicate a dose-
response relationship and provide strong evidence of cause and
effect. The results are consistent with the general consensus con¬
cerning a healthy diet, ie, high fiber intake and a low intake of
saturated fatty acids.
The relationships found between the frequency of consump¬
tion of individual foods, especially those containing fiber, and
the ABPI were also reflected in the relationships between the
calculated nutrient intakes and the ABPI in the regression anal¬
yses. In a multiple linear regression model, high intake of cereal
fiber in males was significantly associated with high ABPIs, in¬
dependent of smoking. This finding was consistent with the re¬
cent case-control study in Greece, in which it was found that a
significant relationship existed between intake of crude fiber,
which presumably included cereal fiber, and peripheral arterial
disease, independently of smoking (5). In addition, in the
Edinburgh Artery Study alcohol intake in males was associated
with an increase in the ABPI. Alcohol intake in males was sig¬
nificantly higher than in females, and it is possible that this effect
was mediated through recreational and sporting activity rather
than a direct effect of alcohol, although there is some evidence
that high wine consumption may be beneficial for coronary heart
disease (21).
Food supplements contribute to the intake of nutrients, es¬
pecially vitamin intake. Although this was not measured in the
present study, a British survey (22) suggests that the frequency
of food supplementation is low: 16% in the age range 50-64 y
compared with that in the United States (23), 21%-40% in the
age range 55-74 y. Thus our measures of vitamin intake may
be underestimated, but despite this we still found significant
relationships between ABPI and vitamin intake.
It is interesting that dietary a-tocopherol intake had a signif¬
icantly positive effect on the ABPI (P = 0.04), independently of
smoking. This finding is consistent with population studies in
which a low plasma vitamin E concentration was correlated with
ischemic heart disease (24) and angina (25). The association of
dietary a-tocopherol intake and the ABPI occurred despite the
fact that vitamin E measures derived from food-frequency ques¬
tionnaires are not as accurate as blood measures (24). The other
main dietary antioxidant, vitamin C, which is also thought to
be related to atherosclerosis, showed some positive relationship
to the ABPI, but this was only significant for those who had ever
smoked. Nonsmokers already had significantly higher ABPIs
and dietary vitamin C intake than did smokers; thus a high
intake of vitamin C would have little effect in nonsmokers. By
contrast, high dietary vitamin C intake may partly compensate
for the reduction of vitamin C through smoking, although never
reaching the amounts in nonsmokers. Hence, smoking re¬
mained one of the strongest risk factors for peripheral arterial
disease. E3
We are grateful to the general practitioners who collaborated in the
study, and to Elizabeth Cawood, Margaret Apps, Janet Dunbar, Eileen
Kerracher, Anna Rattray, and Felicity Smith for collecting the data.
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Fibrinogen genotype and risk of peripheral
atherosclerosis
F. g. r. Fowkes j. m. Connor F. b. Smith J. Wood
P. t. Donnan g. D. O. Lowe
There is conflicting evidence about the influence
of fibrinogen genotype on plasma fibrinogen
concentrations, and the relation between genotype
and atherosclerotic disease has not been studied. In
a population-based case-control studywe aimed to
find out whether certain fibrinogen genotypes are
associated with an increased risk of peripheral
atherosclerosis.
121 subjects with peripheral arterial disease and
126 healthy controls matched for age and sex were
selected from a random population sample aged
55-74 years in the Edinburgh Artery Study. Mean
fibrinogen concentrations were higher in cases than
in controls (3-12 [95% confidence interval 2-99-
3-26] vs 2-75 [2-64-2-85], p<0-001). A greater
proportion of cases than controls were
homozygous or heterozygous for an allele at the p
fibrinogen locus (4-2 kb allele, Bel I digestion); the
allele frequency was 0-197 in cases and 0 097 in
controls (p<0 005). Extended haplotypes for 4-2
kb heterozygotes were also associated with an
increased risk of peripheral arterial disease.
However, hapiotype had only a small effect on the
association of plasma fibrinogen concentration
with disease, and the relation of hapiotype with
disease was independent of age, sex, social class,
smoking status, plasma fibrinogen, alcohol
consumption, body mass index, and diabetes
mellitus.
We conclude that variation at the p fibrinogen
locus is associated with an increased risk of
peripheral atherosclerosis. The influence is not
mediated simply by way of increased fibrinogen
concentrations but could be due to a structurally
variant fibrinogen or linkage disequilibrium with a
neighbouring gene.
Lancet 1992: 339: 693-96.
Introduction
Fibrinogen concentration in the blood is believed to be
important in the pathogenesis of atherosclerosis. High
plasma concentrations are associated with increased risks of
ischaemic heart disease,1"*, stroke,'"* and arterial disease in
the legs.5-7 In population surveys, cigarette smoking has
been related to fibrinogen concentrations,8-13 and after
smoking cessation the concentration falls.14 Other factors
that may influence fibrinogen concentrations include age,
social class, obesity, serum cholesterol, diabetes mellitus,
alcohol consumption, intake of cereal fibre, use of oral
contraceptives, and the menopause.4-8 '-11-15
Attention has focused lately on the extent to which
fibrinogen concentrations are genencallv determined. There
are conflicting results: variation at the (3 fibrinogen locus
related to fibrinogen concentrations was seen in selected
populations in the UK16-17 but not in Norway.18 These
studies, however, did not include the relation between
fibrinogen genotype and atherosclerotic disease. We aimed,
in this study, to find out the extent to which fibrinogen
genotypes are associated with an increased risk ofperipheral
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arterial disease, taking account of cigarette smoking and
other cultural factors.
Subjects and methods
The designwas a population-based case-control study. Cases and
controls were selected from the 1988 Edinburgh Artery Study, a
cross-sectional survey of peripheral arterial disease in the leg. Men
and women aged 55-74 years were randomly selected from the
registers of ten general practices. 1592 (65% response) attended for
a clinical examination. Follow-up of a random sample of non-
responders revealed no substantial bias. The severity of peripheral
arterial disease was assessed by means of the World Health
Organisation questionnaireon intermittent claudication,19 the ankle
brachial pressure index (ABPI), and a reactive hyperaemia test. A
history of angina and myocardial infarction was taken,19 and a
12-lead resting electrocardiogram (ECG; /Minnesota coded) was
done.20 Social class was coded according to the method of the
Registrar General.21 The subjects were asked about alcohol
consumption, and height, weight, and glucose tolerance were
measured. Further details have been published elsewhere.22
153 subjects were classified as cases, defined as having ABPI of
0-7 or below, hvperaemic reduction in ankle pressure of at ieast
35%, or two or more of the following—intermittent claudication,
ABPI of0-9 or lower, and hyperaemic reduction in ankle pressure of
at least 20%. The cut-off points were based on validity studies in
hospital patients.23-24 Subsequent duplex scanningofsubsampies of
the cases and controls confirmed the validity.22 Exclusion criteria
were pain at rest, gangrene, ulcer, or previous arterial surgery.
The controls met none of the inclusion criteria and had no
evidence of angina pectoris, previous myocardial infarction, or
ischaenua on ECG. They were matched to the cases by sex and by
5-year age bands. They were not matched for smoking history,
which was elicited by questionnaire and correlated with thiocyanate
concentrations measured in the community survey.
The cases and controls were invited in March, 1989, to attend a
clinicat theUniversity Health Centre, Edinburgh. Non-responders
were reminded by a second letter and by telephone. Subjects unable
to travel but willing to take part were visited at home. Subjects
completed a questionnaire on medical history, current smoking
status, and medication. After the subject had rested supine for
5 min, blood was sampled from the antecubital vein without stasis.
Plasma fibrinogen was assayed by a dotting method (modified
Clauss assay with a Coag-A-mate coagulometer and Organon
Teknika reagents and standards; Organon Teknika, Cambridge,
UK) and by heat predpitation with a nephelometric method.2
Plasma glucose was measured on a Cobas-Bio autoanalvser' Roche
Products, Welwvn Garden City, UK). DNA was extracted from
white blood cells and digestedwith appropriate restriction enzymes.
DNA fragments were separated by electrophoresis in 0-8% agarose
gels and transferred to a DNA binding filter ;'Hybond-N',
Amersham) by Southern blotting. Hybridisation was earned out
under standard conditions.25 Autoradiographs were developed at
-70°C with Kodak 'Exomar films and super-rapid intensifying
screens for 1-7 days. The probes used were cDNAs for the alpha
(pFAl), beta (pFB5), and gamma (pFGl) fibrinogen loci, which
detect polymorphic fragments of 2-4 kb and 1-6 kb (Taq I), 5-3 kb
and 4-2 kb (Bel I), and 14 kb and 11 kb {Kpn USac I), respectively.
Data were analysed on the University of Edinburgh mainframe
computer with the BMDP statistical package.26 Subjects were
TABLE I—PLASMA FIBRINOGEN AND CIGARETTE SMOKING





(n = 1 26) 0
Mean fibrinogen
concentration (g/l)*
Clotting method 3-12 (2-99-3-261 2-75 (2-64-2-85)! <0-001
Nephelometric method 4-48 (4-31—4-65) 3-91 (3-74-4-06) 1 < o-ooi
Cigarette smoking
20 n% current smokers 44
% ex-smokers 42 30 1 r <0-001
% non-smokers 14 50 J
Mean ./pack years (SE) 4-82 (0-22) 2 04 (0-20) ; <0-001
Cases Controls




2-4 1-6 41 32 y on ..
1-6 1-6 4 9 1
Genotype 3
5 3 5-3 65 82
5 3 4-2 31 18 vo-oi
4-2 4-2 4 1 j
Genotype y
11 11 60 59
14 11 37 33 iO-37
14 14 4 8
Hapiotype
1:22-4.2-4; 85-3/5-3; yll/11 42 58 0-18
2:22-4/1-6; 35-3/5-3; y14/11 29 36 0-56
3:22-4/2-4; 35-3/4-2; yll/11 24 19 0-30
4:22-4/1-6; 85-3/5-3; yll/11 7 5 0-14 0-47
5:22-4/1-6; 85-3/4-2; yl4/ll 14 5 0-03






*95% confidence interval in parentheses.
"Significance of overall association between genotype/haplotvpe and peripheral
artenai disease.
'Significance of difference between each hapiotype and every other hapiotvpe.
classified as current smokers, ex-smokers (<5 years), or non-
smokers; life-time consumption in pack years was also studied
oecause it is also associated with the risk of disease.22 The square
root of pack years was used, so as to reduce the influence of a few
very heavy smokers. Diabetic status was classified by WHO
criteria.28 Alcohol consumption was analysed separately for men
andwomen. Dummy variableswere created to assess theassociation
with disease of each hapiotype in relation to the commonest
hapiotype. Multiple logistic regression on peripheral arterial disease
was used to determine the independent effect of each factor on the
odds of disease in relation to fibrinogen concentration. The logistic
regressions were adjusted for age and sex.29
Results
121 cases and 126 controls of 153 selected in each group
took part in the study (overall response rate 81%). In neither
group did responders differ from the subjects selected in
age, sex, smoking status, frequency of intermittent
claudication, or mean ABPI. The mean age of cases and
controls was the same (67 years) and there were
approximately equal numbers in each group of men and
women. Among the cases, 21% had claudication and the
mean ABPI was 0-7.
Mean fibrinogen concentrations were significantly higher
in subjects with peripheral artenai disease than in controls
table I;. Significantlymore of the cases than of the controls
had ever smoked (table I). Acohol consumption was lower
in cases than in controls (median 2 0 vs 4-0 units per week;
p = 0-06). There was no difference between the groups in
body mass index or frequency of diabetes mellitus (both
p = 0-7). The social-class distribution differed slightly; there
were fewer cases than controls in classes I and II and more
cases than controls in classes III-V (p = 0-07).
The genotype frequencies among the 247 subjects were
compared with those predicted from the Hardy-Weinberg
equilibrium; no significant differences were found. The
frequencies of allele combinations at the a, (3, and y
fibrinogen loci in cases and controls are shown in table 11.
There were significant excesses (p < 0-01) at the (3 locus of
cases compared with controls heterozygous or homozygous
for 4-2 kb but no significant differences between cases and
controls in allele combinations at the a and y loci.
Frequencies of the individual alleles at the 3 locus reflected
differences in allelic combinations; there were highly
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TABLE III—UNIVARIATE AND MULTIVARIATE REGRESSIONS OF
FIBRINOGEN HAPLOTYPES. CIGARETTE SMOKING. AND PLASMA
FIBRINOGEN WITH PERIPHERAL ARTERIAL DISEASE
Odds ratio (95% CI)




Type 2 1-110 5-2-2) 1-1- 0-4-2-7)
Type 3 2-3 (l-0-5-4)t 4-1 (1-3-12-4)1
Type 4 2-1 (0-4-8-0) 2-3 (0-5-10-9)
Type 5 4-8 (1-2-19-0)1 7-6 (1-5-39-1)1
Type 6 0-5(0-1-8-0) 0-3(0-1-1-7)
Cigarette smoking"
,/pack years 4-3 (2-5, 7-2)*' 4-5 (2-4, 8-2)'
Current smokers 0-9 (0-3, 2-3) 1-3 (0-4. 3-9)
Ex-smokers 0-6 (0-2, 2-2) 0-6(0-1.2-4)
Fibrinogen ( + 0-2 g/IJ 1-82 (1-38, 2-41)* 1-52(1-08, 2-14)1
All analyses adjusted for sex and age group.
•Change in pack years is one unit on sauare root scale: current ana ex-smokers < 5
years are compared with non-smokers and are adjusted for pack years.
Tp<0 10; tp<0-05: «p<0-001
significant (p< 0-005) differences between cases and
controls in the frequencies of the 5-3 kb (0-802 vs 0-903) and
4-2 kb (0-197 vs 0-097) alleles.
Variation at the (3 locus was also shown in the haplotvpe
analysis; types 3 and 5 were more common in cases than in
controls, although the difference in type 3 was small and not
significant (p =0-3). A finding of one significant difference
(type 5, p = 0-03) is more than would be expected by chance
with multiple tests. Overall, the haplotvpe distribution
among cases and controls did not differ significantly
(p = 0-14), but the differences between type 3 or type 5 and
type 1 were sufficient to be associated in univariate analysis
with an increased risk of disease (table III).
To examine the relation between fibrinogen
concentrations and vascular disease, concentrations
measured by the clotting method were chosen for further
analysis. An increase in fibrinogen concentranon of 0-2 g 1
was associatedwith an odds ratio ofdiseaseof 1 ■82 (table III).
Cigarette smoking, adjusted for lifetime consumption in
pack years, current smoking, and ex-smoking, reduced the
odds ratio to 1 -68 ip < 0 0T. Adjustment for haplotvpe alone
had little effect on the odds ratio for fibrinogen (1-77,
p < 0-001). This limited effect may have been related partly
to the lower prevalence of smoking in subjects with type 3
haplotype than in thewhole study sample (50% vs 65% ever
smoked). With adjustment for both smoking and hapiotype.
the odds ratio for fibrinogen fell to 1 -52. but it was snll
significant liable ill). The odds ratios after separate
adjustment for body mass index, diabetes meilitus. and
alcohol consumptionwere 1 -80,1 -79, and 1 -76, respectively,
with no change in significance. Social class had a stronger
effect, lowering the odds ratio to 1 -70, but it was related to
social-class differences in cigarette smoking.
The factors significantly associated with peripheral
arterial disease (haplotype, cigarette smoking, and
fibrinogen concentration) were included in a multivariate
analysis (table ill); both haplotype and cigarette smoking
retained significant associations with disease independently
of fibrinogen concentranon. Inclusion of social class, alcohol
consumption, body mass index, and diabetes meiiitus had
little effect; none of the latter factors was associated
independently with disease.
Discussion
The influence of fibrinogen genotype on plasma
fibrinogen concentrations in the general population is not
well established. In a UK study of three restriction-
fragment length polymorphisms,16 the strongest association
of fibrinogen concentrations was with polymorphism
detected by means of the 3-fibrinogen probe and Bel I.
Genetic variation at the fibrinogen locus accounted for 15%
of total phenotvpic variance in fibrinogen concentration. In
a larger subsequent study, variation in the promoter region
of the 3 gene {Hae III polymorphism) explained 3-1% of
variance in fibrinogen concentrations.17 By contrast, a study
in Norway18 found no association between pLasma
fibrinogen concentrations and genotype in two
polymorphisms (at the a and p loci). We too have found in
thewholepopulationofour study that polymorphismsat the
r, P, and v loci are not significandy related to fibrinogen
concentrations.30 Furthermore, estimates of the heritability
ofplasma fibrinogen concentrations have varied from27%18
to 51%.31
We have examined the possible influence of fibrinogen
genotype on the risk of atherosclerotic disease. The main
findingwas that at the fibrinogen P locus the 4-2 kb allele was
over-represented in cases compared with controls. Variation
at the P fibrinogen locus might well affect fibrinogen
concentrations, because the p gene controls formation ofthe
BP chain, the rate-limiting step in fibrinogen synthesis.
Interestingly, however, the higher odds of disease related to
p-locus genotype seemed not to be attributable solely to the
present plasma fibrinogen concentrations; they were also
independent of other likely factors. The fact that the
association between genotype and disease was not strong is
not surprising, because atherosclerosis is a heterogeneous
trait influenced bymany environmental and genetic factors.
The association may also have been affected by variation in
the measurement of fibrinogen concentration.
Berg and Kierulf have pointed out18 that genes may be
important in causing diseasewithout having any direct effect
on the extent of a risk factor. The significant effect of
fibrinogen haplotype on disease was retained after
adjustment for fibrinogen concentration: thus there may be
a mechanism of pathogenesis other than the effect of
haplotype on fibrinogen. The polymorphic variant might be
in a linkage disequilibrium with a mutation within the P
fibrinogen gene or a neighbouring gene that has a direct role
in atherogenesis. Mutations in the p fibrinogen locus could
produce a protein with abnormal phvsicochemical
characteristics and hence increased atherogenic potential.
.Also, theremight bemechanisms by which genes can help to
set the framework for lifestyle ana cultural characteristics to
cause vanarions in risk factors. We noted, for example, a
slight but unexplained relation between hapiotype and
smoking, although thismay have been a chance finding. The
association between fibrinogen genotypeand atherosclerosis
needs to be investigated in different populanons, and the
interaction with other risk factors should be analysed.
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Voluntary dehydration and heat intolerance in
cystic fibrosis
Oded Bar-Or Cameron J. R. Blimkie John A. Hay
J. Duncan MacDougall Dianne S. Ward WilliamM. Wilson
Although exercise may be beneficial in cystic
fibrosis (CF), patients' low tolerance to climatic heat
stress means that physical exertion can increase
morbidity and mortality. We postulated that the high
salt content of CF patients' sweat and the
consequent absence of body-fluid hyperosmoiality
during a long episode of sweating might deprive
such patients of a thirst stimulus.
Eight children with CF (four boys, four giris; aged
9-5-14-1 years) and eight controls, matched forage
and sex, attended two randomly ordered sessions of
exercise (cycling) in a chamber at 31-33°C, relative
humidity 43-47%. 20 min bouts of exercise (at 45%
of predetermined maximum oxygen uptake) were
interspersed with 25 min rest periods. At one session,
chilled water was given every 15-20 min to replace
fluid lost; at the other, drinking was guided by the
child'sthirst. At the thirst-guided session, CF patients
drank much less than the controls did (0-80% vs
1 -73% initial body weight) and lost twice as much
fluid (1-57% vs 0-78% initial body weight). The
recovery of heart rate after exercise was slower in CF
patients, but there were no other signs of heat strain.
The groups did not differ in any variable during tne
forced drinking session.
We conclude that children with CF underestimate
their fluid needs and undergo excessive dehydration
during extended exposure to hot conditions.
Lancet 1992; 339: 696-99
Introduction
Interest in exercise prescription for patients with cystic
fibrosis (CF) has increased during the past few years.13 but
physical exertion has two potentially detrimental effects in
CF; arterial oxygen desaturation, mostly in patients with
advanced disease during high-intensity exercise;1 and low
tolerance to climatic heat stress, which increases morbidity
and mortality.-" No deficiency in the ability of CF patients
to dissipate heat during exercise in hot conditions has been
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Genetic variation at fibrinogen loci and plasma
fibrinogen levels
J M Connor, F G R Fowkes, J Wood, F B Smith, P T Donnan, G D O Lowe
Abstract
In view of the controversy regarding gen¬
etic variation at the fibrinogen loci and
plasma fibrinogen levels, we have ana¬
lysed DNA polymorphisms at the alpha
(TnqJ), beta (Bell and HaeIII), and
gamma (Kpnl/Sacl) fibrinogen loci in 247
subjects whose plasma fibrinogen was
determined by clotting and nephelo¬
metric assays. Strong linkage disequilib¬
rium was found between the alpha/7nql
and gamma/KpnlfSacl markers and
between the beta/Bell and beta/J/aelll
markers. A lesser association was found
between the alpha/JaqI and beta/Bell
loci, beta/Bell and gamma/Kpnl/Sacl
markers, alpha/7"agl and beta/7/aeIII
markers, and the gamma/Kpnl/Sacl and
beta///aeIII markers. This is consistent
with the known physical order of these
loci and suggests a relative excess of
recombination in the alpha/gamma to
beta interval. Plasma fibrinogen levels,
by either assay method, when corrected
or uncorrected for age, sex, and smoking
habit, did not show any statistically signi¬
ficant associations with the four fibrino¬
gen polymorphisms examined at the
alpha, beta, and gamma fibrinogen loci
either singly or when analysed as a haplo-
type.
Plasma levels of fibrinogen rise acutely in
response to infection, injury, or other trauma
and in population surveys are associated with
age, smoking, obesity, cholesterol, alcohol, and
the menopause.1 Raised levels of fibrinogen
have been a consistent risk factor for athero¬
sclerosis and this has led to studies to see if
plasma levels of fibrinogen are influenced
by genetic variation at the fibrinogen loci.
Humphries et aP performed DNA analysis for
the fibrinogen alpha and beta loci on 91
healthy English subjects and concluded that
genetic variation at these loci accounted for
15% of the total variance. In contrast, Berg
and KierulP could detect no association in 118
Norwegian subjects between levels of plasma
fibrinogen and the fibrinogen alpha and beta
genotypes. More recently, Thomas et al' ana¬
lysed the HaeIII polymorphism at the 5' end
of the beta fibrinogen gene in 292 healthy
subjects and found a significant association
with fibrinogen levels which explained 31% of
the variance. We therefore undertook clotting
and nephelometric plasma fibrinogen assays
and analysis of polymorphic variation at the
fibrinogen gamma locus in addition to poly¬
morphisms at the alpha and beta loci in 247
subjects to help understand the role of geneti
variation at the fibrinogen loci in determina
tion of plasma fibrinogen levels.
Subjects and methods
The subjects (121 cases and 126 age and se:
matched controls) were recruited from th
1988 Edinburgh Artery Study for a case-con
trol study of peripheral arterial disease.' Aftc
five minutes rest in the supine position, :
specimen of venous blood was obtained fron
the antecubital vein usually without stasis. It
the laboratory, fibrinogen was assayed usins
two methods: firstly, a clotting method (modi
fied Clauss assay using a Coag-A-Mate Xi
coagulometer and reagents and standards fron
Organon Teknika) and, secondly, heat prccip
itation by a nephelometric method.6 DNA wa:
extracted from white blood cells and digestcc
with the appropriate restriction enzyme. DN/
fragments were then separated by electrophor¬
esis in 0-8% agarose gels and transferred to :
DNA binding filter (Hybond-N, Amersham
by Southern blotting. Hybridisation was per¬
formed with "P labelled probes in 2 x Dcn-
hardts, 4-5 x SSC, 0-1% SDS, 6% w/v PEG ai
65°C overnight followed by several high strin¬
gency washes in 1 to 0 05 * SSC/01% SDS ai
65"C. Autoradiographs were developed al
— 70°C using Kodak Exomat films and intensi¬
fying screens for one to seven days. The probe;
used were all cDNAs, pAFl (alpha), pFB5
(beta), and pFGl (gamma) which detect poly¬
morphic fragments of 2-4 kb and 1 -6 kb (7a?I),
5-3 kb and 4-2 kb (Bell), and 14 kb and 11 kb
(Kpnl/Sacl) respectively (appropriate restric¬
tion enzymes indicated in parentheses in each
instance). The Hae Ill/beta polymorphism
(alleles of 958 bp/575 bp + 383 bp) was shown
after PCR amplification and DNA digestion.4
Gene frequencies were calculated by gene
counting, x2 analysis using Yates's correction
was applied for comparison of allele frequen¬
cies, the standardised disequilibrium coeffi¬
cients'(delta values) were calculated according
to Chakravarti et al,7 and probability values
were calculated according to Fisher's exact
probabilities. As the fibrinogen concentrations
measured by the clotting method were posit¬
ively skewed, a logarithmic transformation was
used, yielding geometric means and their
confidence intervals as summary measures.
Fibrinogen levels were adjusted by age, sex,
and cumulative smoking using multiple linear
regression. Cumulative smoking was ex¬
pressed in terms of packyears: the average
number of packs of cigarettes smoked per
day x number of years as a smoker. One way
analysis of variance was carried out on the
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Table I Mean fibrinogen values adjusted for age, sex, and smoking habit in groups
with different fibrinogen genotypes at the alpha, beta and gamma loci. <
Clotting method Nephelometric method






2-94 (2 89,2 98)
2 90 (2 80,3 00)
p = 0 83













4 15 (4 06,4-23)
4-25 (4 00,4-48)
p = 0-48
Beta locus (Hael 11)
575 + 383/575 + 383
575 + 383/958
958/958
2 92 (2 80,3 05)
2-99 (2-76,3-24)






2 92 (2 80,3-04)
2 93 (2 88,2 98)
2-94 (2-90,2-97)
p = 0 94
4 19 (4 03,4-36)
4 19 (4-12,4 26)
4 19 (4 14,4-25)
p = 0 99
* Mean for clotting assay is the geometric mean as the distribution is positively skewed.
adjusted fibrinogen values to assess differences
between genotypes.
Results
The overall frequencies for each polymorphic
allele in the 247 subjects were 0-75 for the
2-4 kb (A) allele and 0-25 for the l-6kb (a)
allele at the alpha fibrinogen locus; 0-84 for the
5-3 kb (B) and 0-16 for the 4-2 kb (b) alleles at
the beta fibrinogen locus; 0-82 for the
575bp + 383bp (HI) and 0-18 for the 958 bp
(H2) alleles at the 5' end of the beta fibrinogen
locus; and 0-24 for the 14 kb (D) and 0-76 for
the 11 kb (d) alleles at the gamma fibrinogen
locus. The overall genotype frequencies were
compared with those predicted from the
Hardy-Weinberg equilibrium and no signific¬
ant differences were noted.
Strong linkage disequilibrium was found
between the alpha/Tat/1 and gamma/Kpnl/
S'acI markers and between the beta/Bc/I and
beta///aeIII markers which was highly signi¬
ficant at any level (delta values of 0-6981 and
0-462, p<0 001 and p<0-001 respectively). A
lesser association was found between the
alpha/7at/I and beta/Bc/I loci (delta value of
— 0-1423, p< 0-001); beta/Bc/I and gamma/
Kpnl/Sacl markers (delta value of — 0-1450,
p < 0 01); alpha/Tugl and beta/Haelll markers
(delta value of —0174, p<0001); and the
gamma/Kpnl/Sacl and beta/Haelll markers
(delta value of — 0188, p<0 001).
Table 1 indicates the mean fibrinogen values
adjusted for age, sex, and smoking history
analysed by the clotting and nephelometric
assays for different fibrinogen genotypes at the
alpha, beta, and gamma fibrinogen loci. No
trend is apparent and no statistically signific¬
ant differences were noted. Similarly no stat¬
istically significant differences were apparent
in an analysis using fibrinogen levels uncor¬
rected for age, sex, and smoking history or if
cases and controls were considered separately
(data not shown).
Table 2 indicates the mean fibrinogen values
adjusted for age, sex, and smoking history
analysed by the clotting and nephelometric
assays for different fibrinogen haplotypcs. No
statistically significant differences are appar¬
ent, nor were they present in an analysis using
fibrinogen levels uncorrected for age, sex, and
smoking history or if cases and controls were
considered separately (data not shown).
Discussion
Plasma fibrinogen is synthesised in the liver
from three polypeptide subunits (A alpha, B
beta, and gamma) whose structural genes oc¬
cur as a cluster at 4q31.8 These genes show
considerable homology and are believed to
have arisen by duplication of an ancestral gene
with subsequent divergence.9 Each gene is
approximately 10 kb in size and as all three are
found on a 50 kb stretch of DNA, linkage
disequilibrium between these loci would be
expected. In this study strong linkage disequi¬
librium was found between the two polymor¬
phisms at the beta fibrinogen locus and
between the polymorphisms at the alpha and
gamma loci with a weaker association between
beta and alpha or beta and gamma polymor¬
phisms. This is consistent with previous re¬
ports on linkage disequilibrium for these
loci21011 and with the physical order of gamma-
alpha-beta.9 The relative excess of recombina¬
tion in the gamma/alpha to beta interval can¬
not be explained by physical distance and
recombination in this interval has also been
implicated in the evolution of these loci to
account for the reverse orientation of tran¬
scription of the beta gene relative to the alpha
and gamma fibrinogen genes.9
In the present study, in cases or controls or
both combined, the plasma level of fibrinogen
assayed by the clotting and nephelometric
methods when corrected or uncorrected for
age, sex, and smoking showed no association
with the fibrinogen genotype at the alpha,
beta, or gamma loci. This is consistent with
the experience of Berg and Kierulf' using the
Table 2 Mean fibrinogen levels assayed by the clotting and nephelometric methods corrected for age, sex, and





Haplotype Alpha Beta Gamma % Mean* (95% CI) Mean (95% CI)
1 2-4/24 5-3/5-3 11/11 37 2 94 (2 90,2 99) 4 22 (4 15,4 29)
2 2 4/16 5-3/5 3 14/11 24 2 93 (2 87,3 00) 4 19 (4 09,4 28)
3 2 4/2 4 5 3/4-2 11/11 16 2 91 (2 83,2 99) 4 12 (4 00,4 24)
4 2 4/16 5-3/5-3 11/11 4 2 91 (2 80,3 03) 4 16(3 97,4 36)
5 2.4/1 6 5 3/4 2 14/11 . 7 2 93 (2 84,3 02) 4 19(4 07,4 32)
6 1-6/1 6 5-3/5-3 14/14 5 2 94 (2 82,3 06) 4 23 (4 08,4 38)
Others 7
• Mean for clotting assay is the geometric mean as the distribution is positively skewed.
alpha (Taql) and beta {Bell) polymorphisms,
but differs from the findings of Humphries el
al2 and Thomas el al.* Humphries et aP found
a statistically significant rise of plasma fibrino¬
gen levels in homozygotes for the rarer beta/
Bell polymorphism but not with the beta/
Avail (which is in strong linkage disequili¬
brium with the beta/Bc/I polymorphism2) or
alpha/Taql polymorphisms. Thomas et aP also
found a statistically significant rise of plasma
fibrinogen in homozygotes for the rarer beta/
Haelll polymorphism when smokers and non-
smokers were combined. Although numbers in
these studies were large (91 in Humphries et
al,2 118 in Berg and Kierulf,3 292 in Thomas el
al,* and 247 in the present study) the numbers
of key homozygous subjects were small (4 bb
homozygotes in Humphries et al,2 2 bb homo¬
zygotes in Berg and Kierulf,3 and six in the
present study; 11 H2H2 homozygotes in
Thomas et aP and five H2H2 homozygotes in
the present study). This, rather than popula¬
tion differences, is probably the main problem
for these studies together with the consider¬
able within person variation of fibrinogen
values over time.12
Berg and Kierulf3 also analysed the mono¬
zygotic twin intraclass correlation coefficient
in respect of plasma fibrinogen levels and gave
heritability estimates of 0-27 in the total series
and 0-29 in non-smokers alone. Hamsten et
al," using path analysis in 170 nuclear families
(half with a proband with premature myocar¬
dial infarction), suggested that 51% of the
variance in plasma fibrinogen levels was
because of genetic heritability after adjusting
for cultural factors such as smoking and obes¬
ity. These studies thus suggest that there are
genetic determinants of plasma fibrinogen
levels although the magnitude of this effect and
the importance of the fibrinogen genotype in
this respect is unresolved. These studies have
been hampered by the marked within indi¬
vidual variation which occurs for plasma
fibrinogen levels, which in one study
accounted for 27% of the sample variance.12
Longitudinal studies of plasma fibrinogen
levels in genotyped subjects would thus be of
value in helping to resolve the role of fibrino¬
gen and other genes in determination of
plasma fibrinogen levels.
This study was funded by the British Heart
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Steve Humphries, Charing Cross Sunley Re¬
search Institute, London, who generously
donated the cDNA probes for the alpha, beta,
and gamma fibrinogen genes.
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Blood Viscosity, Fibrinogen, and Activation of
Coagulation and Leukocytes in Peripheral
Arterial Disease and the Normal Population in
the Edinburgh Arteiy Study
G.D.O. Lowe, MD, FRCP; F.G.R. Fowkes, PhD, FRCPE, FFPHM; J. Dawes, PhD;
P.T. Donnan, MSc; S.E. Lennie, MI Biol; and E. Housley, FRCP
Background. Increased blood and plasma viscosity, hematocrit, fibrinogen, and activation of coagulation
and leukocytes have been reported in patients with- claudication; however, their associations with
symptomatic and asymptomatic peripheral arterial disease have not been reported in an epidemiological
study.
Methods and Results. Blood and plasma viscosity, hematocrit, fibrinogen, urinary fibrinopeptide A,
plasma leukocyte eiastase, and uric acid were measured in a random sample of 1,581 men and women aged
55-74 years in Edinburgh, Scotland, and related to peripheral arterial stenosis (ankle-brachial systolic
pressure index, ABPI) and to lower limb ischemia (intermittent claudication and reactive hyperemia test).
Each variable (except fibrinopeptide A) was significantly related to prevalent symptomatic and asymp¬
tomatic peripheral arterial disease. On multivariate analysis, blood viscosity (p<0.05) and fibrinogen
(p<0.01) were independently associated with peripheral arterial narrowing (ABPI); a positive interaction
was found between fibrinogen and smoking in the association with ABPI. Plasma viscosity was associated
with claudication in the presence of a given degree of arterial narrowing (odds ratio of claudication in top
quintile compared with bottom quintile of plasma viscosity, 3.35; 95% CI, 132, 831). Leukocyte eiastase
and uric acid were each associated with reactive hyperemia independently of arterial narrowing (p<0.01).
Conclusions. Blood Theological factors and leukocyte activation as well as arterial narrowing are
associated with lower limb ischemia in the general population and may be implicated in its pathogenesis.
(<Circulation 1993;87:1915-1920)
Key Words • plasma viscosity • fibrinopeptide A • atherosclerosis • claudication
Chronic ischemia of the lower limbs may resultfrom not only atherosclerotic stenoses but alsofrom thrombotic occlusions' and rheoiogical
abnormalities such as increased blood viscosity and
impaction of activated leukocytes in the nutritive micro¬
circulation.2-3 Previous studies have suggested that pa¬
tients with intermittent claudication may have activation
of blood coagulation.4-5 increased blood viscosity caused
by elevation of hematocrit and plasma fibrinogen,2-6-9
and increased leukocyte activation and rigidity.10-11
However, these factors have not been related to periph¬
eral arterial disease in epidemiological studies in the
general population, nor have relations with other car-
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diovascular risk factors (e.g., smoking) been taken into
account.
The Edinburgh Artery Study is a cross-sectional
survey of 1,592 men and women aged 55-74 years
residing in Edinburgh, Scotland. A high prevalence of
symptomatic and asymptomatic peripheral arterial dis¬
ease has been identified in this population12 as well as
associations with conventional cardiovascular risk fac¬
tors.13 We now report the relations of whole blood
viscosity and its major determinants (hematocrit,
plasma viscosity, fibrinogen) as well as measurements of
activation of blood coagulation (urinary fibrinopeptide
A)14 and of blood leukocytes (plasma leukocyte
eiastase)15 to symptomatic and asymptomatic peripheral
arterial disease in this population. We also tested the
hypothesis that, for a given degree of atherosclerotic
arterial narrowing (measured by the ankle-brachial
pressure index. ABPI), leg ischemia (measured by the
World Health Organization [WHO] intermittent clau¬
dication questionnaire16 and by a reactive hyperemia
test12) was related to viscosity7 and to leukocyte
activation.10
Methods
In this cross-sectional survey,12 1.592 men and women
aged 55-74 years were selected from the age/sex regis-
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ters of 10 general practices with catchment area popu¬
lations spread geographically and socioeconomically
throughout the city. The sample was selected randomly
within sex-specific 5-year age groups to produce equal
numbers in each group and an adequate sample size to
conduct a future cohort study. Subjects attended a
university clinic to complete a questionnaire and have a
comprehensive medical examination. The response rate
was 65%, and follow-up of a sample of nonresponders
did not show any significant bias. Details of the study
population, recruitment, and prevalence of peripheral
arterial disease are described elsewhere.12 The ques¬
tionnaire included validated questions on cardiovascu¬
lar history, intermittent claudication and angina (WHO
questionnaire16), and smoking history. A 12-lead ECG
was taken and coded independently by two observers
using the Minnesota code.17 Arm blood pressure was
taken supine after 10 minutes of rest using a random
zero sphygmomanometer. Peripheral pulses were pal¬
pated, and ankle systolic pressures were then measured
using a Sonicaid Doppler probe and random zero
sphygmomanometer with the patient supine. The ABPI
was calculated as a measure of arterial narrowing in the
lower limb.12
A reactive hyperemia test was then carried out in
which ankle systolic pressures were measured 15 sec¬
onds after the release of a cuff occluding arterial flow
for 4 minutes above the knee at 50 mm Hg above systolic
pressure.12 Reactive hyperemia tests have been shown
to have adequate validity in detecting angiogram-posi-
tive disease in hospital patients.1819 In preliminary
studies, we found that our technique detected the
greatest hyperemic response and had adequate repro¬
ducibility.20 The main purpose of this test was to detect
those with substantial peripheral atherosclerosis who
might have had a normal ABPI. as may occur in
diabetics. Details of the results of the reactive hyper¬
emia test in this population are published elsewhere.21
From a fasting blood sample taken on each patient at
about 9:00 am, serum uric acid was estimated on a
Cobas Bio analyzer, using a standard kit. Fibrinogen
was measured in citrated plasma by a thrombin-clotting
turbidometric method in a centrifugal analyzer.22 Blood
and plasma viscosity were measured from a blood
sample anticoagulated with dry dipotassium edetate
(EDTA, 1.5 mg/mL) at high shear rates (over 300 sec-1)
in a Coulter-Harkness viscometer at 37°C.23 Hematocrit
was measured using a Hawksley microcentrifuge and
reader. Blood viscosity was corrected to a standard
hematocrit of 45% using the formula of Matrai et al.24
Relative blood viscosity (corrected blood viscosity/
plasma viscosity) was calculated as a measure of red cell
deformability.3-25 Urinary fibrinopeptide A was mea¬
sured by radioimmunoassay as previously described,14
using reagents from IMCO (Stockholm). Plasma leuko¬
cyte elastase was also measured by radioimmunoassay
as previously described.15 Quality control was moni¬
tored by means of blind duplicate samples taken inter¬
mittently throughout the study.
Data were analyzed on the Edinburgh University
mainframe computer using spssx and bmdp statistical
packages. In the univariate analysis, the population was
divided for descriptive purposes into four categories of
peripheral arterial disease12: intermittent claudication
(WHO questionnaire positive and ABPI <0.9 or reac¬
tive hyperemia >20%), major asymptomatic disease
(ABPI <0.9 and reactive hyperemia >20% or ABPI
<0.7 or reactive hyperemia >35%), minor asymptom¬
atic disease (ABPI <0.9 or reactive hyperemia >20%),
and normal (none of the above). Because these catego¬
ries have not been used in other studies, the validities
were unknown, but results of studies comparing the
ABPI and reactive hyperemia separately with arteriog¬
raphy26 suggest that the classification has adequate face
validity. The main analysis, however, concentrated on
the ABPI because it was almost completely recorded
and is a continuous measure, thus giving more power to
detect associations. The minimum ABPI in the two legs
was used because disease often occurs unilaterally. The
minimum of two measurements induced slight negative
skewness caused by random variation between legs, but
this was not sufficient to justify transformation.
Multiple linear regression was used to investigate the
relations between the ABPI and age, sex, blood and
plasma viscosity, hematocrit, fibrinogen, leukocyte
elastase, urinary fibrinopeptide A, uric acid, and smok¬
ing. Logarithmic transformations27 were carried out on
the values for leukocyte elastase and urinary fibrinopep¬
tide A because of positive skewness in their distribu¬
tions. Height was also included in the regressions be¬
cause a positive association with the ABPI was
demonstrated.12 This may have been due to the widen¬
ing of pulse pressure, as blood flows through arteries
leading to a relatively high systolic pressure at the ankle
in taller individuals.28 Exclusion of height would have
affected the association with sex, tending to increase the
ABPI in male subjects. The multivariate analysis was
carried out with all of the above factors estimated
simultaneously, with the subsequent insertion of total
cholesterol, high density lipoprotein (HDL) cholesterol,
triglycerides, and diabetic status. (The prevalence of
diabetes was 10% in claudicants and 6% in those
without evidence of peripheral arterial disease.13)
The association with smoking was modeled using
number of "'pack-years" with additional variables for
current smokers, recent ex-smokers (stopped within the
last 5 years), and smokers of pipe/cigars only. The
additional variable for current smokers, for example,
measures the difference between ABPI in a current
smoker and an ex-smoker who gave up more than 5
years ago but who had smoked the same amount of
pack-years. The distribution of pack-years was highly
skewed with a few very heavy smokers, therefore the
square root of the pack-years was used to reduce the
influence of these few individuals. The smoking histo¬
ries were considered reasonably valid because the stated
amount was related to mean thiocyanate levels, another
measure (albeit imperfect) of cigarette consumption.
Only smoking history is reported in this article.
Multiple regressions of age, sex, height, smoking, and
the Theological factors were also carried out on inter¬
mittent claudication, the reactive hyperemia test, and
three separate measures of heart disease: 1) subject
recall of physician's diagnosis of angina or heart attack,
2) WHO questionnaire positive for angina or previous
myocardial infarction, and 3) ECG evidence of
ischemia.
Results
The mean levels of the rheological factors in the total
population of 1,581 men and women from whom blood
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Table 1. Distribution of Hemostatic and Rheological Factors by Category of Peripheral Arterial Disease and Normal Subjects
Intermittent Major Minor
claudication asymptomatic asymptomatic Normal Missing Total
("=45) II o (n=238) (/i= l,096) ("=97) (7i=l,581) P'
Mean (standard error of mean)
Blood viscosity (mPa) 3.90 3.67 3.66 3.53 3.63 3.58 <0.0001
(0.1) (0.1) (0.04) (0.02) (0.06) (0.01)
Hematocrit (%) 47.2 46.7 46.0 45.7 45.2 45.8 0.0003
(0.5) (0.5) (0.3) (0.1) (0.3) (0.1)
Corrected blood viscosity (mPa) 3.65 3.55 3.55 3.46 3.59 3.49 <0.0001
(0.05) (0.04) (0.02) (0.01) (0.05) (0.01)
Relative blood viscosity 2.65 2.61 2.65 2.61 2.64 2.62 0.26
(0.03) (0.02) (0.01) (0.01) (0.03) (0.01)
Plasma viscosity (mPa) 1.39 1.37 1.34 1.32 1.37 1.33 <0.0001
(0.01) (0.02) (0.01) (0.002) (0.01) (0.002)
Fibrinogen (g/L) 3.03 3.03 2.70 2.65 2.97 2.72 <0.0001
(0.11) (0.07) (0.04) (0.02) (0.07) (0.02)
Uric acid (jrmol/L) 331.5 332.8 320.4 313.0 314.7 316.3 0.0008
(9.6) (8.3) (5.3) (2.3) (7.6) (1.9)
Geometric mean (95% confidence interval)
Urinary fibrinopeptide A (ng/mL) 1.66 1.46 1.45 1.52 1.58 1.52 0.62
(1.39.1.99) (1.33, 1.61) (1.36. 1.54) (1.49, 1.55) (1.46. 1.71) (1.49, 1.55)
Leukocyte elastase (ng/mL) 40.8 36.6 35.2 32.1 32.8 33.1 0.002
(32.5, 51.3) (31.9, 41.9) (31.9, 38.0) (30.9, 33.4) (29.9, 36.7) (32.1, 34.2)
'Test for linear trend across categories of peripheral arterial disease and normal subjects.
was obtained are shown in Table 1. Analysis by age and
sex showed that blood viscosity, hematocrit, urinary
fibrinopeptide A, and leukocyte elastase were signifi¬
cantly higher in men (p<0.001), whereas fibrinogen was
higher in women (p<0.001). Fibrinogen increased
markedly with age from 2.52 g/L (SEM, 0.03) in those
aged 55-59 years to 2.90 g/L (SEM 0.04) in those aged
70-74 years (p<0.001). A significant increase with age
also occurred with plasma viscosity (/? <0.001) and
leukocyte elastase (p<0.05). Substantial positive corre¬
lations were present between many of these factors and
also with cigarette consumption (measured by pack-
years). The highest correlations were between hemato¬
crit and blood viscosity (r=0.69), fibrinogen and plasma
viscosity (r=0.46), and blood viscosity and plasma vis¬
cosity (r=0.45).
Table 1 also shows the mean levels of the rheological
factors according to categories of peripheral arterial
disease. Blood viscosity, hematocrit, hematocrit-
corrected blood viscosity, plasma viscosity, fibrinogen.
Table 2. Univariate and Multivariate Regressions of Hemostatic and Rheologicai Variables on Intermittent Claudication and the
Ankle-Brachial Pressure Index
Odds ratio (95% CI) of ABPI coefficient
intermittent claudication differencex 100 (SEMI
Change in risk factor Univariate Multivariate Univariate Multivariate
Age (+10 years) 1.90 (1.09. 3.28)t 2.20(1.06. 4.58)t -5.3 (0.9)§ -4.7 ■ 0.9)§
Female (vs. male) 1.12 (0.61.2.05) 0.79 (0.26. 2.45) 4.9 (0.9)§ 6.8 11-5)8
Height (+ 10 cm) 0.75 (0.54, 1.05)* 0.57 (0.33. 1.00)+ 3.3 (0.5)§ 1.3 (0.7)*
Blood viscosity ( + 1 mPa) 2.06(1.24,3.44)$ 1.40(0.59.3.33) -3.0 (0.9)§ -2.7 11-3)+
Hematocrit (+ 10%) 3.41 (1.29, 9.04)t 1.86(0.46. 7.55) -2.1 (1.4) -0.8 .1.9)
Plasma viscosity (+0.1 mPa) 1.36(1.07, 1.74)$ 1.18(0.5". 1.78) -2.8 (0.6)§ 0.7 0.7)
Fibrinogen (+0.1 g/L) 1.67(1.05, 2.65)+ 1.01 (0.5". 1.80) -0.6 (0.1)§ -0.3 •0.1)$
Urinary fibrinopeptide A (>1 ng/mL) 1.05 (0.51.2.19) 0.87 (0.40. 1.88) -0.2 (1.0) -0.2 0.9)
Uric acid ( + 10 /rmol/L) 1.21 (0.77. 1.90) 0.93 (0.55. 1.56) -0.03 (0.07) -0.08 ,0.07)
Leukocyte elastase ( + 1 ng/mL) 1.61 (0.97. 2.67)* 1.42 (0.82. 2.45) -1.8 (0.8)+ -1.5 0.8)*
Current cigarette smoker 2.39(1.30, 4.42)$ 1.06 (0.40. 2.76) -7.7 (1.1)8 -3.5 ' L4)$
Ex-smoker <5 years 4.29(1.99, 9.22)§ 2.42 (0.75. 7.89)* -6.2 (2.1)$ -4.6 ■:-i)+
V- Pack-years ( +1) 1.32(1.19, 1.47)§ 1.29(1.10. 1.52)§ -1.4 (0.2)§ -1.06 <0-2)8
ABPI. ankle-brachial pressure index.
*p<0.1, +p<0.05, $/><0.01, §p<0.001.
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leukocyte elastase, and uric acid were each related
significantly to the severity of the disease. Urinary fibri-
nopeptide A levels were higher in claudicants than in the
other groups, but there was no significant trend across all
categories of peripheral arterial disease (p=0.62). Rela¬
tive blood viscosity (a measure of red cell deformabil-
ity)3-25 was unrelated to peripheral arterial disease
0=0.26).
Multiple logistic regression on claudication and mul¬
tiple linear regression on the ABPI are shown in Table
2. Blood viscosity and fibrinogen remained significantly
independently related to the ABPI but not to claudica¬
tion (although this may have been related to the small
number of claudicants). Plasma viscosity was related to
both claudication (p<0.01) and the ABPI (p<0.001) on
univariate analysis, but this disappeared on multivariate
analysis including blood viscosity and fibrinogen. Blood
viscosity and fibrinogen remained significantly associ¬
ated with the ABPI on the inclusion of other vascular
risk factors (diabetes mellitus. cholesterol, HDL choles¬
terol, and triglycerides). Conversely, these vascular risk
factors did not lose their independent relations with the
ABPI on the inclusion of fibrinogen and viscosity.
Analysis of possible interactions among age, sex,
cigarette smoking, fibrinogen, and blood viscosity with
the ABPI showed that the relations between both
fibrinogen and blood viscosity and the ABPI occurred
predominantly in male subjects (p<0.01) and were less
marked and nonsignificant in female subjects. Figure 1
shows that the association between fibrinogen and the
ABPI was strongly related to the amount of cigarette
smoking, with the slope of the graphs increasing at
higher levels of smoking. No interactions were found
among blood viscosity, smoking, and the ABPI.
Multiple logistic regressions of age, sex, height, smok¬
ing, and the rheological factors on separate measures of
ischemic heart disease showed that fibrinogen was as¬
sociated only with a history of heart disease on the
WHO questionnaire (/><0.01). Blood viscosity was not
related to any measure of heart disease, although
plasma viscosity was associated with recall of a physi¬
cian's diagnosis of heart disease (p<0.1). A major
difference from the findings in peripheral arterial dis¬
ease was that uric acid remained independently related
to all measures of heart disease, namely ECG evidence
of ischemia (p<0.001), WHO questionnaire positive for
heart disease (/?<0.01), and recall of physician's diag¬
nosis of heart disease (p<0.1).
To study the possible impact of rheological factors on
ischemic symptoms and on reaction to vascular stress in
the presence of a given degree of arterial narrowing,
multiple logistic regressions were carried out separately
on intermittent claudication and the reactive hyperemia
test, with the inclusion of the ABPI as a measure of
arterial narrowing. Plasma viscosity was the only factor
that was independently related to claudication after
adjustment for the ABPI: Figure 2 shows that the odds
of having claudication in the top quintile of plasma
viscosity were 3.35 times that in the bottom quintile
(95% CI, 1.32, 8.51). Leukocyte elastase and uric acid
were the only factors associated with the results of the
reactive hyperemia test independently of the ABPI and
other factors (p<0.01).
Discussion
Blood rheological factors (viscosity, hematocrit, fibrin¬
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FIGURE 2. Graph ofodds ratios of intermittent
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FIGURE 1. Graph of regression of fibrinogen on ante¬
brachial pressure index (APBI) at different levels of lifetime
cigarette consumption.
Lowe et al Viscosity and Fibrinogen in Peripheral Arterial Disease 1919
promoting atherosclerosis, thrombosis, or obstruction to
microcirculatory flow distal to atherosclerotic stenoses.2-3
The results of our study support the hypothesis that
rheological factors are related in an older population
aged 55-74 years to both atherosclerotic peripheral
arterial disease (measured by the ABPI) and to leg
ischemia (measured by the presence of intermittent
claudication on questionnaire or an abnormal reactive
hyperemia test).
Blood viscosity and its major determinants (hemato¬
crit, plasma viscosity, and fibrinogen) as well as leuko¬
cyte activation (plasma leukocyte elastase) were found
to be significantly related to increasing severity of
peripheral arterial disease within the population (Ta¬
bles 1 and 2). No such relation was evident for activation
of blood coagulation (urinary fibrinopeptide A), but this
may have been related to insensitivity of the assay
because 38% of the population had levels <1 ng/mL.
Indeed, plasma fibrinopeptide A levels have been re¬
lated to several major cardiovascular risk factors22 as
well as to angiographic coronary artery disease29 and
peripheral arterial disease.4
In the Edinburgh Artery Study, peripheral arterial
disease has been related to conventional risk factors
such as age, cigarette smoking, systolic blood pressure,
and HDL and non-HDL cholesterol.13 Several Theolog¬
ical factors were also associated with these risk factors,
particularly age and cigarette smoking, as previously
reported.2-323 On multivariate analyses including age,
sex, and cigarette smoking, the associations between the
Theological factors and intermittent claudication be¬
came nonsignificant (Table 2). However, this finding
may be related to the small number of claudicants and
does not exclude the possibility that increases in viscos¬
ity, fibrinogen, and leukocyte activation may be mech¬
anisms whereby age and smoking promote development
of peripheral arterial disease.
Are Theological factors related to the extent of ath¬
erosclerotic narrowing in the arteries to the lower
limbs? The latter was assessed using the ABPI. which at
a level of 0.9 has been shown to be up to 95% sensitive
in detecting angiogram positive peripheral arterial dis¬
ease30 and in the Edinburgh Artery Study has been
shown to be related to the severity of disease on duplex
scanning.31 The ABPI was significantly associated with
blood viscosity, plasma viscosity, and fibrinogen, and
the relations with blood viscosity and fibrinogen per¬
sisted after multivariate analysis including conventional
risk factors (Table 2). These findings suggest that blood
viscosity and fibrinogen each may have an independent
role in atherogenesis. Several biologically plausible
mechanisms have been suggested, including an effect of
blood viscosity on the localization of atherosclerotic
lesions.2-3 Fibrinogen levels may influence infiltration of
fibrinogen into the arterial wall, platelet aggregation,
and fibrin formation as well as increasing plasma and
blood viscosity.2-3 Interestingly, the association between
fibrinogen and the ABPI was strongly related to the
amount of cigarette smoking (Figure 1). Possible expla¬
nations include a synergistic effect of smoking (which
disturbs endothelial cells and activates platelets) and
fibrinogen (which infiltrates the arterial wall through
damaged endothelium and promotes platelet aggrega¬
tion).2-3 An interaction between cigarette smoking and
plasma fibrinogen has also been reported in the predic¬
tion of occlusion of femoropopliteal grafts in peripheral
arterial disease.32
In the presence of a given degree of atherosclerotic
narrowing (ABPI), do Theological factors predispose to
leg ischemia? If blood viscosity is reduced by lowering
the hematocrit, blood flow in the leg increases,33 but this
may reflect vasodilation caused by changes in oxygen
carriage and blood volume rather than blood viscosity.34
However, lowering plasma fibrinogen also reduces
plasma and blood viscosity and increases leg blood flow,
including nutritive skin flow,35 and this cannot be as¬
cribed to changes in oxygen carriage or blood volume.
The importance of plasma viscosity has been shown in
the present study, in which higher levels significantly
increased the likelihood of symptomatic intermittent
claudication at a given level of arterial narrowing (Fig¬
ure 2). It is likely that this association reflects a direct
effect of plasma viscosity on leg muscle blood flow distal
to arterial stenosis, not only from theoretical consider¬
ations36 but also because reductions in plasma viscosity
after exercise training,37 cessation of cigarette smok¬
ing,22-38 or treatment with some pharmacological
agents39 are accompanied by improvements in claudica¬
tion that are quite consistent with the relation shown in
Figure 2. Indeed, the relation shown in Figure 2 be¬
tween plasma viscosity in the population and prevalent
symptomatic leg ischemia is very similar to the recently
described relation between plasma viscosity in the male
population and incident coronary heart disease.40 It is
therefore possible that plasma viscosity may also pro¬
mote myocardial ischemia distal to coronary arterial
stenoses, although measurement of the latter in popu¬
lation studies is more problematical than measurement
of lower limb arterial stenoses using the ABPI.
We have also shown that leukocyte elastase was
related to leg ischemia as measured by the reactive
hyperemia test. Again, it is possible that this is a direct
effect: Elastase release is a measure of leukocyte acti¬
vation, which is also associated with production of
oxygen metabolites that cause skeletal muscle vasodila¬
tation.41 Uric acid was also related to leg ischemia as
measured by the reactive hyperemia test as well as to
ischemic heart disease. Because of the importance of
the uric acid/xanthine oxidase pathway in reactive oxy¬
gen metabolism, these associations may also be relevant
to oxygen metabolite-related ischemia. Leukocyte acti¬
vation may play a role in atherosclerosis and thrombosis
as well as in ischemia.3-42 However, an overall interpre¬
tation of the findings of the present study is that, in the
presence of a given degree of arterial narrowing, deter¬
minants of microcirculatory blood flow (plasma viscos¬
ity, leukocyte activation) may be important determi¬
nants of leg ischemia.2-3 Conversely, reduction of plasma
viscosity (for example, by reduction of plasma fibrino¬
gen or lipoproteins) and inhibition of leukocyte activa¬
tion may be rational approaches to prevention and
treatment of ischemia.39
Conclusions
Our findings suggest that rheological factors are
associated with both the severity of atherosclerosis in
the older population and with the presence of leg
ischemia for a given degree of arterial occlusion. We are
currently assessing the predictive value of rheological
factors for arterial events in the limbs, heart, and brain
1920 Circulation Vol 87, No 6 June 1993
in both this and other cohorts as well as the effects of
interventions on blood rheology and prognosis in pe¬
ripheral arterial disease.
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